AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|RACE|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-14|3.4|3.7|3.6|1946|Incidence|54370170|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|3.5|3.8|3.7|1995|Incidence|54640710|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|3.7|4.0|3.8|2164|Incidence|57196067|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|3.5|3.8|3.6|2065|Incidence|57215071|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|3.4|3.7|3.6|2109|Incidence|59503617|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|3.6|3.8|3.7|11020|Incidence|294993192|All Races|Male and Female|Acute Lymphocytic|2003-2007|||
0-14|3.6|4.0|3.8|2310|Incidence|60736931|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|3.5|3.8|3.7|2237|Incidence|60630500|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|3.6|3.9|3.8|2310|Incidence|60652932|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|3.6|3.9|3.8|2317|Incidence|60306965|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|0.6|0.8|0.7|372|Incidence|54370170|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.5|0.7|0.6|322|Incidence|54640710|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.6|0.7|0.7|383|Incidence|57196067|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.6|0.7|0.7|387|Incidence|57215071|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.6|0.7|0.6|385|Incidence|59503617|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.6|0.7|0.7|1965|Incidence|294993192|All Races|Male and Female|Acute Myeloid|2003-2007|||
0-14|0.6|0.8|0.7|425|Incidence|60736931|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.6|0.7|0.6|388|Incidence|60630500|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.6|0.7|0.7|410|Incidence|60652932|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.6|0.7|0.6|394|Incidence|60306965|All Races|Male and Female|Acute Myeloid|2007|||
0-14|14.2|14.9|14.6|7899|Incidence|54370170|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|14.5|15.2|14.9|8100|Incidence|54640710|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|15.2|15.9|15.5|8876|Incidence|57196067|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|15.1|15.7|15.4|8816|Incidence|57215071|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|14.8|15.4|15.1|9011|Incidence|59503617|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|15.3|15.6|15.4|45861|Incidence|294993192|All Races|Male and Female|All Cancer Sites Combined|2003-2007|||
0-14|15.5|16.1|15.8|9649|Incidence|60736931|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|15.0|15.6|15.3|9337|Incidence|60630500|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|15.1|15.7|15.4|9440|Incidence|60652932|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|15.2|15.8|15.5|9478|Incidence|60306965|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|0.7|0.8|0.7|403|Incidence|54370170|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.6|0.8|0.7|374|Incidence|54640710|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.6|0.8|0.7|409|Incidence|57196067|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.7|0.8|0.7|414|Incidence|57215071|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.6|0.8|0.7|422|Incidence|59503617|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.7|0.7|0.7|2083|Incidence|294993192|All Races|Male and Female|Bones and Joints|2003-2007|||
0-14|0.7|0.8|0.7|450|Incidence|60736931|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.6|0.8|0.7|417|Incidence|60630500|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.7|0.8|0.7|435|Incidence|60652932|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.6|0.8|0.7|413|Incidence|60306965|All Races|Male and Female|Bones and Joints|2007|||
0-14|3.1|3.4|3.2|1747|Incidence|54370170|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|3.2|3.5|3.4|1836|Incidence|54640710|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|3.1|3.4|3.3|1881|Incidence|57196067|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|3.3|3.6|3.5|1981|Incidence|57215071|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|3.2|3.5|3.3|1965|Incidence|59503617|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|3.3|3.4|3.4|9942|Incidence|294993192|All Races|Male and Female|Brain and Other Nervous System|2003-2007|||
0-14|3.3|3.6|3.5|2118|Incidence|60736931|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|3.1|3.4|3.2|1974|Incidence|60630500|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|3.2|3.5|3.3|2020|Incidence|60652932|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|3.3|3.6|3.4|2063|Incidence|60306965|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|0.5|0.6|0.5|297|Incidence|54370170|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|0.5|0.7|0.6|325|Incidence|54640710|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|0.5|0.7|0.6|338|Incidence|57196067|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|0.5|0.6|0.5|310|Incidence|57215071|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|0.5|0.6|0.6|350|Incidence|59503617|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|0.5|0.6|0.6|1691|Incidence|294993192|All Races|Male and Female|Hodgkin Lymphoma|2003-2007|||
0-14|0.5|0.6|0.5|326|Incidence|60736931|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|0.5|0.7|0.6|362|Incidence|60630500|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|0.6|0.7|0.6|371|Incidence|60652932|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|0.5|0.6|0.5|319|Incidence|60306965|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|0.8|0.9|0.8|451|Incidence|54370170|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.8|1.0|0.9|484|Incidence|54640710|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.8|1.0|0.9|501|Incidence|57196067|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.8|0.9|0.8|483|Incidence|57215071|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.8|0.9|0.9|516|Incidence|59503617|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.8|0.9|0.8|2527|Incidence|294993192|All Races|Male and Female|Kidney and Renal Pelvis|2003-2007|||
0-14|0.8|0.9|0.8|507|Incidence|60736931|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.8|0.9|0.8|513|Incidence|60630500|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.8|0.9|0.8|518|Incidence|60652932|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.8|0.9|0.9|528|Incidence|60306965|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|4.4|4.8|4.6|2490|Incidence|54370170|All Races|Male and Female|Leukemia|1999|||
0-14|4.4|4.8|4.6|2500|Incidence|54640710|All Races|Male and Female|Leukemia|2000|||
0-14|4.7|5.0|4.9|2765|Incidence|57196067|All Races|Male and Female|Leukemia|2001|||
0-14|4.5|4.9|4.7|2693|Incidence|57215071|All Races|Male and Female|Leukemia|2002|||
0-14|4.4|4.7|4.5|2692|Incidence|59503617|All Races|Male and Female|Leukemia|2003|||
0-14|4.7|4.8|4.7|14083|Incidence|294993192|All Races|Male and Female|Leukemia|2003-2007|||
0-14|4.7|5.1|4.9|2975|Incidence|60736931|All Races|Male and Female|Leukemia|2004|||
0-14|4.5|4.8|4.7|2861|Incidence|60630500|All Races|Male and Female|Leukemia|2005|||
0-14|4.6|5.0|4.8|2946|Incidence|60652932|All Races|Male and Female|Leukemia|2006|||
0-14|4.6|5.0|4.8|2932|Incidence|60306965|All Races|Male and Female|Leukemia|2007|||
0-14|0.8|1.0|0.9|482|Incidence|54370170|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.8|1.0|0.9|505|Incidence|54640710|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.8|1.0|0.9|519|Incidence|57196067|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.8|1.0|0.9|519|Incidence|57215071|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.8|1.0|0.9|529|Incidence|59503617|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.9|1.0|0.9|2721|Incidence|294993192|All Races|Male and Female|Non-Hodgkin Lymphoma|2003-2007|||
0-14|0.9|1.0|0.9|574|Incidence|60736931|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.8|1.0|0.9|549|Incidence|60630500|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.8|1.0|0.9|541|Incidence|60652932|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.9|1.1|1.0|584|Incidence|60306965|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|2.8|3.1|2.9|1574|Incidence|54370170|All Races|Male and Female|Other|1999|||
0-14|2.7|3.0|2.9|1560|Incidence|54640710|All Races|Male and Female|Other|2000|||
0-14|3.2|3.5|3.3|1903|Incidence|57196067|All Races|Male and Female|Other|2001|||
0-14|3.0|3.3|3.2|1835|Incidence|57215071|All Races|Male and Female|Other|2002|||
0-14|3.1|3.4|3.3|1967|Incidence|59503617|All Races|Male and Female|Other|2003|||
0-14|3.2|3.4|3.3|9896|Incidence|294993192|All Races|Male and Female|Other|2003-2007|||
0-14|3.2|3.5|3.4|2095|Incidence|60736931|All Races|Male and Female|Other|2004|||
0-14|3.2|3.5|3.3|2052|Incidence|60630500|All Races|Male and Female|Other|2005|||
0-14|3.1|3.4|3.3|2017|Incidence|60652932|All Races|Male and Female|Other|2006|||
0-14|3.1|3.4|3.3|2027|Incidence|60306965|All Races|Male and Female|Other|2007|||
0-14|0.8|0.9|0.8|455|Incidence|54370170|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.9|1.0|0.9|516|Incidence|54640710|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.9|1.1|1.0|560|Incidence|57196067|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.9|1.1|1.0|581|Incidence|57215071|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.9|1.0|0.9|570|Incidence|59503617|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.9|1.0|1.0|2918|Incidence|294993192|All Races|Male and Female|Soft Tissue|2003-2007|||
0-14|0.9|1.1|1.0|604|Incidence|60736931|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.9|1.1|1.0|609|Incidence|60630500|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.9|1.0|1.0|592|Incidence|60652932|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.9|1.1|1.0|612|Incidence|60306965|All Races|Male and Female|Soft Tissue|2007|||
0-14|0.3|0.4|0.3|194|Mortality|59955368|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|0.3|0.4|0.4|234|Mortality|60280093|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|0.3|0.4|0.3|208|Mortality|60465841|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|0.3|0.4|0.4|217|Mortality|60596958|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|0.4|0.5|0.4|246|Mortality|60686212|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|0.3|0.4|0.3|1022|Mortality|303565633|All Races|Male and Female|Acute Lymphocytic|2003-2007|||
0-14|0.3|0.4|0.3|202|Mortality|60736931|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|0.3|0.4|0.3|188|Mortality|60630500|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|0.2|0.3|0.3|174|Mortality|60652932|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|0.3|0.4|0.4|212|Mortality|60859058|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|0.2|0.3|0.2|141|Mortality|59955368|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.2|0.3|0.2|145|Mortality|60280093|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.2|0.3|0.3|157|Mortality|60465841|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.2|0.3|0.2|131|Mortality|60596958|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.2|0.3|0.2|142|Mortality|60686212|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.2|0.2|0.2|679|Mortality|303565633|All Races|Male and Female|Acute Myeloid|2003-2007|||
0-14|0.2|0.3|0.2|147|Mortality|60736931|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.2|0.3|0.2|137|Mortality|60630500|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.2|0.2|0.2|124|Mortality|60652932|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.2|0.3|0.2|129|Mortality|60859058|All Races|Male and Female|Acute Myeloid|2007|||
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|2.4|2.7|2.5|1526|Mortality|60280093|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|2.3|2.6|2.5|1494|Mortality|60465841|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|2.4|2.7|2.6|1548|Mortality|60596958|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|2.4|2.7|2.5|1543|Mortality|60686212|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|2.3|2.4|2.4|7242|Mortality|303565633|All Races|Male and Female|All Cancer Sites Combined|2003-2007|||
0-14|2.3|2.6|2.5|1492|Mortality|60736931|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|2.3|2.5|2.4|1452|Mortality|60630500|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|2.1|2.4|2.2|1360|Mortality|60652932|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|2.2|2.4|2.3|1395|Mortality|60859058|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|0.1|0.2|0.1|82|Mortality|59955368|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.1|0.2|0.1|83|Mortality|60280093|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.1|0.2|0.1|88|Mortality|60465841|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.1|0.2|0.1|85|Mortality|60596958|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.1|0.2|0.1|82|Mortality|60686212|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.1|0.1|0.1|365|Mortality|303565633|All Races|Male and Female|Bones and Joints|2003-2007|||
0-14|0.1|0.2|0.1|75|Mortality|60736931|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.1|0.2|0.1|88|Mortality|60630500|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.1|0.1|0.1|59|Mortality|60652932|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.1|0.1|0.1|61|Mortality|60859058|All Races|Male and Female|Bones and Joints|2007|||
0-14|0.7|0.8|0.7|431|Mortality|59955368|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|0.7|0.8|0.7|440|Mortality|60280093|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|0.6|0.8|0.7|416|Mortality|60465841|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|0.7|0.8|0.8|463|Mortality|60596958|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|0.7|0.8|0.8|458|Mortality|60686212|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|0.7|0.8|0.7|2178|Mortality|303565633|All Races|Male and Female|Brain and Other Nervous System|2003-2007|||
0-14|0.7|0.8|0.7|446|Mortality|60736931|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|0.6|0.8|0.7|426|Mortality|60630500|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|0.6|0.8|0.7|422|Mortality|60652932|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|0.6|0.8|0.7|426|Mortality|60859058|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|~|~|~|~|Mortality|59955368|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|~|~|~|~|Mortality|60280093|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|~|~|~|~|Mortality|60465841|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|~|~|~|~|Mortality|60596958|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|~|~|~|~|Mortality|60686212|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|0.0|0.0|0.0|30|Mortality|303565633|All Races|Male and Female|Hodgkin Lymphoma|2003-2007|||
0-14|~|~|~|~|Mortality|60736931|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|~|~|~|~|Mortality|60630500|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|~|~|~|~|Mortality|60652932|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|~|~|~|~|Mortality|60859058|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|0.1|0.1|0.1|54|Mortality|59955368|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.1|0.1|0.1|46|Mortality|60280093|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.1|0.1|0.1|58|Mortality|60465841|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.1|0.1|0.1|42|Mortality|60596958|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.1|0.1|0.1|54|Mortality|60686212|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.1|0.1|0.1|238|Mortality|303565633|All Races|Male and Female|Kidney and Renal Pelvis|2003-2007|||
0-14|0.1|0.1|0.1|51|Mortality|60736931|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.1|0.1|0.1|54|Mortality|60630500|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.1|0.1|0.1|43|Mortality|60652932|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.0|0.1|0.1|36|Mortality|60859058|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|0.7|0.8|0.8|451|Mortality|59955368|All Races|Male and Female|Leukemia|1999|||
0-14|0.7|0.9|0.8|490|Mortality|60280093|All Races|Male and Female|Leukemia|2000|||
0-14|0.8|0.9|0.8|503|Mortality|60465841|All Races|Male and Female|Leukemia|2001|||
0-14|0.7|0.8|0.7|441|Mortality|60596958|All Races|Male and Female|Leukemia|2002|||
0-14|0.8|0.9|0.8|505|Mortality|60686212|All Races|Male and Female|Leukemia|2003|||
0-14|0.7|0.8|0.7|2229|Mortality|303565633|All Races|Male and Female|Leukemia|2003-2007|||
0-14|0.7|0.8|0.8|455|Mortality|60736931|All Races|Male and Female|Leukemia|2004|||
0-14|0.6|0.8|0.7|417|Mortality|60630500|All Races|Male and Female|Leukemia|2005|||
0-14|0.6|0.7|0.7|411|Mortality|60652932|All Races|Male and Female|Leukemia|2006|||
0-14|0.7|0.8|0.7|441|Mortality|60859058|All Races|Male and Female|Leukemia|2007|||
0-14|0.1|0.1|0.1|55|Mortality|59955368|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.1|0.1|0.1|55|Mortality|60280093|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.0|0.1|0.1|40|Mortality|60465841|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.1|0.2|0.1|74|Mortality|60596958|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.1|0.1|0.1|50|Mortality|60686212|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.1|0.1|0.1|233|Mortality|303565633|All Races|Male and Female|Non-Hodgkin Lymphoma|2003-2007|||
0-14|0.1|0.1|0.1|44|Mortality|60736931|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.1|0.1|0.1|55|Mortality|60630500|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.1|0.1|0.1|44|Mortality|60652932|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.0|0.1|0.1|40|Mortality|60859058|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|0.5|0.6|0.5|328|Mortality|59955368|All Races|Male and Female|Other|1999|||
0-14|0.5|0.6|0.6|333|Mortality|60280093|All Races|Male and Female|Other|2000|||
0-14|0.4|0.6|0.5|297|Mortality|60465841|All Races|Male and Female|Other|2001|||
0-14|0.5|0.6|0.6|342|Mortality|60596958|All Races|Male and Female|Other|2002|||
0-14|0.5|0.6|0.5|311|Mortality|60686212|All Races|Male and Female|Other|2003|||
0-14|0.5|0.5|0.5|1548|Mortality|303565633|All Races|Male and Female|Other|2003-2007|||
0-14|0.5|0.6|0.5|317|Mortality|60736931|All Races|Male and Female|Other|2004|||
0-14|0.5|0.6|0.5|318|Mortality|60630500|All Races|Male and Female|Other|2005|||
0-14|0.4|0.5|0.5|296|Mortality|60652932|All Races|Male and Female|Other|2006|||
0-14|0.4|0.6|0.5|306|Mortality|60859058|All Races|Male and Female|Other|2007|||
0-14|0.1|0.2|0.1|87|Mortality|59955368|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.1|0.1|0.1|71|Mortality|60280093|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.1|0.2|0.1|86|Mortality|60465841|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.1|0.2|0.2|95|Mortality|60596958|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.1|0.2|0.1|78|Mortality|60686212|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.1|0.2|0.1|421|Mortality|303565633|All Races|Male and Female|Soft Tissue|2003-2007|||
0-14|0.1|0.2|0.2|98|Mortality|60736931|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.1|0.2|0.1|83|Mortality|60630500|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.1|0.2|0.1|80|Mortality|60652932|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.1|0.2|0.1|82|Mortality|60859058|All Races|Male and Female|Soft Tissue|2007|||
0-19|2.5|2.8|2.7|938|Incidence|35359689|All Races|Female|Acute Lymphocytic|1999|2.5|2.8|2.7
0-19|2.7|3.0|2.8|1009|Incidence|35570416|All Races|Female|Acute Lymphocytic|2000|2.7|3.0|2.8
0-19|2.8|3.1|2.9|1089|Incidence|37225915|All Races|Female|Acute Lymphocytic|2001|2.8|3.1|2.9
0-19|2.6|2.9|2.7|1014|Incidence|37250070|All Races|Female|Acute Lymphocytic|2002|2.6|2.9|2.7
0-19|2.5|2.9|2.7|1042|Incidence|38811900|All Races|Female|Acute Lymphocytic|2003|2.5|2.9|2.7
0-19|2.7|2.8|2.8|5380|Incidence|193784328|All Races|Female|Acute Lymphocytic|2003-2007|2.7|2.9|2.8
0-19|2.6|2.9|2.8|1094|Incidence|39727610|All Races|Female|Acute Lymphocytic|2004|2.6|2.9|2.8
0-19|2.6|2.9|2.7|1095|Incidence|39837382|All Races|Female|Acute Lymphocytic|2005|2.6|2.9|2.7
0-19|2.6|3.0|2.8|1127|Incidence|39976439|All Races|Female|Acute Lymphocytic|2006|2.7|3.0|2.8
0-19|2.7|3.0|2.9|1152|Incidence|39830901|All Races|Female|Acute Lymphocytic|2007|2.7|3.1|2.9
0-19|0.6|0.8|0.7|240|Incidence|35359689|All Races|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.6|224|Incidence|35570416|All Races|Female|Acute Myeloid|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.7|246|Incidence|37225915|All Races|Female|Acute Myeloid|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|252|Incidence|37250070|All Races|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|244|Incidence|38811900|All Races|Female|Acute Myeloid|2003|0.6|0.7|0.6
0-19|0.6|0.7|0.6|1267|Incidence|193784328|All Races|Female|Acute Myeloid|2003-2007|0.6|0.7|0.7
0-19|0.5|0.7|0.6|242|Incidence|39727610|All Races|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|261|Incidence|39837382|All Races|Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|285|Incidence|39976439|All Races|Female|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.7|0.7|263|Incidence|39830901|All Races|Female|Acute Myeloid|2007|0.6|0.7|0.7
0-19|14.4|15.3|14.8|5236|Incidence|35359689|All Races|Female|All Cancer Sites Combined|1999|14.4|15.2|14.8
0-19|15.0|15.8|15.4|5459|Incidence|35570416|All Races|Female|All Cancer Sites Combined|2000|14.9|15.8|15.3
0-19|15.7|16.6|16.1|6005|Incidence|37225915|All Races|Female|All Cancer Sites Combined|2001|15.7|16.5|16.1
0-19|15.3|16.1|15.7|5842|Incidence|37250070|All Races|Female|All Cancer Sites Combined|2002|15.3|16.1|15.7
0-19|15.7|16.5|16.1|6264|Incidence|38811900|All Races|Female|All Cancer Sites Combined|2003|15.7|16.5|16.1
0-19|16.0|16.3|16.1|31518|Incidence|193784328|All Races|Female|All Cancer Sites Combined|2003-2007|16.1|16.4|16.3
0-19|15.9|16.7|16.3|6512|Incidence|39727610|All Races|Female|All Cancer Sites Combined|2004|16.0|16.8|16.4
0-19|15.8|16.6|16.2|6495|Incidence|39837382|All Races|Female|All Cancer Sites Combined|2005|15.9|16.7|16.3
0-19|15.4|16.2|15.8|6392|Incidence|39976439|All Races|Female|All Cancer Sites Combined|2006|15.6|16.4|16.0
0-19|15.8|16.6|16.2|6541|Incidence|39830901|All Races|Female|All Cancer Sites Combined|2007|16.0|16.8|16.4
0-19|0.7|0.9|0.8|276|Incidence|35359689|All Races|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|283|Incidence|35570416|All Races|Female|Bones and Joints|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|308|Incidence|37225915|All Races|Female|Bones and Joints|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|290|Incidence|37250070|All Races|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|0.9|0.9|332|Incidence|38811900|All Races|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1591|Incidence|193784328|All Races|Female|Bones and Joints|2003-2007|0.8|0.9|0.8
0-19|0.8|1.0|0.9|352|Incidence|39727610|All Races|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|0.9|0.8|319|Incidence|39837382|All Races|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|323|Incidence|39976439|All Races|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.8|0.8|300|Incidence|39830901|All Races|Female|Bones and Joints|2007|0.7|0.8|0.8
0-19|2.6|2.9|2.7|965|Incidence|35359689|All Races|Female|Brain and Other Nervous System|1999|2.6|2.9|2.7
0-19|2.6|3.0|2.8|998|Incidence|35570416|All Races|Female|Brain and Other Nervous System|2000|2.6|3.0|2.8
0-19|2.7|3.0|2.8|1056|Incidence|37225915|All Races|Female|Brain and Other Nervous System|2001|2.7|3.0|2.8
0-19|2.6|3.0|2.8|1033|Incidence|37250070|All Races|Female|Brain and Other Nervous System|2002|2.6|2.9|2.8
0-19|2.8|3.1|2.9|1138|Incidence|38811900|All Races|Female|Brain and Other Nervous System|2003|2.8|3.1|2.9
0-19|2.9|3.0|2.9|5709|Incidence|193784328|All Races|Female|Brain and Other Nervous System|2003-2007|2.9|3.0|2.9
0-19|2.9|3.2|3.1|1220|Incidence|39727610|All Races|Female|Brain and Other Nervous System|2004|2.9|3.2|3.1
0-19|2.7|3.0|2.9|1145|Incidence|39837382|All Races|Female|Brain and Other Nervous System|2005|2.7|3.0|2.9
0-19|2.7|3.0|2.8|1128|Incidence|39976439|All Races|Female|Brain and Other Nervous System|2006|2.7|3.0|2.8
0-19|2.8|3.2|3.0|1197|Incidence|39830901|All Races|Female|Brain and Other Nervous System|2007|2.8|3.2|3.0
0-19|1.0|1.2|1.1|375|Incidence|35359689|All Races|Female|Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|429|Incidence|35570416|All Races|Female|Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.3|1.2|449|Incidence|37225915|All Races|Female|Hodgkin Lymphoma|2001|1.1|1.3|1.2
0-19|1.1|1.3|1.2|451|Incidence|37250070|All Races|Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.1|1.3|1.2|452|Incidence|38811900|All Races|Female|Hodgkin Lymphoma|2003|1.1|1.3|1.2
0-19|1.1|1.2|1.2|2295|Incidence|193784328|All Races|Female|Hodgkin Lymphoma|2003-2007|1.1|1.2|1.2
0-19|1.1|1.3|1.2|478|Incidence|39727610|All Races|Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.1|1.3|1.2|486|Incidence|39837382|All Races|Female|Hodgkin Lymphoma|2005|1.1|1.3|1.2
0-19|1.1|1.3|1.2|476|Incidence|39976439|All Races|Female|Hodgkin Lymphoma|2006|1.1|1.3|1.2
0-19|1.0|1.2|1.1|450|Incidence|39830901|All Races|Female|Hodgkin Lymphoma|2007|1.0|1.2|1.1
0-19|0.6|0.8|0.7|252|Incidence|35359689|All Races|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|259|Incidence|35570416|All Races|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|279|Incidence|37225915|All Races|Female|Kidney and Renal Pelvis|2001|0.7|0.8|0.7
0-19|0.6|0.8|0.7|247|Incidence|37250070|All Races|Female|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.7|0.9|0.8|302|Incidence|38811900|All Races|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1425|Incidence|193784328|All Races|Female|Kidney and Renal Pelvis|2003-2007|0.7|0.8|0.7
0-19|0.6|0.8|0.7|270|Incidence|39727610|All Races|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|292|Incidence|39837382|All Races|Female|Kidney and Renal Pelvis|2005|0.7|0.8|0.7
0-19|0.6|0.8|0.7|282|Incidence|39976439|All Races|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|316|Incidence|39830901|All Races|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|3.4|3.8|3.6|1283|Incidence|35359689|All Races|Female|Leukemia|1999|3.4|3.8|3.6
0-19|3.6|4.0|3.8|1344|Incidence|35570416|All Races|Female|Leukemia|2000|3.6|4.0|3.8
0-19|3.8|4.2|4.0|1477|Incidence|37225915|All Races|Female|Leukemia|2001|3.8|4.2|4.0
0-19|3.6|4.0|3.8|1416|Incidence|37250070|All Races|Female|Leukemia|2002|3.6|4.0|3.8
0-19|3.5|3.8|3.6|1412|Incidence|38811900|All Races|Female|Leukemia|2003|3.5|3.8|3.6
0-19|3.7|3.9|3.8|7340|Incidence|193784328|All Races|Female|Leukemia|2003-2007|3.7|3.9|3.8
0-19|3.5|3.9|3.7|1479|Incidence|39727610|All Races|Female|Leukemia|2004|3.5|3.9|3.7
0-19|3.6|3.9|3.7|1500|Incidence|39837382|All Races|Female|Leukemia|2005|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1560|Incidence|39976439|All Races|Female|Leukemia|2006|3.7|4.1|3.9
0-19|3.7|4.1|3.9|1562|Incidence|39830901|All Races|Female|Leukemia|2007|3.7|4.1|3.9
0-19|0.6|0.8|0.7|250|Incidence|35359689|All Races|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|274|Incidence|35570416|All Races|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|296|Incidence|37225915|All Races|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|295|Incidence|37250070|All Races|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|284|Incidence|38811900|All Races|Female|Non-Hodgkin Lymphoma|2003|0.6|0.8|0.7
0-19|0.7|0.8|0.8|1499|Incidence|193784328|All Races|Female|Non-Hodgkin Lymphoma|2003-2007|0.7|0.8|0.8
0-19|0.7|0.9|0.8|315|Incidence|39727610|All Races|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|314|Incidence|39837382|All Races|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.7|297|Incidence|39976439|All Races|Female|Non-Hodgkin Lymphoma|2006|0.7|0.8|0.7
0-19|0.7|0.9|0.8|313|Incidence|39830901|All Races|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|4.1|4.6|4.3|1522|Incidence|35359689|All Races|Female|Other|1999|4.1|4.5|4.3
0-19|4.1|4.5|4.3|1523|Incidence|35570416|All Races|Female|Other|2000|4.1|4.5|4.3
0-19|4.5|5.0|4.7|1769|Incidence|37225915|All Races|Female|Other|2001|4.5|5.0|4.8
0-19|4.5|4.9|4.7|1746|Incidence|37250070|All Races|Female|Other|2002|4.5|4.9|4.7
0-19|4.8|5.2|5.0|1946|Incidence|38811900|All Races|Female|Other|2003|4.8|5.2|5.0
0-19|4.8|5.0|4.9|9649|Incidence|193784328|All Races|Female|Other|2003-2007|4.9|5.1|5.0
0-19|4.7|5.1|4.9|1974|Incidence|39727610|All Races|Female|Other|2004|4.8|5.2|5.0
0-19|4.9|5.3|5.1|2049|Incidence|39837382|All Races|Female|Other|2005|4.9|5.4|5.1
0-19|4.5|5.0|4.7|1929|Incidence|39976439|All Races|Female|Other|2006|4.6|5.0|4.8
0-19|4.6|5.0|4.8|1961|Incidence|39830901|All Races|Female|Other|2007|4.7|5.1|4.9
0-19|0.8|1.0|0.9|313|Incidence|35359689|All Races|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|349|Incidence|35570416|All Races|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|371|Incidence|37225915|All Races|Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|364|Incidence|37250070|All Races|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|0.9|1.1|1.0|398|Incidence|38811900|All Races|Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.1|1.0|2010|Incidence|193784328|All Races|Female|Soft Tissue|2003-2007|1.0|1.1|1.0
0-19|1.0|1.2|1.1|424|Incidence|39727610|All Races|Female|Soft Tissue|2004|1.0|1.2|1.1
0-19|0.9|1.1|1.0|390|Incidence|39837382|All Races|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|397|Incidence|39976439|All Races|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|442|Incidence|39830901|All Races|Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|3.2|3.6|3.4|1260|Incidence|37188457|All Races|Male|Acute Lymphocytic|1999|3.2|3.6|3.4
0-19|3.2|3.6|3.4|1278|Incidence|37412192|All Races|Male|Acute Lymphocytic|2000|3.2|3.6|3.4
0-19|3.4|3.7|3.5|1378|Incidence|39161547|All Races|Male|Acute Lymphocytic|2001|3.3|3.7|3.5
0-19|3.3|3.7|3.5|1361|Incidence|39168369|All Races|Male|Acute Lymphocytic|2002|3.3|3.7|3.5
0-19|3.2|3.5|3.3|1359|Incidence|40753348|All Races|Male|Acute Lymphocytic|2003|3.2|3.5|3.3
0-19|3.5|3.6|3.6|7257|Incidence|203288185|All Races|Male|Acute Lymphocytic|2003-2007|3.5|3.7|3.6
0-19|3.5|3.9|3.7|1551|Incidence|41686807|All Races|Male|Acute Lymphocytic|2004|3.5|3.9|3.7
0-19|3.3|3.7|3.5|1468|Incidence|41786904|All Races|Male|Acute Lymphocytic|2005|3.3|3.7|3.5
0-19|3.5|3.8|3.6|1532|Incidence|41922622|All Races|Male|Acute Lymphocytic|2006|3.5|3.8|3.7
0-19|3.4|3.8|3.6|1520|Incidence|41760052|All Races|Male|Acute Lymphocytic|2007|3.5|3.8|3.6
0-19|0.7|0.9|0.8|291|Incidence|37188457|All Races|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|251|Incidence|37412192|All Races|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.7|294|Incidence|39161547|All Races|Male|Acute Myeloid|2001|0.7|0.8|0.8
0-19|0.7|0.8|0.8|298|Incidence|39168369|All Races|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|301|Incidence|40753348|All Races|Male|Acute Myeloid|2003|0.7|0.8|0.7
0-19|0.7|0.8|0.7|1503|Incidence|203288185|All Races|Male|Acute Myeloid|2003-2007|0.7|0.8|0.7
0-19|0.8|0.9|0.9|359|Incidence|41686807|All Races|Male|Acute Myeloid|2004|0.8|1.0|0.9
0-19|0.6|0.7|0.7|279|Incidence|41786904|All Races|Male|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|297|Incidence|41922622|All Races|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|293|Incidence|41760052|All Races|Male|Acute Myeloid|2007|0.6|0.8|0.7
0-19|16.4|17.3|16.8|6254|Incidence|37188457|All Races|Male|All Cancer Sites Combined|1999|16.4|17.2|16.8
0-19|16.7|17.6|17.1|6403|Incidence|37412192|All Races|Male|All Cancer Sites Combined|2000|16.7|17.5|17.1
0-19|17.3|18.1|17.7|6940|Incidence|39161547|All Races|Male|All Cancer Sites Combined|2001|17.3|18.1|17.7
0-19|17.8|18.6|18.2|7122|Incidence|39168369|All Races|Male|All Cancer Sites Combined|2002|17.8|18.6|18.2
0-19|16.8|17.6|17.2|7044|Incidence|40753348|All Races|Male|All Cancer Sites Combined|2003|16.9|17.7|17.3
0-19|17.7|18.1|17.9|36609|Incidence|203288185|All Races|Male|All Cancer Sites Combined|2003-2007|17.8|18.2|18.0
0-19|17.8|18.7|18.2|7642|Incidence|41686807|All Races|Male|All Cancer Sites Combined|2004|17.9|18.7|18.3
0-19|17.4|18.3|17.8|7516|Incidence|41786904|All Races|Male|All Cancer Sites Combined|2005|17.6|18.4|18.0
0-19|17.6|18.4|18.0|7628|Incidence|41922622|All Races|Male|All Cancer Sites Combined|2006|17.8|18.6|18.2
0-19|17.5|18.4|17.9|7578|Incidence|41760052|All Races|Male|All Cancer Sites Combined|2007|17.7|18.6|18.1
0-19|0.9|1.1|1.0|379|Incidence|37188457|All Races|Male|Bones and Joints|1999|0.9|1.1|1.0
0-19|0.8|1.0|0.9|351|Incidence|37412192|All Races|Male|Bones and Joints|2000|0.8|1.0|0.9
0-19|1.0|1.2|1.1|430|Incidence|39161547|All Races|Male|Bones and Joints|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|429|Incidence|39168369|All Races|Male|Bones and Joints|2002|1.0|1.2|1.1
0-19|0.9|1.1|1.0|392|Incidence|40753348|All Races|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|1.0|1.0|1.0|2055|Incidence|203288185|All Races|Male|Bones and Joints|2003-2007|1.0|1.1|1.0
0-19|0.9|1.1|1.0|407|Incidence|41686807|All Races|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|419|Incidence|41786904|All Races|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.2|1.1|460|Incidence|41922622|All Races|Male|Bones and Joints|2006|1.0|1.2|1.1
0-19|0.9|1.1|1.0|421|Incidence|41760052|All Races|Male|Bones and Joints|2007|0.9|1.1|1.0
0-19|2.9|3.3|3.1|1146|Incidence|37188457|All Races|Male|Brain and Other Nervous System|1999|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1239|Incidence|37412192|All Races|Male|Brain and Other Nervous System|2000|3.1|3.5|3.3
0-19|3.0|3.3|3.1|1231|Incidence|39161547|All Races|Male|Brain and Other Nervous System|2001|3.0|3.3|3.1
0-19|3.3|3.7|3.5|1361|Incidence|39168369|All Races|Male|Brain and Other Nervous System|2002|3.3|3.7|3.5
0-19|2.9|3.3|3.1|1267|Incidence|40753348|All Races|Male|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.1|3.3|3.2|6531|Incidence|203288185|All Races|Male|Brain and Other Nervous System|2003-2007|3.1|3.3|3.2
0-19|3.1|3.5|3.3|1372|Incidence|41686807|All Races|Male|Brain and Other Nervous System|2004|3.1|3.5|3.3
0-19|2.9|3.3|3.1|1293|Incidence|41786904|All Races|Male|Brain and Other Nervous System|2005|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1378|Incidence|41922622|All Races|Male|Brain and Other Nervous System|2006|3.1|3.5|3.3
0-19|3.1|3.4|3.2|1345|Incidence|41760052|All Races|Male|Brain and Other Nervous System|2007|3.1|3.4|3.2
0-19|1.2|1.4|1.3|480|Incidence|37188457|All Races|Male|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.1|1.4|1.2|469|Incidence|37412192|All Races|Male|Hodgkin Lymphoma|2000|1.1|1.4|1.3
0-19|1.2|1.4|1.3|511|Incidence|39161547|All Races|Male|Hodgkin Lymphoma|2001|1.2|1.4|1.3
0-19|1.1|1.3|1.2|483|Incidence|39168369|All Races|Male|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.2|1.4|1.3|544|Incidence|40753348|All Races|Male|Hodgkin Lymphoma|2003|1.2|1.5|1.3
0-19|1.3|1.4|1.3|2704|Incidence|203288185|All Races|Male|Hodgkin Lymphoma|2003-2007|1.3|1.4|1.3
0-19|1.1|1.3|1.2|511|Incidence|41686807|All Races|Male|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.3|1.5|1.4|579|Incidence|41786904|All Races|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.2|1.5|1.4|572|Incidence|41922622|All Races|Male|Hodgkin Lymphoma|2006|1.3|1.5|1.4
0-19|1.2|1.4|1.3|552|Incidence|41760052|All Races|Male|Hodgkin Lymphoma|2007|1.2|1.4|1.3
0-19|0.5|0.7|0.6|226|Incidence|37188457|All Races|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.6|0.8|0.7|248|Incidence|37412192|All Races|Male|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.6|252|Incidence|39161547|All Races|Male|Kidney and Renal Pelvis|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|261|Incidence|39168369|All Races|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|243|Incidence|40753348|All Races|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.7|0.6|1300|Incidence|203288185|All Races|Male|Kidney and Renal Pelvis|2003-2007|0.6|0.7|0.6
0-19|0.6|0.7|0.7|276|Incidence|41686807|All Races|Male|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.6|270|Incidence|41786904|All Races|Male|Kidney and Renal Pelvis|2005|0.6|0.7|0.6
0-19|0.6|0.8|0.7|284|Incidence|41922622|All Races|Male|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|255|Incidence|41760052|All Races|Male|Kidney and Renal Pelvis|2007|0.5|0.7|0.6
0-19|4.4|4.8|4.6|1696|Incidence|37188457|All Races|Male|Leukemia|1999|4.3|4.8|4.6
0-19|4.2|4.7|4.4|1657|Incidence|37412192|All Races|Male|Leukemia|2000|4.2|4.6|4.4
0-19|4.5|4.9|4.7|1837|Incidence|39161547|All Races|Male|Leukemia|2001|4.5|4.9|4.7
0-19|4.5|4.9|4.7|1824|Incidence|39168369|All Races|Male|Leukemia|2002|4.4|4.9|4.7
0-19|4.3|4.7|4.5|1827|Incidence|40753348|All Races|Male|Leukemia|2003|4.3|4.7|4.5
0-19|4.6|4.8|4.7|9648|Incidence|203288185|All Races|Male|Leukemia|2003-2007|4.7|4.8|4.7
0-19|4.8|5.2|5.0|2091|Incidence|41686807|All Races|Male|Leukemia|2004|4.8|5.2|5.0
0-19|4.4|4.8|4.6|1940|Incidence|41786904|All Races|Male|Leukemia|2005|4.4|4.9|4.6
0-19|4.6|5.0|4.8|2019|Incidence|41922622|All Races|Male|Leukemia|2006|4.6|5.0|4.8
0-19|4.5|4.9|4.7|1989|Incidence|41760052|All Races|Male|Leukemia|2007|4.6|5.0|4.8
0-19|1.3|1.5|1.4|518|Incidence|37188457|All Races|Male|Non-Hodgkin Lymphoma|1999|1.3|1.5|1.4
0-19|1.4|1.6|1.5|554|Incidence|37412192|All Races|Male|Non-Hodgkin Lymphoma|2000|1.4|1.6|1.5
0-19|1.3|1.5|1.4|559|Incidence|39161547|All Races|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.4
0-19|1.3|1.6|1.4|565|Incidence|39168369|All Races|Male|Non-Hodgkin Lymphoma|2002|1.3|1.6|1.4
0-19|1.3|1.5|1.4|575|Incidence|40753348|All Races|Male|Non-Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.4|1.5|1.5|3015|Incidence|203288185|All Races|Male|Non-Hodgkin Lymphoma|2003-2007|1.4|1.5|1.5
0-19|1.3|1.6|1.4|603|Incidence|41686807|All Races|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.4|1.7|1.5|643|Incidence|41786904|All Races|Male|Non-Hodgkin Lymphoma|2005|1.4|1.7|1.5
0-19|1.4|1.6|1.5|621|Incidence|41922622|All Races|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.6|1.5|628|Incidence|41760052|All Races|Male|Non-Hodgkin Lymphoma|2007|1.4|1.6|1.5
0-19|3.8|4.2|4.0|1492|Incidence|37188457|All Races|Male|Other|1999|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1492|Incidence|37412192|All Races|Male|Other|2000|3.8|4.2|4.0
0-19|4.2|4.6|4.4|1724|Incidence|39161547|All Races|Male|Other|2001|4.2|4.6|4.4
0-19|4.3|4.7|4.5|1778|Incidence|39168369|All Races|Male|Other|2002|4.3|4.8|4.5
0-19|4.1|4.5|4.3|1778|Incidence|40753348|All Races|Male|Other|2003|4.2|4.6|4.4
0-19|4.4|4.6|4.5|9227|Incidence|203288185|All Races|Male|Other|2003-2007|4.4|4.6|4.5
0-19|4.4|4.8|4.6|1952|Incidence|41686807|All Races|Male|Other|2004|4.5|4.9|4.7
0-19|4.3|4.7|4.5|1901|Incidence|41786904|All Races|Male|Other|2005|4.3|4.8|4.5
0-19|4.2|4.6|4.4|1865|Incidence|41922622|All Races|Male|Other|2006|4.2|4.7|4.4
0-19|4.4|4.8|4.6|1960|Incidence|41760052|All Races|Male|Other|2007|4.5|4.9|4.7
0-19|0.8|1.0|0.9|317|Incidence|37188457|All Races|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|393|Incidence|37412192|All Races|Male|Soft Tissue|2000|0.9|1.2|1.1
0-19|0.9|1.1|1.0|396|Incidence|39161547|All Races|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|421|Incidence|39168369|All Races|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|0.9|1.1|1.0|418|Incidence|40753348|All Races|Male|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.1|1.0|2129|Incidence|203288185|All Races|Male|Soft Tissue|2003-2007|1.0|1.1|1.0
0-19|0.9|1.1|1.0|430|Incidence|41686807|All Races|Male|Soft Tissue|2004|0.9|1.1|1.0
0-19|1.0|1.2|1.1|471|Incidence|41786904|All Races|Male|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|429|Incidence|41922622|All Races|Male|Soft Tissue|2006|0.9|1.1|1.0
0-19|0.9|1.1|1.0|428|Incidence|41760052|All Races|Male|Soft Tissue|2007|0.9|1.1|1.0
0-19|2.9|3.2|3.0|2198|Incidence|72548146|All Races|Male and Female|Acute Lymphocytic|1999|2.9|3.2|3.0
0-19|3.0|3.3|3.1|2287|Incidence|72982608|All Races|Male and Female|Acute Lymphocytic|2000|3.0|3.3|3.1
0-19|3.1|3.4|3.2|2467|Incidence|76387462|All Races|Male and Female|Acute Lymphocytic|2001|3.1|3.4|3.2
0-19|3.0|3.2|3.1|2375|Incidence|76418439|All Races|Male and Female|Acute Lymphocytic|2002|3.0|3.2|3.1
0-19|2.9|3.1|3.0|2401|Incidence|79565248|All Races|Male and Female|Acute Lymphocytic|2003|2.9|3.1|3.0
0-19|3.1|3.2|3.2|12637|Incidence|397072513|All Races|Male and Female|Acute Lymphocytic|2003-2007|3.1|3.2|3.2
0-19|3.1|3.4|3.2|2645|Incidence|81414417|All Races|Male and Female|Acute Lymphocytic|2004|3.1|3.4|3.2
0-19|3.0|3.3|3.1|2563|Incidence|81624286|All Races|Male and Female|Acute Lymphocytic|2005|3.0|3.3|3.1
0-19|3.1|3.4|3.2|2659|Incidence|81899061|All Races|Male and Female|Acute Lymphocytic|2006|3.1|3.4|3.2
0-19|3.1|3.4|3.3|2672|Incidence|81590953|All Races|Male and Female|Acute Lymphocytic|2007|3.2|3.4|3.3
0-19|0.7|0.8|0.7|531|Incidence|72548146|All Races|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.7|475|Incidence|72982608|All Races|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|540|Incidence|76387462|All Races|Male and Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.7|0.8|0.7|550|Incidence|76418439|All Races|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.7|545|Incidence|79565248|All Races|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2770|Incidence|397072513|All Races|Male and Female|Acute Myeloid|2003-2007|0.7|0.7|0.7
0-19|0.7|0.8|0.7|601|Incidence|81414417|All Races|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.7|540|Incidence|81624286|All Races|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|582|Incidence|81899061|All Races|Male and Female|Acute Myeloid|2006|0.7|0.8|0.7
0-19|0.6|0.7|0.7|556|Incidence|81590953|All Races|Male and Female|Acute Myeloid|2007|0.6|0.7|0.7
0-19|15.6|16.2|15.9|11490|Incidence|72548146|All Races|Male and Female|All Cancer Sites Combined|1999|15.5|16.1|15.8
0-19|16.0|16.6|16.3|11862|Incidence|72982608|All Races|Male and Female|All Cancer Sites Combined|2000|16.0|16.5|16.3
0-19|16.7|17.2|17.0|12945|Incidence|76387462|All Races|Male and Female|All Cancer Sites Combined|2001|16.7|17.2|16.9
0-19|16.7|17.3|17.0|12964|Incidence|76418439|All Races|Male and Female|All Cancer Sites Combined|2002|16.7|17.3|17.0
0-19|16.4|17.0|16.7|13308|Incidence|79565248|All Races|Male and Female|All Cancer Sites Combined|2003|16.4|17.0|16.7
0-19|16.9|17.2|17.0|68127|Incidence|397072513|All Races|Male and Female|All Cancer Sites Combined|2003-2007|17.0|17.3|17.2
0-19|17.0|17.6|17.3|14154|Incidence|81414417|All Races|Male and Female|All Cancer Sites Combined|2004|17.1|17.7|17.4
0-19|16.7|17.3|17.0|14011|Incidence|81624286|All Races|Male and Female|All Cancer Sites Combined|2005|16.9|17.5|17.2
0-19|16.7|17.2|17.0|14020|Incidence|81899061|All Races|Male and Female|All Cancer Sites Combined|2006|16.8|17.4|17.1
0-19|16.8|17.4|17.1|14119|Incidence|81590953|All Races|Male and Female|All Cancer Sites Combined|2007|17.0|17.6|17.3
0-19|0.8|1.0|0.9|655|Incidence|72548146|All Races|Male and Female|Bones and Joints|1999|0.8|1.0|0.9
0-19|0.8|0.9|0.9|634|Incidence|72982608|All Races|Male and Female|Bones and Joints|2000|0.8|0.9|0.9
0-19|0.9|1.0|1.0|738|Incidence|76387462|All Races|Male and Female|Bones and Joints|2001|0.9|1.0|1.0
0-19|0.9|1.0|0.9|719|Incidence|76418439|All Races|Male and Female|Bones and Joints|2002|0.9|1.0|0.9
0-19|0.8|1.0|0.9|724|Incidence|79565248|All Races|Male and Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.9|0.9|0.9|3646|Incidence|397072513|All Races|Male and Female|Bones and Joints|2003-2007|0.9|0.9|0.9
0-19|0.9|1.0|0.9|759|Incidence|81414417|All Races|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.8|1.0|0.9|738|Incidence|81624286|All Races|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.0|1.0|783|Incidence|81899061|All Races|Male and Female|Bones and Joints|2006|0.9|1.0|1.0
0-19|0.8|1.0|0.9|721|Incidence|81590953|All Races|Male and Female|Bones and Joints|2007|0.8|1.0|0.9
0-19|2.8|3.0|2.9|2111|Incidence|72548146|All Races|Male and Female|Brain and Other Nervous System|1999|2.8|3.0|2.9
0-19|2.9|3.2|3.1|2237|Incidence|72982608|All Races|Male and Female|Brain and Other Nervous System|2000|2.9|3.2|3.1
0-19|2.9|3.1|3.0|2287|Incidence|76387462|All Races|Male and Female|Brain and Other Nervous System|2001|2.9|3.1|3.0
0-19|3.0|3.3|3.1|2394|Incidence|76418439|All Races|Male and Female|Brain and Other Nervous System|2002|3.0|3.3|3.1
0-19|2.9|3.1|3.0|2405|Incidence|79565248|All Races|Male and Female|Brain and Other Nervous System|2003|2.9|3.1|3.0
0-19|3.0|3.1|3.1|12240|Incidence|397072513|All Races|Male and Female|Brain and Other Nervous System|2003-2007|3.0|3.1|3.1
0-19|3.1|3.3|3.2|2592|Incidence|81414417|All Races|Male and Female|Brain and Other Nervous System|2004|3.1|3.3|3.2
0-19|2.9|3.1|3.0|2438|Incidence|81624286|All Races|Male and Female|Brain and Other Nervous System|2005|2.9|3.1|3.0
0-19|2.9|3.2|3.1|2506|Incidence|81899061|All Races|Male and Female|Brain and Other Nervous System|2006|2.9|3.2|3.1
0-19|3.0|3.2|3.1|2542|Incidence|81590953|All Races|Male and Female|Brain and Other Nervous System|2007|3.0|3.2|3.1
0-19|1.1|1.3|1.2|855|Incidence|72548146|All Races|Male and Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.1|1.3|1.2|898|Incidence|72982608|All Races|Male and Female|Hodgkin Lymphoma|2000|1.2|1.3|1.2
0-19|1.2|1.3|1.3|960|Incidence|76387462|All Races|Male and Female|Hodgkin Lymphoma|2001|1.2|1.3|1.3
0-19|1.1|1.3|1.2|934|Incidence|76418439|All Races|Male and Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.2|1.3|1.2|996|Incidence|79565248|All Races|Male and Female|Hodgkin Lymphoma|2003|1.2|1.3|1.3
0-19|1.2|1.3|1.2|4999|Incidence|397072513|All Races|Male and Female|Hodgkin Lymphoma|2003-2007|1.2|1.3|1.3
0-19|1.1|1.3|1.2|989|Incidence|81414417|All Races|Male and Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.4|1.3|1065|Incidence|81624286|All Races|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1048|Incidence|81899061|All Races|Male and Female|Hodgkin Lymphoma|2006|1.2|1.4|1.3
0-19|1.1|1.3|1.2|1002|Incidence|81590953|All Races|Male and Female|Hodgkin Lymphoma|2007|1.2|1.3|1.2
0-19|0.6|0.7|0.7|478|Incidence|72548146|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.7
0-19|0.6|0.8|0.7|507|Incidence|72982608|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|531|Incidence|76387462|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.7|508|Incidence|76418439|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Incidence|79565248|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2725|Incidence|397072513|All Races|Male and Female|Kidney and Renal Pelvis|2003-2007|0.7|0.7|0.7
0-19|0.6|0.7|0.7|546|Incidence|81414417|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|562|Incidence|81624286|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|566|Incidence|81899061|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.6|0.7|0.7|571|Incidence|81590953|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|4.0|4.3|4.1|2979|Incidence|72548146|All Races|Male and Female|Leukemia|1999|4.0|4.3|4.1
0-19|4.0|4.3|4.1|3001|Incidence|72982608|All Races|Male and Female|Leukemia|2000|4.0|4.3|4.1
0-19|4.2|4.5|4.4|3314|Incidence|76387462|All Races|Male and Female|Leukemia|2001|4.2|4.5|4.3
0-19|4.1|4.4|4.2|3240|Incidence|76418439|All Races|Male and Female|Leukemia|2002|4.1|4.4|4.2
0-19|3.9|4.2|4.1|3239|Incidence|79565248|All Races|Male and Female|Leukemia|2003|3.9|4.2|4.1
0-19|4.2|4.3|4.3|16988|Incidence|397072513|All Races|Male and Female|Leukemia|2003-2007|4.2|4.3|4.3
0-19|4.2|4.5|4.4|3570|Incidence|81414417|All Races|Male and Female|Leukemia|2004|4.2|4.5|4.4
0-19|4.1|4.3|4.2|3440|Incidence|81624286|All Races|Male and Female|Leukemia|2005|4.1|4.4|4.2
0-19|4.2|4.5|4.3|3579|Incidence|81899061|All Races|Male and Female|Leukemia|2006|4.2|4.5|4.4
0-19|4.2|4.5|4.3|3551|Incidence|81590953|All Races|Male and Female|Leukemia|2007|4.2|4.5|4.4
0-19|1.0|1.1|1.1|768|Incidence|72548146|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.1|1.1
0-19|1.1|1.2|1.1|828|Incidence|72982608|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.2|1.1
0-19|1.0|1.2|1.1|855|Incidence|76387462|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|1.0|1.2|1.1
0-19|1.1|1.2|1.1|860|Incidence|76418439|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|1.1|1.2|1.1
0-19|1.0|1.2|1.1|859|Incidence|79565248|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.1|1.2|1.1|4514|Incidence|397072513|All Races|Male and Female|Non-Hodgkin Lymphoma|2003-2007|1.1|1.2|1.1
0-19|1.1|1.2|1.1|918|Incidence|81414417|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|1.1|1.2|1.1
0-19|1.1|1.2|1.2|957|Incidence|81624286|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.2|1.2
0-19|1.0|1.2|1.1|918|Incidence|81899061|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|1.1|1.2|1.2|941|Incidence|81590953|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.2|1.2
0-19|4.0|4.3|4.2|3014|Incidence|72548146|All Races|Male and Female|Other|1999|4.0|4.3|4.2
0-19|4.0|4.3|4.1|3015|Incidence|72982608|All Races|Male and Female|Other|2000|4.0|4.3|4.1
0-19|4.4|4.7|4.6|3493|Incidence|76387462|All Races|Male and Female|Other|2001|4.4|4.7|4.6
0-19|4.4|4.8|4.6|3524|Incidence|76418439|All Races|Male and Female|Other|2002|4.5|4.8|4.6
0-19|4.5|4.8|4.6|3724|Incidence|79565248|All Races|Male and Female|Other|2003|4.5|4.8|4.7
0-19|4.6|4.7|4.7|18876|Incidence|397072513|All Races|Male and Female|Other|2003-2007|4.7|4.8|4.8
0-19|4.6|4.9|4.8|3926|Incidence|81414417|All Races|Male and Female|Other|2004|4.7|5.0|4.8
0-19|4.6|4.9|4.8|3950|Incidence|81624286|All Races|Male and Female|Other|2005|4.7|5.0|4.8
0-19|4.4|4.7|4.5|3794|Incidence|81899061|All Races|Male and Female|Other|2006|4.5|4.8|4.6
0-19|4.5|4.8|4.7|3921|Incidence|81590953|All Races|Male and Female|Other|2007|4.7|5.0|4.8
0-19|0.8|0.9|0.9|630|Incidence|72548146|All Races|Male and Female|Soft Tissue|1999|0.8|0.9|0.9
0-19|0.9|1.1|1.0|742|Incidence|72982608|All Races|Male and Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|767|Incidence|76387462|All Races|Male and Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.1|1.0|785|Incidence|76418439|All Races|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|0.9|1.1|1.0|816|Incidence|79565248|All Races|Male and Female|Soft Tissue|2003|1.0|1.1|1.0
0-19|1.0|1.1|1.0|4139|Incidence|397072513|All Races|Male and Female|Soft Tissue|2003-2007|1.0|1.1|1.0
0-19|1.0|1.1|1.0|854|Incidence|81414417|All Races|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.1|1.0|861|Incidence|81624286|All Races|Male and Female|Soft Tissue|2005|1.0|1.1|1.1
0-19|0.9|1.1|1.0|826|Incidence|81899061|All Races|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.1|1.0|870|Incidence|81590953|All Races|Male and Female|Soft Tissue|2007|1.0|1.1|1.1
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|1.1|2.1|1.6|44|Incidence|2805280|American Indian/Alaska Native|Female|Acute Lymphocytic|2003-2007|1.1|2.1|1.6
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|0.4|1.1|0.7|20|Incidence|2805280|American Indian/Alaska Native|Female|Acute Myeloid|2003-2007|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|6.8|12.5|9.4|46|Incidence|496850|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|6.8|12.3|9.3
0-19|6.3|11.6|8.6|44|Incidence|513506|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|6.2|11.5|8.6
0-19|9.1|15.0|11.8|65|Incidence|552260|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|9.1|15.0|11.8
0-19|8.5|14.3|11.1|62|Incidence|553942|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|8.6|14.3|11.2
0-19|6.3|11.3|8.5|48|Incidence|561922|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|6.3|11.3|8.5
0-19|8.6|10.9|9.7|276|Incidence|2805280|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003-2007|8.7|11.1|9.8
0-19|7.1|12.3|9.4|54|Incidence|566574|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|7.2|12.4|9.5
0-19|8.3|13.8|10.8|63|Incidence|569744|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|8.5|14.1|11.1
0-19|8.1|13.6|10.6|62|Incidence|573581|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|8.3|13.9|10.8
0-19|7.0|12.1|9.3|54|Incidence|571786|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|7.1|12.3|9.4
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|0.4|1.0|0.6|18|Incidence|2805280|American Indian/Alaska Native|Female|Bones and Joints|2003-2007|0.4|1.0|0.6
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|1.2|2.1|1.6|45|Incidence|2805280|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003-2007|1.2|2.1|1.6
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|2805280|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.3|0.9|0.6|17|Incidence|2805280|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003-2007|0.4|1.0|0.6
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|2.2|5.6|3.6|20|Incidence|552260|American Indian/Alaska Native|Female|Leukemia|2001|2.2|5.6|3.6
0-19|2.1|5.4|3.5|19|Incidence|553942|American Indian/Alaska Native|Female|Leukemia|2002|2.1|5.4|3.4
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|2.0|3.2|2.5|72|Incidence|2805280|American Indian/Alaska Native|Female|Leukemia|2003-2007|2.0|3.2|2.6
0-19|1.6|4.6|2.9|16|Incidence|566574|American Indian/Alaska Native|Female|Leukemia|2004|1.6|4.6|2.8
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|1.7|4.7|3.0|17|Incidence|573581|American Indian/Alaska Native|Female|Leukemia|2006|1.7|4.7|3.0
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|2805280|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|2.0|5.6|3.5|17|Incidence|496850|American Indian/Alaska Native|Female|Other|1999|2.0|5.5|3.4
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|2.4|5.8|3.8|21|Incidence|552260|American Indian/Alaska Native|Female|Other|2001|2.4|5.8|3.8
0-19|2.1|5.3|3.4|19|Incidence|553942|American Indian/Alaska Native|Female|Other|2002|2.1|5.4|3.4
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|2.2|3.5|2.8|81|Incidence|2805280|American Indian/Alaska Native|Female|Other|2003-2007|2.3|3.6|2.9
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|2.5|5.9|3.9|23|Incidence|569744|American Indian/Alaska Native|Female|Other|2005|2.6|6.1|4.0
0-19|2.1|5.2|3.4|20|Incidence|573581|American Indian/Alaska Native|Female|Other|2006|2.1|5.4|3.5
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|513506|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|552260|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|553942|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|561922|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|0.5|1.2|0.8|24|Incidence|2805280|American Indian/Alaska Native|Female|Soft Tissue|2003-2007|0.5|1.3|0.9
0-19|~|~|~|~|Incidence|566574|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|569744|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|573581|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|571786|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|2.0|5.4|3.4|17|Incidence|515305|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|1.9|5.3|3.3
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|1.9|5.0|3.2|18|Incidence|571230|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|1.9|5.0|3.2
0-19|1.9|5.0|3.2|18|Incidence|571826|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|1.9|5.0|3.1
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|2.3|3.6|2.9|83|Incidence|2887153|American Indian/Alaska Native|Male|Acute Lymphocytic|2003-2007|2.3|3.6|2.9
0-19|1.9|5.1|3.2|19|Incidence|583658|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|2.0|5.1|3.3
0-19|1.6|4.5|2.8|16|Incidence|586324|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|1.6|4.4|2.7
0-19|1.6|4.4|2.7|16|Incidence|590064|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|1.5|4.4|2.7
0-19|2.0|5.1|3.3|20|Incidence|588152|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|2.1|5.3|3.4
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|2887153|American Indian/Alaska Native|Male|Acute Myeloid|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|6.3|11.6|8.6|44|Incidence|515305|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|6.2|11.5|8.5
0-19|7.0|12.4|9.4|50|Incidence|531926|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|7.0|12.4|9.4
0-19|8.5|14.1|11.0|63|Incidence|571230|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|8.5|14.1|11.0
0-19|9.5|15.4|12.2|70|Incidence|571826|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|9.5|15.5|12.2
0-19|7.5|12.8|9.9|58|Incidence|578791|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|7.6|13.0|10.0
0-19|9.5|11.9|10.7|310|Incidence|2887153|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003-2007|9.6|12.0|10.7
0-19|8.1|13.6|10.6|62|Incidence|583658|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|8.1|13.6|10.6
0-19|9.5|15.3|12.2|71|Incidence|586324|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|9.5|15.3|12.1
0-19|8.5|14.0|11.0|65|Incidence|590064|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|8.5|14.0|11.0
0-19|7.1|12.2|9.4|56|Incidence|588152|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|7.2|12.4|9.5
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|2887153|American Indian/Alaska Native|Male|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|1.3|2.3|1.8|50|Incidence|2887153|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003-2007|1.3|2.3|1.7
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|2887153|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|2887153|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|2.1|5.7|3.6|18|Incidence|515305|American Indian/Alaska Native|Male|Leukemia|1999|2.1|5.5|3.5
0-19|1.9|5.2|3.2|17|Incidence|531926|American Indian/Alaska Native|Male|Leukemia|2000|1.9|5.1|3.2
0-19|2.6|6.1|4.1|23|Incidence|571230|American Indian/Alaska Native|Male|Leukemia|2001|2.6|6.0|4.0
0-19|2.8|6.5|4.4|25|Incidence|571826|American Indian/Alaska Native|Male|Leukemia|2002|2.8|6.5|4.4
0-19|2.0|5.2|3.3|19|Incidence|578791|American Indian/Alaska Native|Male|Leukemia|2003|2.0|5.1|3.3
0-19|3.0|4.4|3.6|105|Incidence|2887153|American Indian/Alaska Native|Male|Leukemia|2003-2007|3.0|4.4|3.6
0-19|2.5|5.9|3.9|23|Incidence|583658|American Indian/Alaska Native|Male|Leukemia|2004|2.5|5.9|3.9
0-19|2.5|5.9|4.0|23|Incidence|586324|American Indian/Alaska Native|Male|Leukemia|2005|2.5|5.9|3.9
0-19|2.1|5.3|3.4|20|Incidence|590064|American Indian/Alaska Native|Male|Leukemia|2006|2.1|5.2|3.4
0-19|2.1|5.3|3.4|21|Incidence|588152|American Indian/Alaska Native|Male|Leukemia|2007|2.2|5.5|3.6
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.6|1.4|0.9|27|Incidence|2887153|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003-2007|0.6|1.4|0.9
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|2.4|5.8|3.8|22|Incidence|571826|American Indian/Alaska Native|Male|Other|2002|2.4|5.8|3.8
0-19|1.7|4.6|2.9|17|Incidence|578791|American Indian/Alaska Native|Male|Other|2003|1.7|4.7|2.9
0-19|2.0|3.2|2.5|74|Incidence|2887153|American Indian/Alaska Native|Male|Other|2003-2007|2.0|3.2|2.6
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|1.7|4.6|2.9|17|Incidence|590064|American Indian/Alaska Native|Male|Other|2006|1.7|4.6|2.9
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|531926|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|571230|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|571826|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|578791|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|0.4|1.1|0.7|20|Incidence|2887153|American Indian/Alaska Native|Male|Soft Tissue|2003-2007|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|583658|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|586324|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|590064|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|588152|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|1.9|4.1|2.8|28|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|1.8|4.0|2.8
0-19|1.5|3.5|2.3|24|Incidence|1045432|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|1.5|3.4|2.3
0-19|2.0|4.1|2.9|33|Incidence|1123490|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|2.0|4.1|2.9
0-19|1.8|3.8|2.7|30|Incidence|1125768|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|1.8|3.8|2.7
0-19|1.1|2.8|1.8|20|Incidence|1140713|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|1.1|2.7|1.8
0-19|1.9|2.6|2.2|127|Incidence|5692433|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003-2007|1.9|2.7|2.2
0-19|1.8|3.8|2.7|31|Incidence|1150232|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|1.8|3.8|2.7
0-19|1.5|3.3|2.3|26|Incidence|1156068|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|1.5|3.3|2.2
0-19|1.3|3.1|2.1|24|Incidence|1163645|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|1.3|3.1|2.1
0-19|1.6|3.4|2.3|28|Incidence|1159938|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|1.6|3.5|2.4
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|0.4|0.7|0.5|30|Incidence|5692433|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003-2007|0.4|0.8|0.5
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|7.2|11.0|9.0|90|Incidence|1012155|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|7.2|10.9|8.9
0-19|7.3|11.0|9.0|94|Incidence|1045432|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|7.3|11.0|9.0
0-19|9.5|13.5|11.4|128|Incidence|1123490|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|9.5|13.5|11.4
0-19|9.8|13.9|11.7|132|Incidence|1125768|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|9.8|13.9|11.7
0-19|7.6|11.2|9.2|106|Incidence|1140713|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|7.6|11.2|9.3
0-19|9.4|11.0|10.2|586|Incidence|5692433|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003-2007|9.5|11.2|10.3
0-19|8.3|12.0|10.0|116|Incidence|1150232|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|8.3|12.1|10.1
0-19|9.6|13.6|11.5|134|Incidence|1156068|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|9.7|13.7|11.6
0-19|9.0|12.9|10.8|127|Incidence|1163645|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|9.1|13.0|10.9
0-19|7.7|11.3|9.4|110|Incidence|1159938|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|7.8|11.4|9.5
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|0.4|0.8|0.6|32|Incidence|5692433|American Indian/Alaska Native|Male and Female|Bones and Joints|2003-2007|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|0.9|2.6|1.6|16|Incidence|1012155|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|0.9|2.6|1.6
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|1.2|2.8|1.9|21|Incidence|1123490|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|1.2|2.9|1.9
0-19|1.1|2.7|1.8|20|Incidence|1125768|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|1.1|2.7|1.8
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|1.4|2.0|1.7|95|Incidence|5692433|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003-2007|1.4|2.0|1.7
0-19|1.2|2.9|2.0|22|Incidence|1150232|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|1.2|2.9|1.9
0-19|1.5|3.3|2.2|26|Incidence|1156068|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|1.5|3.3|2.2
0-19|0.9|2.4|1.5|18|Incidence|1163645|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|0.9|2.4|1.5
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|0.2|0.6|0.4|22|Incidence|5692433|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003-2007|0.2|0.6|0.4
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.3|0.7|0.5|28|Incidence|5692433|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003-2007|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|2.3|4.7|3.3|33|Incidence|1012155|American Indian/Alaska Native|Male and Female|Leukemia|1999|2.2|4.6|3.3
0-19|2.0|4.2|3.0|31|Incidence|1045432|American Indian/Alaska Native|Male and Female|Leukemia|2000|2.0|4.2|3.0
0-19|2.8|5.2|3.8|43|Incidence|1123490|American Indian/Alaska Native|Male and Female|Leukemia|2001|2.8|5.2|3.8
0-19|2.9|5.3|3.9|44|Incidence|1125768|American Indian/Alaska Native|Male and Female|Leukemia|2002|2.8|5.2|3.9
0-19|2.0|4.1|2.9|33|Incidence|1140713|American Indian/Alaska Native|Male and Female|Leukemia|2003|2.0|4.1|2.9
0-19|2.7|3.6|3.1|177|Incidence|5692433|American Indian/Alaska Native|Male and Female|Leukemia|2003-2007|2.7|3.6|3.1
0-19|2.4|4.6|3.4|39|Incidence|1150232|American Indian/Alaska Native|Male and Female|Leukemia|2004|2.4|4.6|3.4
0-19|2.3|4.5|3.3|38|Incidence|1156068|American Indian/Alaska Native|Male and Female|Leukemia|2005|2.3|4.5|3.3
0-19|2.2|4.4|3.2|37|Incidence|1163645|American Indian/Alaska Native|Male and Female|Leukemia|2006|2.2|4.4|3.2
0-19|1.8|3.8|2.7|32|Incidence|1159938|American Indian/Alaska Native|Male and Female|Leukemia|2007|1.9|3.9|2.8
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.4|0.8|0.6|33|Incidence|5692433|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|1.5|3.6|2.4|24|Incidence|1012155|American Indian/Alaska Native|Male and Female|Other|1999|1.5|3.5|2.4
0-19|1.2|3.0|1.9|20|Incidence|1045432|American Indian/Alaska Native|Male and Female|Other|2000|1.2|3.0|1.9
0-19|2.2|4.4|3.2|36|Incidence|1123490|American Indian/Alaska Native|Male and Female|Other|2001|2.2|4.4|3.2
0-19|2.6|4.9|3.6|41|Incidence|1125768|American Indian/Alaska Native|Male and Female|Other|2002|2.6|4.9|3.6
0-19|1.9|3.9|2.8|32|Incidence|1140713|American Indian/Alaska Native|Male and Female|Other|2003|1.9|4.0|2.8
0-19|2.3|3.1|2.7|155|Incidence|5692433|American Indian/Alaska Native|Male and Female|Other|2003-2007|2.3|3.2|2.7
0-19|1.3|3.0|2.0|24|Incidence|1150232|American Indian/Alaska Native|Male and Female|Other|2004|1.3|3.1|2.1
0-19|2.2|4.3|3.1|37|Incidence|1156068|American Indian/Alaska Native|Male and Female|Other|2005|2.3|4.4|3.2
0-19|2.2|4.3|3.1|37|Incidence|1163645|American Indian/Alaska Native|Male and Female|Other|2006|2.2|4.4|3.2
0-19|1.5|3.3|2.3|27|Incidence|1159938|American Indian/Alaska Native|Male and Female|Other|2007|1.5|3.4|2.3
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1045432|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1123490|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1125768|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1140713|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|0.5|1.0|0.8|44|Incidence|5692433|American Indian/Alaska Native|Male and Female|Soft Tissue|2003-2007|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|1150232|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|1156068|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|1163645|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|1159938|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|1.9|3.6|2.7|42|Incidence|1570391|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|1.9|3.6|2.7
0-19|1.3|2.8|1.9|32|Incidence|1615974|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|1.4|2.8|2.0
0-19|2.1|3.8|2.8|48|Incidence|1667386|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|2.1|3.8|2.9
0-19|2.2|3.9|3.0|52|Incidence|1693452|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|2.3|4.0|3.1
0-19|1.8|3.3|2.5|45|Incidence|1775335|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|1.8|3.4|2.5
0-19|2.3|3.0|2.7|252|Incidence|9157060|Asian/Pacific Islander|Female|Acute Lymphocytic|2003-2007|2.4|3.1|2.8
0-19|1.9|3.4|2.6|49|Incidence|1822285|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|2.0|3.6|2.7
0-19|2.1|3.6|2.7|54|Incidence|1861345|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|2.2|3.8|2.9
0-19|1.9|3.3|2.5|49|Incidence|1901294|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|1.9|3.4|2.6
0-19|2.2|3.8|2.9|58|Incidence|1922123|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|2.3|3.9|3.0
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1693452|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|0.6|1.0|0.8|71|Incidence|9157060|Asian/Pacific Islander|Female|Acute Myeloid|2003-2007|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1861345|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|0.6|1.6|1.0|20|Incidence|1901294|Asian/Pacific Islander|Female|Acute Myeloid|2006|0.6|1.6|1.1
0-19|~|~|~|~|Incidence|1922123|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|10.5|14.1|12.2|193|Incidence|1570391|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|10.6|14.2|12.3
0-19|8.7|11.9|10.2|166|Incidence|1615974|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|8.8|12.0|10.3
0-19|11.4|14.9|13.1|219|Incidence|1667386|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|11.5|15.0|13.1
0-19|11.1|14.5|12.7|216|Incidence|1693452|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|11.1|14.6|12.8
0-19|9.7|12.9|11.2|201|Incidence|1775335|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|9.8|13.0|11.3
0-19|12.0|13.5|12.7|1179|Incidence|9157060|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003-2007|12.2|13.6|12.9
0-19|10.7|13.9|12.2|226|Incidence|1822285|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|10.8|14.1|12.4
0-19|12.2|15.6|13.8|260|Incidence|1861345|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|12.3|15.8|14.0
0-19|11.4|14.7|13.0|248|Incidence|1901294|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|11.5|14.8|13.0
0-19|11.6|14.9|13.2|257|Incidence|1922123|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|11.8|15.1|13.4
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1693452|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|0.4|0.8|0.6|52|Incidence|9157060|Asian/Pacific Islander|Female|Bones and Joints|2003-2007|0.4|0.7|0.6
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1861345|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|1901294|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|0.6|1.5|1.0|18|Incidence|1922123|Asian/Pacific Islander|Female|Bones and Joints|2007|0.6|1.5|0.9
0-19|1.2|2.6|1.8|28|Incidence|1570391|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|1.2|2.6|1.8
0-19|1.3|2.7|1.9|31|Incidence|1615974|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|1.3|2.7|1.9
0-19|1.8|3.4|2.5|42|Incidence|1667386|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|1.8|3.4|2.5
0-19|1.1|2.5|1.7|29|Incidence|1693452|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|1.1|2.5|1.7
0-19|1.4|2.7|1.9|35|Incidence|1775335|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|1.4|2.7|2.0
0-19|1.8|2.4|2.1|198|Incidence|9157060|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003-2007|1.9|2.5|2.2
0-19|1.7|3.2|2.4|44|Incidence|1822285|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|1.8|3.2|2.4
0-19|1.8|3.3|2.4|46|Incidence|1861345|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|1.8|3.3|2.5
0-19|1.4|2.7|2.0|38|Incidence|1901294|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|1.4|2.7|2.0
0-19|1.4|2.7|2.0|39|Incidence|1922123|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|1.4|2.8|2.0
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1693452|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|0.5|0.8|0.6|55|Incidence|9157060|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003-2007|0.5|0.8|0.6
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1861345|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.6|1.6|1.0|19|Incidence|1901294|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1922123|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1693452|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.2|0.5|0.3|31|Incidence|9157060|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003-2007|0.2|0.5|0.3
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1861345|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1901294|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|1922123|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|2.7|4.7|3.6|57|Incidence|1570391|Asian/Pacific Islander|Female|Leukemia|1999|2.7|4.7|3.6
0-19|1.6|3.2|2.3|38|Incidence|1615974|Asian/Pacific Islander|Female|Leukemia|2000|1.7|3.2|2.4
0-19|3.0|4.9|3.9|65|Incidence|1667386|Asian/Pacific Islander|Female|Leukemia|2001|3.0|5.0|3.9
0-19|3.1|5.1|4.0|69|Incidence|1693452|Asian/Pacific Islander|Female|Leukemia|2002|3.2|5.2|4.1
0-19|2.6|4.3|3.4|61|Incidence|1775335|Asian/Pacific Islander|Female|Leukemia|2003|2.6|4.4|3.4
0-19|3.3|4.1|3.7|349|Incidence|9157060|Asian/Pacific Islander|Female|Leukemia|2003-2007|3.4|4.2|3.8
0-19|2.9|4.7|3.7|70|Incidence|1822285|Asian/Pacific Islander|Female|Leukemia|2004|3.0|4.9|3.8
0-19|3.1|4.9|3.9|75|Incidence|1861345|Asian/Pacific Islander|Female|Leukemia|2005|3.2|5.1|4.0
0-19|2.9|4.6|3.7|71|Incidence|1901294|Asian/Pacific Islander|Female|Leukemia|2006|2.9|4.7|3.7
0-19|3.0|4.8|3.9|76|Incidence|1922123|Asian/Pacific Islander|Female|Leukemia|2007|3.1|4.9|4.0
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1693452|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.7|1.0|0.8|75|Incidence|9157060|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003-2007|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.7|1.7|1.1|21|Incidence|1861345|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|0.7|1.7|1.1
0-19|0.5|1.4|0.9|16|Incidence|1901294|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|0.5|1.4|0.8
0-19|~|~|~|~|Incidence|1922123|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|2.9|4.9|3.8|61|Incidence|1570391|Asian/Pacific Islander|Female|Other|1999|3.0|5.0|3.9
0-19|2.5|4.4|3.4|55|Incidence|1615974|Asian/Pacific Islander|Female|Other|2000|2.6|4.4|3.4
0-19|2.8|4.7|3.7|62|Incidence|1667386|Asian/Pacific Islander|Female|Other|2001|2.9|4.8|3.7
0-19|2.5|4.3|3.3|55|Incidence|1693452|Asian/Pacific Islander|Female|Other|2002|2.4|4.2|3.2
0-19|2.6|4.3|3.4|61|Incidence|1775335|Asian/Pacific Islander|Female|Other|2003|2.6|4.4|3.4
0-19|3.5|4.3|3.8|356|Incidence|9157060|Asian/Pacific Islander|Female|Other|2003-2007|3.5|4.3|3.9
0-19|2.7|4.4|3.5|64|Incidence|1822285|Asian/Pacific Islander|Female|Other|2004|2.7|4.5|3.5
0-19|3.2|5.1|4.0|75|Incidence|1861345|Asian/Pacific Islander|Female|Other|2005|3.2|5.1|4.0
0-19|3.3|5.2|4.1|79|Incidence|1901294|Asian/Pacific Islander|Female|Other|2006|3.3|5.2|4.2
0-19|3.1|5.0|4.0|78|Incidence|1922123|Asian/Pacific Islander|Female|Other|2007|3.2|5.1|4.1
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1615974|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1667386|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1693452|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1775335|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|0.5|0.9|0.7|63|Incidence|9157060|Asian/Pacific Islander|Female|Soft Tissue|2003-2007|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1822285|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|1861345|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|1901294|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|1922123|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|2.0|3.7|2.8|46|Incidence|1639643|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|2.1|3.7|2.8
0-19|1.9|3.6|2.7|45|Incidence|1683945|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|1.9|3.6|2.7
0-19|2.4|4.2|3.2|56|Incidence|1740343|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|2.4|4.2|3.2
0-19|2.5|4.3|3.3|59|Incidence|1768562|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|2.5|4.3|3.3
0-19|2.4|4.1|3.2|60|Incidence|1855092|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|2.5|4.2|3.2
0-19|2.8|3.5|3.2|313|Incidence|9572983|Asian/Pacific Islander|Male|Acute Lymphocytic|2003-2007|2.9|3.7|3.3
0-19|2.2|3.8|3.0|57|Incidence|1904159|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|2.3|3.9|3.0
0-19|2.8|4.5|3.6|73|Incidence|1945619|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|2.9|4.7|3.8
0-19|2.3|3.9|3.0|62|Incidence|1987530|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|2.4|4.0|3.1
0-19|2.4|4.0|3.1|66|Incidence|2009376|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|2.5|4.2|3.3
0-19|0.6|1.6|1.0|16|Incidence|1639643|Asian/Pacific Islander|Male|Acute Myeloid|1999|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1683945|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1740343|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1768562|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1855092|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|0.7|1.0|0.8|82|Incidence|9572983|Asian/Pacific Islander|Male|Acute Myeloid|2003-2007|0.7|1.1|0.9
0-19|0.7|1.7|1.1|21|Incidence|1904159|Asian/Pacific Islander|Male|Acute Myeloid|2004|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|1945619|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|1987530|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|0.6|1.5|0.9|19|Incidence|2009376|Asian/Pacific Islander|Male|Acute Myeloid|2007|0.6|1.5|0.9
0-19|10.9|14.4|12.5|206|Incidence|1639643|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|10.9|14.4|12.6
0-19|11.6|15.1|13.2|224|Incidence|1683945|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|11.6|15.2|13.3
0-19|13.1|16.8|14.9|259|Incidence|1740343|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|13.1|16.8|14.9
0-19|12.5|16.0|14.2|252|Incidence|1768562|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|12.5|16.1|14.2
0-19|12.2|15.6|13.8|258|Incidence|1855092|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|12.3|15.7|13.9
0-19|13.4|14.9|14.1|1374|Incidence|9572983|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003-2007|13.6|15.1|14.4
0-19|12.2|15.6|13.9|267|Incidence|1904159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|12.4|15.8|14.0
0-19|13.6|17.2|15.3|302|Incidence|1945619|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|13.8|17.4|15.5
0-19|11.7|14.9|13.2|268|Incidence|1987530|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|11.9|15.2|13.5
0-19|12.8|16.1|14.4|295|Incidence|2009376|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|13.1|16.5|14.7
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1683945|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1740343|Asian/Pacific Islander|Male|Bones and Joints|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|16|Incidence|1768562|Asian/Pacific Islander|Male|Bones and Joints|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.9|16|Incidence|1855092|Asian/Pacific Islander|Male|Bones and Joints|2003|0.5|1.4|0.9
0-19|0.6|1.0|0.8|73|Incidence|9572983|Asian/Pacific Islander|Male|Bones and Joints|2003-2007|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|1904159|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|0.6|1.6|1.0|19|Incidence|1945619|Asian/Pacific Islander|Male|Bones and Joints|2005|0.6|1.5|1.0
0-19|0.5|1.3|0.8|16|Incidence|1987530|Asian/Pacific Islander|Male|Bones and Joints|2006|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2009376|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|1.3|2.7|1.9|31|Incidence|1639643|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|1.3|2.7|1.9
0-19|1.4|2.8|2.0|33|Incidence|1683945|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|1.3|2.8|2.0
0-19|1.7|3.1|2.3|40|Incidence|1740343|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|1.6|3.1|2.3
0-19|1.4|2.8|2.0|36|Incidence|1768562|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|1.4|2.8|2.0
0-19|1.7|3.2|2.4|44|Incidence|1855092|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|1.7|3.2|2.4
0-19|1.9|2.5|2.2|215|Incidence|9572983|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003-2007|2.0|2.6|2.2
0-19|1.3|2.5|1.8|35|Incidence|1904159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|1.3|2.6|1.8
0-19|1.6|2.9|2.2|42|Incidence|1945619|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|1.6|2.9|2.2
0-19|1.5|2.8|2.1|43|Incidence|1987530|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|1.6|2.9|2.2
0-19|1.9|3.3|2.6|52|Incidence|2009376|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|1.9|3.4|2.6
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1683945|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1740343|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|0.5|1.5|0.9|16|Incidence|1768562|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|0.5|1.5|0.9
0-19|0.8|1.8|1.2|22|Incidence|1855092|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|0.7|1.8|1.2
0-19|0.8|1.2|1.0|91|Incidence|9572983|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003-2007|0.8|1.2|1.0
0-19|0.5|1.4|0.9|17|Incidence|1904159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|0.5|1.4|0.9
0-19|0.8|1.8|1.2|23|Incidence|1945619|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|0.7|1.8|1.2
0-19|~|~|~|~|Incidence|1987530|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|0.5|1.4|0.9|17|Incidence|2009376|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|0.5|1.4|0.8
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1683945|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1740343|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1768562|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1855092|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.3|0.5|0.4|39|Incidence|9572983|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003-2007|0.3|0.6|0.4
0-19|~|~|~|~|Incidence|1904159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1945619|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1987530|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|2009376|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|3.4|5.5|4.3|71|Incidence|1639643|Asian/Pacific Islander|Male|Leukemia|1999|3.4|5.5|4.3
0-19|3.0|4.9|3.9|65|Incidence|1683945|Asian/Pacific Islander|Male|Leukemia|2000|3.0|4.9|3.9
0-19|3.8|5.9|4.7|82|Incidence|1740343|Asian/Pacific Islander|Male|Leukemia|2001|3.7|5.8|4.7
0-19|3.7|5.8|4.7|83|Incidence|1768562|Asian/Pacific Islander|Male|Leukemia|2002|3.7|5.8|4.7
0-19|3.6|5.5|4.5|84|Incidence|1855092|Asian/Pacific Islander|Male|Leukemia|2003|3.6|5.6|4.5
0-19|4.1|4.9|4.5|440|Incidence|9572983|Asian/Pacific Islander|Male|Leukemia|2003-2007|4.2|5.0|4.6
0-19|3.7|5.7|4.7|90|Incidence|1904159|Asian/Pacific Islander|Male|Leukemia|2004|3.8|5.8|4.7
0-19|3.8|5.8|4.7|96|Incidence|1945619|Asian/Pacific Islander|Male|Leukemia|2005|4.0|6.0|4.9
0-19|3.4|5.2|4.2|86|Incidence|1987530|Asian/Pacific Islander|Male|Leukemia|2006|3.5|5.3|4.3
0-19|3.5|5.3|4.3|90|Incidence|2009376|Asian/Pacific Islander|Male|Leukemia|2007|3.6|5.5|4.5
0-19|0.6|1.7|1.0|17|Incidence|1639643|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|0.6|1.7|1.0
0-19|1.0|2.3|1.6|27|Incidence|1683945|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|1.1|2.3|1.6
0-19|0.8|1.9|1.3|22|Incidence|1740343|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|0.8|1.9|1.3
0-19|0.7|1.7|1.1|19|Incidence|1768562|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|0.6|1.7|1.1
0-19|0.9|2.1|1.4|26|Incidence|1855092|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|0.9|2.1|1.4
0-19|1.0|1.5|1.2|115|Incidence|9572983|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003-2007|1.0|1.4|1.2
0-19|0.6|1.5|1.0|18|Incidence|1904159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|0.6|1.5|0.9
0-19|1.1|2.3|1.6|30|Incidence|1945619|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|1.0|2.2|1.5
0-19|0.7|1.7|1.1|22|Incidence|1987530|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|0.7|1.7|1.1
0-19|0.7|1.6|1.1|21|Incidence|2009376|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|0.6|1.6|1.0
0-19|2.3|4.0|3.1|51|Incidence|1639643|Asian/Pacific Islander|Male|Other|1999|2.3|4.1|3.1
0-19|2.5|4.3|3.3|56|Incidence|1683945|Asian/Pacific Islander|Male|Other|2000|2.5|4.3|3.3
0-19|2.7|4.6|3.6|63|Incidence|1740343|Asian/Pacific Islander|Male|Other|2001|2.8|4.6|3.6
0-19|2.4|4.1|3.1|57|Incidence|1768562|Asian/Pacific Islander|Male|Other|2002|2.4|4.2|3.2
0-19|1.9|3.4|2.5|48|Incidence|1855092|Asian/Pacific Islander|Male|Other|2003|1.9|3.4|2.6
0-19|3.0|3.7|3.3|329|Incidence|9572983|Asian/Pacific Islander|Male|Other|2003-2007|3.1|3.8|3.4
0-19|2.7|4.4|3.5|68|Incidence|1904159|Asian/Pacific Islander|Male|Other|2004|2.8|4.5|3.6
0-19|2.6|4.2|3.3|66|Incidence|1945619|Asian/Pacific Islander|Male|Other|2005|2.6|4.3|3.4
0-19|2.5|4.1|3.2|66|Incidence|1987530|Asian/Pacific Islander|Male|Other|2006|2.6|4.2|3.3
0-19|3.2|5.0|4.1|85|Incidence|2009376|Asian/Pacific Islander|Male|Other|2007|3.4|5.2|4.2
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1683945|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1740343|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|0.8|1.9|1.2|22|Incidence|1768562|Asian/Pacific Islander|Male|Soft Tissue|2002|0.8|1.9|1.2
0-19|~|~|~|~|Incidence|1855092|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|0.6|0.9|0.7|72|Incidence|9572983|Asian/Pacific Islander|Male|Soft Tissue|2003-2007|0.6|0.9|0.8
0-19|0.5|1.5|0.9|18|Incidence|1904159|Asian/Pacific Islander|Male|Soft Tissue|2004|0.6|1.5|0.9
0-19|0.7|1.7|1.1|22|Incidence|1945619|Asian/Pacific Islander|Male|Soft Tissue|2005|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|1987530|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|2009376|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|2.2|3.4|2.7|88|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|2.2|3.4|2.7
0-19|1.8|2.9|2.3|77|Incidence|3299919|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|1.8|2.9|2.3
0-19|2.5|3.7|3.0|104|Incidence|3407729|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|2.5|3.7|3.1
0-19|2.6|3.8|3.2|111|Incidence|3462014|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|2.6|3.9|3.2
0-19|2.3|3.4|2.8|105|Incidence|3630427|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|2.4|3.5|2.9
0-19|2.7|3.2|2.9|565|Incidence|18730043|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003-2007|2.8|3.3|3.0
0-19|2.3|3.4|2.8|106|Incidence|3726444|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|2.3|3.4|2.8
0-19|2.6|3.8|3.2|127|Incidence|3806964|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|2.8|4.0|3.3
0-19|2.3|3.4|2.8|111|Incidence|3888824|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|2.3|3.4|2.9
0-19|2.5|3.6|3.0|124|Incidence|3931499|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|2.6|3.8|3.2
0-19|0.5|1.2|0.8|26|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|0.5|1.2|0.8
0-19|0.3|0.8|0.5|16|Incidence|3299919|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|0.3|0.8|0.5
0-19|0.5|1.1|0.8|26|Incidence|3407729|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|0.5|1.1|0.8
0-19|0.4|0.9|0.6|21|Incidence|3462014|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.4|1.0|0.7|25|Incidence|3630427|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|0.4|1.0|0.7
0-19|0.7|1.0|0.8|153|Incidence|18730043|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003-2007|0.7|1.0|0.8
0-19|0.7|1.3|0.9|35|Incidence|3726444|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|0.7|1.3|0.9
0-19|0.5|1.1|0.7|28|Incidence|3806964|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|0.5|1.1|0.7
0-19|0.6|1.2|0.9|35|Incidence|3888824|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|0.6|1.3|0.9
0-19|0.6|1.1|0.8|32|Incidence|3931499|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|0.6|1.1|0.8
0-19|11.2|13.6|12.4|399|Incidence|3210034|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|11.2|13.7|12.4
0-19|10.6|13.0|11.7|390|Incidence|3299919|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|10.7|13.1|11.8
0-19|12.8|15.3|14.0|478|Incidence|3407729|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|12.8|15.3|14.0
0-19|12.3|14.7|13.4|468|Incidence|3462014|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|12.3|14.8|13.5
0-19|11.4|13.7|12.5|459|Incidence|3630427|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|11.5|13.9|12.6
0-19|12.9|14.0|13.4|2553|Incidence|18730043|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003-2007|13.1|14.2|13.6
0-19|11.9|14.3|13.0|493|Incidence|3726444|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|12.1|14.5|13.2
0-19|13.4|15.9|14.6|562|Incidence|3806964|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|13.6|16.0|14.8
0-19|12.0|14.3|13.1|516|Incidence|3888824|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|12.1|14.5|13.3
0-19|12.7|15.0|13.8|552|Incidence|3931499|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|12.9|15.3|14.0
0-19|0.3|0.8|0.5|17|Incidence|3210034|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|0.3|0.8|0.5
0-19|0.4|1.0|0.7|23|Incidence|3299919|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|0.4|1.0|0.7
0-19|0.6|1.2|0.9|29|Incidence|3407729|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|0.6|1.2|0.9
0-19|0.5|1.1|0.7|25|Incidence|3462014|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|0.5|1.1|0.7
0-19|0.4|1.0|0.7|24|Incidence|3630427|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|0.4|1.0|0.7
0-19|0.6|0.8|0.7|125|Incidence|18730043|Asian/Pacific Islander|Male and Female|Bones and Joints|2003-2007|0.6|0.8|0.7
0-19|0.4|1.0|0.7|24|Incidence|3726444|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|0.4|1.0|0.6
0-19|0.5|1.1|0.7|27|Incidence|3806964|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|0.5|1.0|0.7
0-19|0.4|0.9|0.6|23|Incidence|3888824|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|0.4|0.9|0.6
0-19|0.5|1.0|0.7|27|Incidence|3931499|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|0.5|1.0|0.7
0-19|1.4|2.4|1.8|59|Incidence|3210034|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|1.4|2.4|1.8
0-19|1.5|2.5|1.9|64|Incidence|3299919|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|1.5|2.5|1.9
0-19|1.9|3.0|2.4|82|Incidence|3407729|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|1.9|3.0|2.4
0-19|1.4|2.4|1.9|65|Incidence|3462014|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|1.4|2.4|1.9
0-19|1.7|2.7|2.2|79|Incidence|3630427|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|1.7|2.7|2.2
0-19|2.0|2.4|2.2|413|Incidence|18730043|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003-2007|2.0|2.4|2.2
0-19|1.6|2.6|2.1|79|Incidence|3726444|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|1.7|2.6|2.1
0-19|1.8|2.8|2.3|88|Incidence|3806964|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|1.9|2.8|2.3
0-19|1.6|2.5|2.0|81|Incidence|3888824|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|1.7|2.6|2.1
0-19|1.8|2.8|2.3|91|Incidence|3931499|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|1.9|2.8|2.3
0-19|0.3|0.8|0.5|16|Incidence|3210034|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|0.3|0.8|0.5
0-19|0.3|0.9|0.6|19|Incidence|3299919|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|0.3|0.9|0.6
0-19|0.5|1.2|0.8|27|Incidence|3407729|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|0.5|1.2|0.8
0-19|0.6|1.3|0.9|31|Incidence|3462014|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|0.6|1.3|0.9
0-19|0.5|1.1|0.8|28|Incidence|3630427|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|0.5|1.1|0.8
0-19|0.7|0.9|0.8|146|Incidence|18730043|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003-2007|0.7|0.9|0.8
0-19|0.4|0.9|0.6|23|Incidence|3726444|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|0.4|0.9|0.6
0-19|0.7|1.4|1.0|38|Incidence|3806964|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|0.7|1.4|1.0
0-19|0.6|1.3|0.9|34|Incidence|3888824|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|0.6|1.2|0.9
0-19|0.4|1.0|0.7|26|Incidence|3931499|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|0.4|1.0|0.7
0-19|~|~|~|~|Incidence|3210034|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|3299919|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|3407729|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|3462014|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.8|0.5|19|Incidence|3630427|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|0.3|0.8|0.5
0-19|0.3|0.4|0.3|70|Incidence|18730043|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003-2007|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|3726444|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|3806964|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|3888824|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.2|0.6|0.4|17|Incidence|3931499|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|0.3|0.7|0.4
0-19|3.3|4.7|4.0|128|Incidence|3210034|Asian/Pacific Islander|Male and Female|Leukemia|1999|3.3|4.7|4.0
0-19|2.5|3.8|3.1|103|Incidence|3299919|Asian/Pacific Islander|Male and Female|Leukemia|2000|2.5|3.8|3.1
0-19|3.6|5.1|4.3|147|Incidence|3407729|Asian/Pacific Islander|Male and Female|Leukemia|2001|3.6|5.1|4.3
0-19|3.7|5.1|4.4|152|Incidence|3462014|Asian/Pacific Islander|Male and Female|Leukemia|2002|3.7|5.1|4.4
0-19|3.3|4.6|3.9|145|Incidence|3630427|Asian/Pacific Islander|Male and Female|Leukemia|2003|3.4|4.7|4.0
0-19|3.8|4.4|4.1|789|Incidence|18730043|Asian/Pacific Islander|Male and Female|Leukemia|2003-2007|3.9|4.5|4.2
0-19|3.6|4.9|4.2|160|Incidence|3726444|Asian/Pacific Islander|Male and Female|Leukemia|2004|3.7|5.0|4.3
0-19|3.7|5.0|4.3|171|Incidence|3806964|Asian/Pacific Islander|Male and Female|Leukemia|2005|3.8|5.2|4.5
0-19|3.3|4.6|3.9|157|Incidence|3888824|Asian/Pacific Islander|Male and Female|Leukemia|2006|3.4|4.7|4.0
0-19|3.5|4.8|4.1|166|Incidence|3931499|Asian/Pacific Islander|Male and Female|Leukemia|2007|3.6|4.9|4.2
0-19|0.6|1.3|0.9|30|Incidence|3210034|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|0.6|1.3|0.9
0-19|0.9|1.7|1.3|42|Incidence|3299919|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|0.9|1.7|1.3
0-19|0.7|1.4|1.0|35|Incidence|3407729|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|0.7|1.4|1.0
0-19|0.7|1.5|1.0|36|Incidence|3462014|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|0.7|1.4|1.0
0-19|0.7|1.4|1.0|37|Incidence|3630427|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.4|1.0
0-19|0.9|1.2|1.0|190|Incidence|18730043|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.9|1.2|1.0
0-19|0.6|1.2|0.9|31|Incidence|3726444|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|0.6|1.2|0.8
0-19|1.0|1.8|1.4|51|Incidence|3806964|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.8|1.3
0-19|0.7|1.4|1.0|38|Incidence|3888824|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|0.7|1.3|1.0
0-19|0.7|1.3|0.9|36|Incidence|3931499|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|0.6|1.3|0.9
0-19|2.8|4.1|3.4|112|Incidence|3210034|Asian/Pacific Islander|Male and Female|Other|1999|2.9|4.2|3.5
0-19|2.7|4.0|3.3|111|Incidence|3299919|Asian/Pacific Islander|Male and Female|Other|2000|2.8|4.1|3.4
0-19|3.0|4.3|3.6|125|Incidence|3407729|Asian/Pacific Islander|Male and Female|Other|2001|3.1|4.4|3.7
0-19|2.6|3.9|3.2|112|Incidence|3462014|Asian/Pacific Islander|Male and Female|Other|2002|2.7|3.9|3.2
0-19|2.4|3.6|2.9|109|Incidence|3630427|Asian/Pacific Islander|Male and Female|Other|2003|2.5|3.6|3.0
0-19|3.3|3.9|3.6|685|Incidence|18730043|Asian/Pacific Islander|Male and Female|Other|2003-2007|3.4|3.9|3.7
0-19|2.9|4.1|3.5|132|Incidence|3726444|Asian/Pacific Islander|Male and Female|Other|2004|3.0|4.2|3.5
0-19|3.1|4.3|3.7|141|Incidence|3806964|Asian/Pacific Islander|Male and Female|Other|2005|3.1|4.4|3.7
0-19|3.1|4.3|3.7|145|Incidence|3888824|Asian/Pacific Islander|Male and Female|Other|2006|3.1|4.4|3.7
0-19|3.4|4.7|4.0|163|Incidence|3931499|Asian/Pacific Islander|Male and Female|Other|2007|3.5|4.8|4.1
0-19|0.5|1.1|0.7|24|Incidence|3210034|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|0.5|1.1|0.7
0-19|0.3|0.8|0.5|17|Incidence|3299919|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|0.3|0.8|0.5
0-19|0.4|0.9|0.6|21|Incidence|3407729|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|0.4|0.9|0.6
0-19|0.7|1.5|1.1|37|Incidence|3462014|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|0.8|1.5|1.1
0-19|0.3|0.8|0.5|18|Incidence|3630427|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|0.3|0.8|0.5
0-19|0.6|0.8|0.7|135|Incidence|18730043|Asian/Pacific Islander|Male and Female|Soft Tissue|2003-2007|0.6|0.9|0.7
0-19|0.5|1.1|0.8|30|Incidence|3726444|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|0.5|1.1|0.8
0-19|0.7|1.3|1.0|37|Incidence|3806964|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|0.7|1.3|1.0
0-19|0.4|0.9|0.6|25|Incidence|3888824|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|0.4|0.9|0.6
0-19|0.4|1.0|0.7|26|Incidence|3931499|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|0.4|1.0|0.7
0-19|1.1|1.7|1.4|74|Incidence|5402131|Black|Female|Acute Lymphocytic|1999|1.1|1.7|1.4
0-19|1.2|1.8|1.5|80|Incidence|5446489|Black|Female|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|2.0|1.6|96|Incidence|5841005|Black|Female|Acute Lymphocytic|2001|1.3|2.0|1.6
0-19|1.0|1.6|1.3|73|Incidence|5804974|Black|Female|Acute Lymphocytic|2002|1.0|1.6|1.3
0-19|1.1|1.7|1.4|86|Incidence|6292782|Black|Female|Acute Lymphocytic|2003|1.1|1.7|1.4
0-19|1.2|1.5|1.4|425|Incidence|31495134|Black|Female|Acute Lymphocytic|2003-2007|1.2|1.5|1.3
0-19|1.1|1.7|1.4|91|Incidence|6480837|Black|Female|Acute Lymphocytic|2004|1.1|1.7|1.4
0-19|1.1|1.7|1.4|88|Incidence|6499735|Black|Female|Acute Lymphocytic|2005|1.1|1.7|1.4
0-19|1.2|1.8|1.4|94|Incidence|6524555|Black|Female|Acute Lymphocytic|2006|1.2|1.8|1.4
0-19|1.2|1.8|1.4|94|Incidence|6526055|Black|Female|Acute Lymphocytic|2007|1.2|1.8|1.4
0-19|0.4|0.9|0.6|34|Incidence|5402131|Black|Female|Acute Myeloid|1999|0.4|0.9|0.6
0-19|0.3|0.7|0.5|27|Incidence|5446489|Black|Female|Acute Myeloid|2000|0.3|0.7|0.5
0-19|0.3|0.7|0.5|30|Incidence|5841005|Black|Female|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.5|0.9|0.7|40|Incidence|5804974|Black|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|42|Incidence|6292782|Black|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.6|0.7|0.6|203|Incidence|31495134|Black|Female|Acute Myeloid|2003-2007|0.6|0.7|0.6
0-19|0.4|0.8|0.6|36|Incidence|6480837|Black|Female|Acute Myeloid|2004|0.4|0.8|0.6
0-19|0.4|0.8|0.5|36|Incidence|6499735|Black|Female|Acute Myeloid|2005|0.4|0.8|0.6
0-19|0.6|1.1|0.8|55|Incidence|6524555|Black|Female|Acute Myeloid|2006|0.6|1.1|0.8
0-19|0.4|0.8|0.6|38|Incidence|6526055|Black|Female|Acute Myeloid|2007|0.4|0.8|0.6
0-19|10.5|12.4|11.4|610|Incidence|5402131|Black|Female|All Cancer Sites Combined|1999|10.4|12.2|11.3
0-19|9.8|11.6|10.7|577|Incidence|5446489|Black|Female|All Cancer Sites Combined|2000|9.7|11.5|10.6
0-19|10.6|12.3|11.4|664|Incidence|5841005|Black|Female|All Cancer Sites Combined|2001|10.5|12.3|11.4
0-19|10.5|12.2|11.3|657|Incidence|5804974|Black|Female|All Cancer Sites Combined|2002|10.5|12.2|11.3
0-19|11.8|13.5|12.6|793|Incidence|6292782|Black|Female|All Cancer Sites Combined|2003|11.7|13.5|12.6
0-19|12.1|12.8|12.4|3939|Incidence|31495134|Black|Female|All Cancer Sites Combined|2003-2007|12.1|12.9|12.5
0-19|11.8|13.6|12.7|822|Incidence|6480837|Black|Female|All Cancer Sites Combined|2004|11.8|13.6|12.7
0-19|11.7|13.4|12.5|819|Incidence|6499735|Black|Female|All Cancer Sites Combined|2005|11.8|13.5|12.6
0-19|11.3|13.0|12.1|796|Incidence|6524555|Black|Female|All Cancer Sites Combined|2006|11.4|13.1|12.2
0-19|11.7|13.4|12.5|825|Incidence|6526055|Black|Female|All Cancer Sites Combined|2007|11.8|13.5|12.6
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Bones and Joints|1999|0.5|1.0|0.7
0-19|0.3|0.7|0.5|27|Incidence|5446489|Black|Female|Bones and Joints|2000|0.3|0.7|0.5
0-19|0.5|0.9|0.7|39|Incidence|5841005|Black|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.4|0.8|0.6|35|Incidence|5804974|Black|Female|Bones and Joints|2002|0.4|0.8|0.6
0-19|0.5|0.9|0.6|41|Incidence|6292782|Black|Female|Bones and Joints|2003|0.5|0.9|0.7
0-19|0.6|0.8|0.7|225|Incidence|31495134|Black|Female|Bones and Joints|2003-2007|0.6|0.8|0.7
0-19|0.7|1.2|0.9|59|Incidence|6480837|Black|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.5|0.9|0.7|43|Incidence|6499735|Black|Female|Bones and Joints|2005|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Incidence|6524555|Black|Female|Bones and Joints|2006|0.5|0.9|0.7
0-19|0.5|0.9|0.6|42|Incidence|6526055|Black|Female|Bones and Joints|2007|0.5|0.9|0.6
0-19|1.5|2.2|1.8|99|Incidence|5402131|Black|Female|Brain and Other Nervous System|1999|1.5|2.2|1.8
0-19|1.7|2.4|2.0|110|Incidence|5446489|Black|Female|Brain and Other Nervous System|2000|1.7|2.4|2.0
0-19|1.7|2.4|2.0|120|Incidence|5841005|Black|Female|Brain and Other Nervous System|2001|1.7|2.5|2.1
0-19|1.7|2.4|2.0|118|Incidence|5804974|Black|Female|Brain and Other Nervous System|2002|1.7|2.4|2.0
0-19|1.8|2.6|2.2|137|Incidence|6292782|Black|Female|Brain and Other Nervous System|2003|1.8|2.6|2.2
0-19|2.1|2.5|2.3|715|Incidence|31495134|Black|Female|Brain and Other Nervous System|2003-2007|2.1|2.4|2.3
0-19|2.0|2.8|2.4|153|Incidence|6480837|Black|Female|Brain and Other Nervous System|2004|2.0|2.8|2.4
0-19|2.0|2.7|2.3|152|Incidence|6499735|Black|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|1.9|2.6|2.2|146|Incidence|6524555|Black|Female|Brain and Other Nervous System|2006|1.9|2.6|2.2
0-19|1.9|2.7|2.3|147|Incidence|6526055|Black|Female|Brain and Other Nervous System|2007|1.9|2.6|2.3
0-19|0.5|0.9|0.7|34|Incidence|5402131|Black|Female|Hodgkin Lymphoma|1999|0.4|0.9|0.6
0-19|0.6|1.1|0.8|42|Incidence|5446489|Black|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.5|1.0|0.7|41|Incidence|5841005|Black|Female|Hodgkin Lymphoma|2001|0.5|1.0|0.7
0-19|0.7|1.2|0.9|51|Incidence|5804974|Black|Female|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.7|1.2|1.0|60|Incidence|6292782|Black|Female|Hodgkin Lymphoma|2003|0.7|1.2|1.0
0-19|0.8|1.0|0.9|281|Incidence|31495134|Black|Female|Hodgkin Lymphoma|2003-2007|0.8|1.0|0.9
0-19|0.7|1.1|0.9|57|Incidence|6480837|Black|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|69|Incidence|6499735|Black|Female|Hodgkin Lymphoma|2005|0.8|1.3|1.1
0-19|0.6|1.0|0.8|52|Incidence|6524555|Black|Female|Hodgkin Lymphoma|2006|0.6|1.0|0.8
0-19|0.6|1.0|0.8|53|Incidence|6526055|Black|Female|Hodgkin Lymphoma|2007|0.6|1.1|0.8
0-19|0.7|1.2|0.9|50|Incidence|5402131|Black|Female|Kidney and Renal Pelvis|1999|0.7|1.2|0.9
0-19|0.8|1.4|1.0|57|Incidence|5446489|Black|Female|Kidney and Renal Pelvis|2000|0.8|1.4|1.0
0-19|0.5|1.0|0.7|42|Incidence|5841005|Black|Female|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.6|1.1|0.9|50|Incidence|5804974|Black|Female|Kidney and Renal Pelvis|2002|0.6|1.1|0.9
0-19|0.5|0.9|0.7|44|Incidence|6292782|Black|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.7|0.9|0.8|248|Incidence|31495134|Black|Female|Kidney and Renal Pelvis|2003-2007|0.7|0.9|0.8
0-19|0.5|0.9|0.7|44|Incidence|6480837|Black|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.7|1.2|1.0|61|Incidence|6499735|Black|Female|Kidney and Renal Pelvis|2005|0.7|1.2|0.9
0-19|0.6|1.0|0.8|50|Incidence|6524555|Black|Female|Kidney and Renal Pelvis|2006|0.6|1.0|0.8
0-19|0.7|1.1|0.9|58|Incidence|6526055|Black|Female|Kidney and Renal Pelvis|2007|0.7|1.1|0.9
0-19|2.0|2.9|2.4|130|Incidence|5402131|Black|Female|Leukemia|1999|2.0|2.9|2.4
0-19|1.7|2.5|2.1|115|Incidence|5446489|Black|Female|Leukemia|2000|1.7|2.5|2.1
0-19|2.0|2.8|2.4|141|Incidence|5841005|Black|Female|Leukemia|2001|2.0|2.8|2.4
0-19|1.9|2.7|2.3|135|Incidence|5804974|Black|Female|Leukemia|2002|1.9|2.8|2.3
0-19|1.9|2.6|2.2|141|Incidence|6292782|Black|Female|Leukemia|2003|1.9|2.6|2.2
0-19|2.1|2.5|2.3|728|Incidence|31495134|Black|Female|Leukemia|2003-2007|2.1|2.5|2.3
0-19|2.0|2.8|2.4|153|Incidence|6480837|Black|Female|Leukemia|2004|2.0|2.8|2.4
0-19|1.8|2.6|2.2|141|Incidence|6499735|Black|Female|Leukemia|2005|1.8|2.6|2.2
0-19|2.2|3.0|2.6|169|Incidence|6524555|Black|Female|Leukemia|2006|2.2|3.0|2.6
0-19|2.0|2.8|2.4|158|Incidence|6526055|Black|Female|Leukemia|2007|2.1|2.8|2.4
0-19|0.5|0.9|0.7|36|Incidence|5402131|Black|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.4|0.9|0.6|34|Incidence|5446489|Black|Female|Non-Hodgkin Lymphoma|2000|0.4|0.9|0.6
0-19|0.6|1.1|0.8|46|Incidence|5841005|Black|Female|Non-Hodgkin Lymphoma|2001|0.6|1.1|0.8
0-19|0.6|1.1|0.8|47|Incidence|5804974|Black|Female|Non-Hodgkin Lymphoma|2002|0.6|1.1|0.8
0-19|0.5|0.9|0.7|44|Incidence|6292782|Black|Female|Non-Hodgkin Lymphoma|2003|0.5|0.9|0.7
0-19|0.7|0.9|0.8|252|Incidence|31495134|Black|Female|Non-Hodgkin Lymphoma|2003-2007|0.7|0.9|0.8
0-19|0.7|1.2|0.9|58|Incidence|6480837|Black|Female|Non-Hodgkin Lymphoma|2004|0.7|1.2|0.9
0-19|0.6|1.1|0.8|55|Incidence|6499735|Black|Female|Non-Hodgkin Lymphoma|2005|0.6|1.1|0.8
0-19|0.6|1.0|0.8|53|Incidence|6524555|Black|Female|Non-Hodgkin Lymphoma|2006|0.6|1.1|0.8
0-19|0.5|1.0|0.7|48|Incidence|6526055|Black|Female|Non-Hodgkin Lymphoma|2007|0.5|1.0|0.7
0-19|3.0|4.1|3.5|185|Incidence|5402131|Black|Female|Other|1999|2.9|4.0|3.4
0-19|2.2|3.1|2.6|141|Incidence|5446489|Black|Female|Other|2000|2.2|3.1|2.6
0-19|2.9|3.8|3.3|192|Incidence|5841005|Black|Female|Other|2001|2.8|3.8|3.3
0-19|2.5|3.4|2.9|168|Incidence|5804974|Black|Female|Other|2002|2.5|3.4|2.9
0-19|3.8|4.9|4.3|272|Incidence|6292782|Black|Female|Other|2003|3.8|4.9|4.3
0-19|3.5|3.9|3.7|1182|Incidence|31495134|Black|Female|Other|2003-2007|3.5|4.0|3.8
0-19|2.9|3.8|3.4|218|Incidence|6480837|Black|Female|Other|2004|2.9|3.8|3.4
0-19|3.3|4.3|3.8|247|Incidence|6499735|Black|Female|Other|2005|3.3|4.3|3.8
0-19|2.9|3.8|3.3|223|Incidence|6524555|Black|Female|Other|2006|3.0|3.9|3.4
0-19|3.3|4.2|3.7|248|Incidence|6526055|Black|Female|Other|2007|3.3|4.3|3.8
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|51|Incidence|5446489|Black|Female|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.5|1.0|0.7|43|Incidence|5841005|Black|Female|Soft Tissue|2001|0.5|1.0|0.7
0-19|0.7|1.2|0.9|53|Incidence|5804974|Black|Female|Soft Tissue|2002|0.7|1.2|0.9
0-19|0.6|1.1|0.9|54|Incidence|6292782|Black|Female|Soft Tissue|2003|0.6|1.1|0.9
0-19|0.9|1.1|1.0|308|Incidence|31495134|Black|Female|Soft Tissue|2003-2007|0.9|1.1|1.0
0-19|1.0|1.5|1.2|80|Incidence|6480837|Black|Female|Soft Tissue|2004|1.0|1.5|1.2
0-19|0.6|1.0|0.8|51|Incidence|6499735|Black|Female|Soft Tissue|2005|0.6|1.0|0.8
0-19|0.7|1.1|0.9|57|Incidence|6524555|Black|Female|Soft Tissue|2006|0.7|1.1|0.9
0-19|0.8|1.4|1.1|71|Incidence|6526055|Black|Female|Soft Tissue|2007|0.8|1.4|1.1
0-19|1.5|2.2|1.8|102|Incidence|5567502|Black|Male|Acute Lymphocytic|1999|1.5|2.2|1.8
0-19|1.2|1.8|1.5|83|Incidence|5621019|Black|Male|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|1.9|1.6|95|Incidence|6037215|Black|Male|Acute Lymphocytic|2001|1.3|1.9|1.6
0-19|1.4|2.0|1.7|100|Incidence|6004733|Black|Male|Acute Lymphocytic|2002|1.4|2.0|1.7
0-19|1.4|2.0|1.7|110|Incidence|6496079|Black|Male|Acute Lymphocytic|2003|1.4|2.0|1.7
0-19|1.9|2.2|2.0|650|Incidence|32506235|Black|Male|Acute Lymphocytic|2003-2007|1.8|2.2|2.0
0-19|1.7|2.4|2.0|132|Incidence|6686638|Black|Male|Acute Lymphocytic|2004|1.7|2.3|2.0
0-19|1.8|2.5|2.1|143|Incidence|6705972|Black|Male|Acute Lymphocytic|2005|1.8|2.5|2.1
0-19|1.8|2.5|2.1|140|Incidence|6732249|Black|Male|Acute Lymphocytic|2006|1.7|2.5|2.1
0-19|1.8|2.6|2.2|147|Incidence|6737110|Black|Male|Acute Lymphocytic|2007|1.8|2.6|2.2
0-19|0.6|1.1|0.8|43|Incidence|5567502|Black|Male|Acute Myeloid|1999|0.6|1.0|0.8
0-19|0.5|0.9|0.7|37|Incidence|5621019|Black|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|31|Incidence|6037215|Black|Male|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.4|0.9|0.6|38|Incidence|6004733|Black|Male|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.6|1.1|0.8|54|Incidence|6496079|Black|Male|Acute Myeloid|2003|0.6|1.1|0.8
0-19|0.6|0.8|0.7|222|Incidence|32506235|Black|Male|Acute Myeloid|2003-2007|0.6|0.8|0.7
0-19|0.6|1.0|0.8|51|Incidence|6686638|Black|Male|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.5|0.9|0.7|44|Incidence|6705972|Black|Male|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.5|0.9|0.7|47|Incidence|6732249|Black|Male|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.3|0.6|0.5|31|Incidence|6737110|Black|Male|Acute Myeloid|2007|0.3|0.7|0.5
0-19|11.2|13.0|12.1|666|Incidence|5567502|Black|Male|All Cancer Sites Combined|1999|11.1|12.9|12.0
0-19|11.2|13.0|12.1|675|Incidence|5621019|Black|Male|All Cancer Sites Combined|2000|11.1|12.9|12.0
0-19|11.0|12.8|11.9|715|Incidence|6037215|Black|Male|All Cancer Sites Combined|2001|11.0|12.7|11.8
0-19|11.2|13.0|12.1|721|Incidence|6004733|Black|Male|All Cancer Sites Combined|2002|11.1|12.9|12.0
0-19|12.1|13.8|12.9|838|Incidence|6496079|Black|Male|All Cancer Sites Combined|2003|12.0|13.8|12.9
0-19|12.9|13.7|13.3|4326|Incidence|32506235|Black|Male|All Cancer Sites Combined|2003-2007|12.9|13.7|13.3
0-19|12.5|14.3|13.4|896|Incidence|6686638|Black|Male|All Cancer Sites Combined|2004|12.5|14.3|13.4
0-19|12.9|14.7|13.7|924|Incidence|6705972|Black|Male|All Cancer Sites Combined|2005|12.9|14.7|13.8
0-19|12.4|14.2|13.3|900|Incidence|6732249|Black|Male|All Cancer Sites Combined|2006|12.5|14.3|13.4
0-19|12.1|13.8|12.9|882|Incidence|6737110|Black|Male|All Cancer Sites Combined|2007|12.2|14.0|13.1
0-19|0.7|1.2|0.9|49|Incidence|5567502|Black|Male|Bones and Joints|1999|0.7|1.2|0.9
0-19|0.5|1.0|0.7|40|Incidence|5621019|Black|Male|Bones and Joints|2000|0.5|1.0|0.7
0-19|0.5|0.9|0.7|39|Incidence|6037215|Black|Male|Bones and Joints|2001|0.5|0.9|0.6
0-19|0.6|1.1|0.8|49|Incidence|6004733|Black|Male|Bones and Joints|2002|0.6|1.1|0.8
0-19|0.6|1.0|0.8|50|Incidence|6496079|Black|Male|Bones and Joints|2003|0.6|1.0|0.8
0-19|0.7|0.9|0.8|275|Incidence|32506235|Black|Male|Bones and Joints|2003-2007|0.7|1.0|0.8
0-19|0.7|1.2|0.9|64|Incidence|6686638|Black|Male|Bones and Joints|2004|0.7|1.2|1.0
0-19|0.7|1.2|0.9|64|Incidence|6705972|Black|Male|Bones and Joints|2005|0.7|1.2|1.0
0-19|0.6|1.1|0.8|57|Incidence|6732249|Black|Male|Bones and Joints|2006|0.6|1.1|0.8
0-19|0.5|0.9|0.7|46|Incidence|6737110|Black|Male|Bones and Joints|2007|0.5|0.9|0.7
0-19|1.8|2.6|2.2|124|Incidence|5567502|Black|Male|Brain and Other Nervous System|1999|1.9|2.7|2.2
0-19|2.1|2.9|2.4|139|Incidence|5621019|Black|Male|Brain and Other Nervous System|2000|2.1|2.9|2.5
0-19|1.7|2.5|2.1|124|Incidence|6037215|Black|Male|Brain and Other Nervous System|2001|1.7|2.4|2.1
0-19|2.0|2.9|2.4|145|Incidence|6004733|Black|Male|Brain and Other Nervous System|2002|2.0|2.8|2.4
0-19|1.9|2.6|2.2|145|Incidence|6496079|Black|Male|Brain and Other Nervous System|2003|1.9|2.6|2.2
0-19|2.1|2.4|2.2|726|Incidence|32506235|Black|Male|Brain and Other Nervous System|2003-2007|2.1|2.4|2.2
0-19|2.1|2.9|2.5|164|Incidence|6686638|Black|Male|Brain and Other Nervous System|2004|2.1|2.9|2.5
0-19|1.9|2.6|2.3|150|Incidence|6705972|Black|Male|Brain and Other Nervous System|2005|1.9|2.6|2.2
0-19|1.8|2.5|2.2|145|Incidence|6732249|Black|Male|Brain and Other Nervous System|2006|1.8|2.5|2.2
0-19|1.8|2.5|2.1|140|Incidence|6737110|Black|Male|Brain and Other Nervous System|2007|1.7|2.5|2.1
0-19|0.8|1.4|1.0|56|Incidence|5567502|Black|Male|Hodgkin Lymphoma|1999|0.8|1.3|1.0
0-19|0.9|1.5|1.1|62|Incidence|5621019|Black|Male|Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|0.7|1.3|1.0|58|Incidence|6037215|Black|Male|Hodgkin Lymphoma|2001|0.7|1.2|1.0
0-19|0.7|1.2|0.9|53|Incidence|6004733|Black|Male|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.7|1.2|0.9|58|Incidence|6496079|Black|Male|Hodgkin Lymphoma|2003|0.7|1.2|0.9
0-19|1.0|1.2|1.1|347|Incidence|32506235|Black|Male|Hodgkin Lymphoma|2003-2007|1.0|1.2|1.1
0-19|0.8|1.3|1.0|67|Incidence|6686638|Black|Male|Hodgkin Lymphoma|2004|0.8|1.3|1.0
0-19|1.0|1.5|1.2|84|Incidence|6705972|Black|Male|Hodgkin Lymphoma|2005|1.0|1.6|1.3
0-19|0.8|1.3|1.1|72|Incidence|6732249|Black|Male|Hodgkin Lymphoma|2006|0.8|1.3|1.1
0-19|0.8|1.3|1.0|71|Incidence|6737110|Black|Male|Hodgkin Lymphoma|2007|0.8|1.3|1.1
0-19|0.4|0.9|0.6|36|Incidence|5567502|Black|Male|Kidney and Renal Pelvis|1999|0.5|0.9|0.6
0-19|0.6|1.1|0.9|48|Incidence|5621019|Black|Male|Kidney and Renal Pelvis|2000|0.6|1.1|0.9
0-19|0.5|1.0|0.7|45|Incidence|6037215|Black|Male|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.5|0.9|0.7|41|Incidence|6004733|Black|Male|Kidney and Renal Pelvis|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Incidence|6496079|Black|Male|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.7|0.9|0.8|266|Incidence|32506235|Black|Male|Kidney and Renal Pelvis|2003-2007|0.7|0.9|0.8
0-19|0.7|1.1|0.9|59|Incidence|6686638|Black|Male|Kidney and Renal Pelvis|2004|0.7|1.1|0.9
0-19|0.6|1.0|0.8|53|Incidence|6705972|Black|Male|Kidney and Renal Pelvis|2005|0.6|1.0|0.8
0-19|0.7|1.2|0.9|61|Incidence|6732249|Black|Male|Kidney and Renal Pelvis|2006|0.7|1.2|0.9
0-19|0.6|1.0|0.8|54|Incidence|6737110|Black|Male|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|2.5|3.4|2.9|161|Incidence|5567502|Black|Male|Leukemia|1999|2.5|3.4|2.9
0-19|2.0|2.8|2.4|133|Incidence|5621019|Black|Male|Leukemia|2000|2.0|2.8|2.4
0-19|2.0|2.8|2.4|143|Incidence|6037215|Black|Male|Leukemia|2001|2.0|2.8|2.4
0-19|2.2|3.1|2.6|157|Incidence|6004733|Black|Male|Leukemia|2002|2.2|3.1|2.6
0-19|2.6|3.5|3.0|197|Incidence|6496079|Black|Male|Leukemia|2003|2.6|3.5|3.0
0-19|2.9|3.2|3.0|988|Incidence|32506235|Black|Male|Leukemia|2003-2007|2.9|3.2|3.0
0-19|2.7|3.6|3.1|208|Incidence|6686638|Black|Male|Leukemia|2004|2.7|3.6|3.1
0-19|2.7|3.6|3.1|207|Incidence|6705972|Black|Male|Leukemia|2005|2.7|3.5|3.1
0-19|2.6|3.5|3.0|204|Incidence|6732249|Black|Male|Leukemia|2006|2.6|3.5|3.0
0-19|2.6|3.4|3.0|202|Incidence|6737110|Black|Male|Leukemia|2007|2.6|3.4|3.0
0-19|1.0|1.6|1.3|70|Incidence|5567502|Black|Male|Non-Hodgkin Lymphoma|1999|1.0|1.6|1.3
0-19|0.8|1.4|1.1|59|Incidence|5621019|Black|Male|Non-Hodgkin Lymphoma|2000|0.8|1.4|1.0
0-19|0.9|1.5|1.2|71|Incidence|6037215|Black|Male|Non-Hodgkin Lymphoma|2001|0.9|1.5|1.2
0-19|0.8|1.4|1.1|65|Incidence|6004733|Black|Male|Non-Hodgkin Lymphoma|2002|0.8|1.4|1.1
0-19|1.0|1.5|1.2|81|Incidence|6496079|Black|Male|Non-Hodgkin Lymphoma|2003|1.0|1.5|1.2
0-19|1.3|1.6|1.4|471|Incidence|32506235|Black|Male|Non-Hodgkin Lymphoma|2003-2007|1.3|1.6|1.4
0-19|1.3|1.9|1.5|103|Incidence|6686638|Black|Male|Non-Hodgkin Lymphoma|2004|1.3|1.9|1.5
0-19|1.2|1.8|1.5|103|Incidence|6705972|Black|Male|Non-Hodgkin Lymphoma|2005|1.3|1.9|1.5
0-19|1.2|1.8|1.4|98|Incidence|6732249|Black|Male|Non-Hodgkin Lymphoma|2006|1.2|1.8|1.5
0-19|1.2|1.8|1.5|99|Incidence|6737110|Black|Male|Non-Hodgkin Lymphoma|2007|1.2|1.8|1.5
0-19|2.0|2.8|2.4|129|Incidence|5567502|Black|Male|Other|1999|1.9|2.8|2.3
0-19|2.2|3.1|2.6|144|Incidence|5621019|Black|Male|Other|2000|2.2|3.0|2.6
0-19|2.4|3.3|2.8|171|Incidence|6037215|Black|Male|Other|2001|2.4|3.3|2.8
0-19|2.4|3.3|2.8|169|Incidence|6004733|Black|Male|Other|2002|2.4|3.3|2.8
0-19|2.7|3.6|3.2|204|Incidence|6496079|Black|Male|Other|2003|2.7|3.6|3.1
0-19|2.7|3.1|2.9|961|Incidence|32506235|Black|Male|Other|2003-2007|2.8|3.1|3.0
0-19|2.2|3.0|2.6|175|Incidence|6686638|Black|Male|Other|2004|2.2|3.0|2.6
0-19|2.6|3.4|3.0|199|Incidence|6705972|Black|Male|Other|2005|2.6|3.4|3.0
0-19|2.5|3.4|2.9|200|Incidence|6732249|Black|Male|Other|2006|2.6|3.4|3.0
0-19|2.6|3.4|3.0|208|Incidence|6737110|Black|Male|Other|2007|2.7|3.5|3.1
0-19|0.5|1.0|0.8|41|Incidence|5567502|Black|Male|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|50|Incidence|5621019|Black|Male|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.8|1.4|1.1|64|Incidence|6037215|Black|Male|Soft Tissue|2001|0.8|1.4|1.1
0-19|0.5|1.0|0.7|42|Incidence|6004733|Black|Male|Soft Tissue|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|57|Incidence|6496079|Black|Male|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.8|1.0|0.9|292|Incidence|32506235|Black|Male|Soft Tissue|2003-2007|0.8|1.0|0.9
0-19|0.6|1.1|0.8|56|Incidence|6686638|Black|Male|Soft Tissue|2004|0.6|1.1|0.8
0-19|0.7|1.2|0.9|64|Incidence|6705972|Black|Male|Soft Tissue|2005|0.7|1.2|1.0
0-19|0.7|1.2|0.9|63|Incidence|6732249|Black|Male|Soft Tissue|2006|0.7|1.2|0.9
0-19|0.7|1.1|0.9|62|Incidence|6737110|Black|Male|Soft Tissue|2007|0.7|1.2|0.9
0-19|1.4|1.8|1.6|176|Incidence|10969633|Black|Male and Female|Acute Lymphocytic|1999|1.4|1.9|1.6
0-19|1.2|1.7|1.5|163|Incidence|11067508|Black|Male and Female|Acute Lymphocytic|2000|1.3|1.7|1.5
0-19|1.4|1.9|1.6|191|Incidence|11878220|Black|Male and Female|Acute Lymphocytic|2001|1.4|1.9|1.6
0-19|1.3|1.7|1.5|173|Incidence|11809707|Black|Male and Female|Acute Lymphocytic|2002|1.3|1.7|1.5
0-19|1.3|1.8|1.5|196|Incidence|12788861|Black|Male and Female|Acute Lymphocytic|2003|1.3|1.8|1.5
0-19|1.6|1.8|1.7|1075|Incidence|64001369|Black|Male and Female|Acute Lymphocytic|2003-2007|1.6|1.8|1.7
0-19|1.5|1.9|1.7|223|Incidence|13167475|Black|Male and Female|Acute Lymphocytic|2004|1.5|1.9|1.7
0-19|1.5|2.0|1.8|231|Incidence|13205707|Black|Male and Female|Acute Lymphocytic|2005|1.5|2.0|1.7
0-19|1.5|2.0|1.8|234|Incidence|13256804|Black|Male and Female|Acute Lymphocytic|2006|1.5|2.0|1.8
0-19|1.6|2.1|1.8|241|Incidence|13263165|Black|Male and Female|Acute Lymphocytic|2007|1.6|2.1|1.8
0-19|0.6|0.9|0.7|77|Incidence|10969633|Black|Male and Female|Acute Myeloid|1999|0.6|0.9|0.7
0-19|0.5|0.7|0.6|64|Incidence|11067508|Black|Male and Female|Acute Myeloid|2000|0.4|0.7|0.6
0-19|0.4|0.7|0.5|61|Incidence|11878220|Black|Male and Female|Acute Myeloid|2001|0.4|0.7|0.5
0-19|0.5|0.8|0.7|78|Incidence|11809707|Black|Male and Female|Acute Myeloid|2002|0.5|0.8|0.7
0-19|0.6|0.9|0.8|96|Incidence|12788861|Black|Male and Female|Acute Myeloid|2003|0.6|0.9|0.8
0-19|0.6|0.7|0.7|425|Incidence|64001369|Black|Male and Female|Acute Myeloid|2003-2007|0.6|0.7|0.7
0-19|0.5|0.8|0.7|87|Incidence|13167475|Black|Male and Female|Acute Myeloid|2004|0.5|0.8|0.7
0-19|0.5|0.7|0.6|80|Incidence|13205707|Black|Male and Female|Acute Myeloid|2005|0.5|0.8|0.6
0-19|0.6|0.9|0.8|102|Incidence|13256804|Black|Male and Female|Acute Myeloid|2006|0.6|0.9|0.8
0-19|0.4|0.7|0.5|69|Incidence|13263165|Black|Male and Female|Acute Myeloid|2007|0.4|0.7|0.5
0-19|11.1|12.4|11.7|1276|Incidence|10969633|Black|Male and Female|All Cancer Sites Combined|1999|11.0|12.3|11.6
0-19|10.8|12.0|11.4|1252|Incidence|11067508|Black|Male and Female|All Cancer Sites Combined|2000|10.7|12.0|11.3
0-19|11.1|12.3|11.7|1379|Incidence|11878220|Black|Male and Female|All Cancer Sites Combined|2001|11.0|12.2|11.6
0-19|11.1|12.3|11.7|1378|Incidence|11809707|Black|Male and Female|All Cancer Sites Combined|2002|11.1|12.3|11.7
0-19|12.2|13.4|12.8|1631|Incidence|12788861|Black|Male and Female|All Cancer Sites Combined|2003|12.1|13.4|12.8
0-19|12.6|13.1|12.9|8265|Incidence|64001369|Black|Male and Female|All Cancer Sites Combined|2003-2007|12.6|13.2|12.9
0-19|12.4|13.7|13.0|1718|Incidence|13167475|Black|Male and Female|All Cancer Sites Combined|2004|12.4|13.7|13.0
0-19|12.5|13.8|13.1|1743|Incidence|13205707|Black|Male and Female|All Cancer Sites Combined|2005|12.6|13.8|13.2
0-19|12.1|13.3|12.7|1696|Incidence|13256804|Black|Male and Female|All Cancer Sites Combined|2006|12.2|13.4|12.8
0-19|12.1|13.3|12.7|1707|Incidence|13263165|Black|Male and Female|All Cancer Sites Combined|2007|12.3|13.5|12.9
0-19|0.6|1.0|0.8|87|Incidence|10969633|Black|Male and Female|Bones and Joints|1999|0.6|1.0|0.8
0-19|0.5|0.8|0.6|67|Incidence|11067508|Black|Male and Female|Bones and Joints|2000|0.5|0.8|0.6
0-19|0.5|0.8|0.7|78|Incidence|11878220|Black|Male and Female|Bones and Joints|2001|0.5|0.8|0.7
0-19|0.6|0.9|0.7|84|Incidence|11809707|Black|Male and Female|Bones and Joints|2002|0.6|0.9|0.7
0-19|0.6|0.9|0.7|91|Incidence|12788861|Black|Male and Female|Bones and Joints|2003|0.6|0.9|0.7
0-19|0.7|0.8|0.8|500|Incidence|64001369|Black|Male and Female|Bones and Joints|2003-2007|0.7|0.9|0.8
0-19|0.8|1.1|0.9|123|Incidence|13167475|Black|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.7|1.0|0.8|107|Incidence|13205707|Black|Male and Female|Bones and Joints|2005|0.7|1.0|0.8
0-19|0.6|0.9|0.8|103|Incidence|13256804|Black|Male and Female|Bones and Joints|2006|0.6|0.9|0.8
0-19|0.5|0.8|0.7|88|Incidence|13263165|Black|Male and Female|Bones and Joints|2007|0.5|0.8|0.7
0-19|1.8|2.3|2.0|223|Incidence|10969633|Black|Male and Female|Brain and Other Nervous System|1999|1.8|2.3|2.0
0-19|2.0|2.5|2.2|249|Incidence|11067508|Black|Male and Female|Brain and Other Nervous System|2000|2.0|2.5|2.2
0-19|1.8|2.3|2.1|244|Incidence|11878220|Black|Male and Female|Brain and Other Nervous System|2001|1.8|2.3|2.1
0-19|2.0|2.5|2.2|263|Incidence|11809707|Black|Male and Female|Brain and Other Nervous System|2002|2.0|2.5|2.2
0-19|2.0|2.5|2.2|282|Incidence|12788861|Black|Male and Female|Brain and Other Nervous System|2003|2.0|2.5|2.2
0-19|2.1|2.4|2.3|1441|Incidence|64001369|Black|Male and Female|Brain and Other Nervous System|2003-2007|2.1|2.4|2.3
0-19|2.2|2.7|2.4|317|Incidence|13167475|Black|Male and Female|Brain and Other Nervous System|2004|2.1|2.7|2.4
0-19|2.0|2.6|2.3|302|Incidence|13205707|Black|Male and Female|Brain and Other Nervous System|2005|2.0|2.6|2.3
0-19|2.0|2.5|2.2|291|Incidence|13256804|Black|Male and Female|Brain and Other Nervous System|2006|2.0|2.5|2.2
0-19|1.9|2.4|2.2|287|Incidence|13263165|Black|Male and Female|Brain and Other Nervous System|2007|1.9|2.4|2.2
0-19|0.7|1.0|0.8|90|Incidence|10969633|Black|Male and Female|Hodgkin Lymphoma|1999|0.7|1.0|0.8
0-19|0.8|1.2|1.0|104|Incidence|11067508|Black|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|0.7|1.0|0.8|99|Incidence|11878220|Black|Male and Female|Hodgkin Lymphoma|2001|0.7|1.0|0.8
0-19|0.7|1.1|0.9|104|Incidence|11809707|Black|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|0.8|1.1|0.9|118|Incidence|12788861|Black|Male and Female|Hodgkin Lymphoma|2003|0.8|1.1|0.9
0-19|0.9|1.0|1.0|628|Incidence|64001369|Black|Male and Female|Hodgkin Lymphoma|2003-2007|0.9|1.1|1.0
0-19|0.8|1.1|0.9|124|Incidence|13167475|Black|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|1.0|1.3|1.1|153|Incidence|13205707|Black|Male and Female|Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|0.8|1.1|0.9|124|Incidence|13256804|Black|Male and Female|Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|0.9|124|Incidence|13263165|Black|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.6|1.0|0.8|86|Incidence|10969633|Black|Male and Female|Kidney and Renal Pelvis|1999|0.6|1.0|0.8
0-19|0.8|1.1|0.9|105|Incidence|11067508|Black|Male and Female|Kidney and Renal Pelvis|2000|0.8|1.1|0.9
0-19|0.6|0.9|0.7|87|Incidence|11878220|Black|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.9|0.7
0-19|0.6|0.9|0.8|91|Incidence|11809707|Black|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.9|0.8
0-19|0.6|0.9|0.7|90|Incidence|12788861|Black|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.9|0.7
0-19|0.7|0.9|0.8|514|Incidence|64001369|Black|Male and Female|Kidney and Renal Pelvis|2003-2007|0.7|0.9|0.8
0-19|0.6|1.0|0.8|103|Incidence|13167475|Black|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.9|0.8
0-19|0.7|1.0|0.9|114|Incidence|13205707|Black|Male and Female|Kidney and Renal Pelvis|2005|0.7|1.0|0.9
0-19|0.7|1.0|0.8|111|Incidence|13256804|Black|Male and Female|Kidney and Renal Pelvis|2006|0.7|1.0|0.8
0-19|0.7|1.0|0.8|112|Incidence|13263165|Black|Male and Female|Kidney and Renal Pelvis|2007|0.7|1.0|0.8
0-19|2.4|3.0|2.7|291|Incidence|10969633|Black|Male and Female|Leukemia|1999|2.4|3.0|2.7
0-19|2.0|2.5|2.2|248|Incidence|11067508|Black|Male and Female|Leukemia|2000|2.0|2.5|2.2
0-19|2.1|2.7|2.4|284|Incidence|11878220|Black|Male and Female|Leukemia|2001|2.1|2.7|2.4
0-19|2.2|2.8|2.5|292|Incidence|11809707|Black|Male and Female|Leukemia|2002|2.2|2.8|2.5
0-19|2.4|2.9|2.6|338|Incidence|12788861|Black|Male and Female|Leukemia|2003|2.4|2.9|2.6
0-19|2.6|2.8|2.7|1716|Incidence|64001369|Black|Male and Female|Leukemia|2003-2007|2.6|2.8|2.7
0-19|2.5|3.0|2.7|361|Incidence|13167475|Black|Male and Female|Leukemia|2004|2.5|3.0|2.7
0-19|2.4|2.9|2.6|348|Incidence|13205707|Black|Male and Female|Leukemia|2005|2.4|2.9|2.6
0-19|2.5|3.1|2.8|373|Incidence|13256804|Black|Male and Female|Leukemia|2006|2.5|3.1|2.8
0-19|2.4|3.0|2.7|360|Incidence|13263165|Black|Male and Female|Leukemia|2007|2.4|3.0|2.7
0-19|0.8|1.2|1.0|106|Incidence|10969633|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.2|1.0
0-19|0.7|1.0|0.8|93|Incidence|11067508|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.7|1.0|0.8
0-19|0.8|1.2|1.0|117|Incidence|11878220|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.2|1.0
0-19|0.8|1.1|1.0|112|Incidence|11809707|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.8|1.1|0.9
0-19|0.8|1.2|1.0|125|Incidence|12788861|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.8|1.2|1.0
0-19|1.0|1.2|1.1|723|Incidence|64001369|Black|Male and Female|Non-Hodgkin Lymphoma|2003-2007|1.0|1.2|1.1
0-19|1.0|1.4|1.2|161|Incidence|13167475|Black|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.4|1.2
0-19|1.0|1.4|1.2|158|Incidence|13205707|Black|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|1.0|1.3|1.1|151|Incidence|13256804|Black|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.3|1.1
0-19|0.9|1.3|1.1|147|Incidence|13263165|Black|Male and Female|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|2.6|3.3|2.9|314|Incidence|10969633|Black|Male and Female|Other|1999|2.6|3.2|2.9
0-19|2.3|2.9|2.6|285|Incidence|11067508|Black|Male and Female|Other|2000|2.3|2.9|2.6
0-19|2.8|3.4|3.1|363|Incidence|11878220|Black|Male and Female|Other|2001|2.7|3.4|3.1
0-19|2.6|3.2|2.9|337|Incidence|11809707|Black|Male and Female|Other|2002|2.6|3.2|2.9
0-19|3.4|4.1|3.7|476|Incidence|12788861|Black|Male and Female|Other|2003|3.4|4.1|3.7
0-19|3.2|3.5|3.3|2143|Incidence|64001369|Black|Male and Female|Other|2003-2007|3.2|3.5|3.3
0-19|2.7|3.3|3.0|393|Incidence|13167475|Black|Male and Female|Other|2004|2.7|3.3|3.0
0-19|3.0|3.7|3.3|446|Incidence|13205707|Black|Male and Female|Other|2005|3.1|3.7|3.4
0-19|2.8|3.4|3.1|423|Incidence|13256804|Black|Male and Female|Other|2006|2.9|3.5|3.2
0-19|3.0|3.7|3.3|456|Incidence|13263165|Black|Male and Female|Other|2007|3.1|3.8|3.4
0-19|0.6|0.9|0.7|79|Incidence|10969633|Black|Male and Female|Soft Tissue|1999|0.6|0.9|0.7
0-19|0.8|1.1|0.9|101|Incidence|11067508|Black|Male and Female|Soft Tissue|2000|0.7|1.1|0.9
0-19|0.7|1.1|0.9|107|Incidence|11878220|Black|Male and Female|Soft Tissue|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|95|Incidence|11809707|Black|Male and Female|Soft Tissue|2002|0.7|1.0|0.8
0-19|0.7|1.0|0.9|111|Incidence|12788861|Black|Male and Female|Soft Tissue|2003|0.7|1.0|0.9
0-19|0.9|1.0|0.9|600|Incidence|64001369|Black|Male and Female|Soft Tissue|2003-2007|0.9|1.0|0.9
0-19|0.9|1.2|1.0|136|Incidence|13167475|Black|Male and Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.7|1.0|0.9|115|Incidence|13205707|Black|Male and Female|Soft Tissue|2005|0.7|1.0|0.9
0-19|0.7|1.1|0.9|120|Incidence|13256804|Black|Male and Female|Soft Tissue|2006|0.8|1.1|0.9
0-19|0.8|1.2|1.0|133|Incidence|13263165|Black|Male and Female|Soft Tissue|2007|0.8|1.2|1.0
0-19|2.8|3.6|3.2|208|Incidence|6236914|Hispanic|Female|Acute Lymphocytic|1999|2.9|3.8|3.3
0-19|3.3|4.3|3.8|255|Incidence|6496738|Hispanic|Female|Acute Lymphocytic|2000|3.5|4.4|3.9
0-19|3.2|4.1|3.6|254|Incidence|6777500|Hispanic|Female|Acute Lymphocytic|2001|3.3|4.2|3.7
0-19|3.3|4.1|3.7|270|Incidence|6971829|Hispanic|Female|Acute Lymphocytic|2002|3.4|4.4|3.9
0-19|3.1|3.9|3.5|267|Incidence|7264806|Hispanic|Female|Acute Lymphocytic|2003|3.2|4.1|3.7
0-19|3.3|3.7|3.5|1396|Incidence|38220512|Hispanic|Female|Acute Lymphocytic|2003-2007|3.5|3.8|3.7
0-19|3.0|3.9|3.4|271|Incidence|7525687|Hispanic|Female|Acute Lymphocytic|2004|3.2|4.1|3.6
0-19|2.9|3.7|3.3|273|Incidence|7773221|Hispanic|Female|Acute Lymphocytic|2005|3.1|4.0|3.5
0-19|3.2|4.0|3.6|305|Incidence|8040036|Hispanic|Female|Acute Lymphocytic|2006|3.4|4.2|3.8
0-19|3.1|3.9|3.5|296|Incidence|8194088|Hispanic|Female|Acute Lymphocytic|2007|3.2|4.0|3.6
0-19|0.5|0.9|0.6|41|Incidence|6236914|Hispanic|Female|Acute Myeloid|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|52|Incidence|6496738|Hispanic|Female|Acute Myeloid|2000|0.6|1.0|0.8
0-19|0.5|0.9|0.6|44|Incidence|6777500|Hispanic|Female|Acute Myeloid|2001|0.5|0.9|0.6
0-19|0.5|1.0|0.7|49|Incidence|6971829|Hispanic|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|50|Incidence|7264806|Hispanic|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.7|0.8|0.8|288|Incidence|38220512|Hispanic|Female|Acute Myeloid|2003-2007|0.7|0.8|0.8
0-19|0.6|1.0|0.8|61|Incidence|7525687|Hispanic|Female|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.5|0.9|0.7|56|Incidence|7773221|Hispanic|Female|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Incidence|8040036|Hispanic|Female|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.7|1.1|0.9|71|Incidence|8194088|Hispanic|Female|Acute Myeloid|2007|0.7|1.1|0.9
0-19|12.9|14.7|13.8|867|Incidence|6236914|Hispanic|Female|All Cancer Sites Combined|1999|13.0|14.9|13.9
0-19|14.3|16.2|15.2|989|Incidence|6496738|Hispanic|Female|All Cancer Sites Combined|2000|14.3|16.2|15.2
0-19|13.9|15.8|14.8|1021|Incidence|6777500|Hispanic|Female|All Cancer Sites Combined|2001|14.2|16.0|15.1
0-19|14.1|15.9|15.0|1051|Incidence|6971829|Hispanic|Female|All Cancer Sites Combined|2002|14.2|16.0|15.1
0-19|14.5|16.3|15.4|1132|Incidence|7264806|Hispanic|Female|All Cancer Sites Combined|2003|14.7|16.5|15.6
0-19|15.2|16.0|15.6|6011|Incidence|38220512|Hispanic|Female|All Cancer Sites Combined|2003-2007|15.3|16.1|15.7
0-19|15.7|17.5|16.6|1256|Incidence|7525687|Hispanic|Female|All Cancer Sites Combined|2004|15.8|17.6|16.7
0-19|14.4|16.2|15.3|1192|Incidence|7773221|Hispanic|Female|All Cancer Sites Combined|2005|14.5|16.2|15.3
0-19|14.6|16.4|15.5|1246|Incidence|8040036|Hispanic|Female|All Cancer Sites Combined|2006|14.6|16.4|15.5
0-19|14.5|16.2|15.3|1268|Incidence|8194088|Hispanic|Female|All Cancer Sites Combined|2007|14.6|16.4|15.5
0-19|0.7|1.1|0.9|52|Incidence|6236914|Hispanic|Female|Bones and Joints|1999|0.6|1.1|0.8
0-19|0.7|1.2|0.9|56|Incidence|6496738|Hispanic|Female|Bones and Joints|2000|0.7|1.1|0.9
0-19|0.5|1.0|0.7|46|Incidence|6777500|Hispanic|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.5|1.0|0.7|48|Incidence|6971829|Hispanic|Female|Bones and Joints|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|59|Incidence|7264806|Hispanic|Female|Bones and Joints|2003|0.6|1.0|0.8
0-19|0.7|0.9|0.8|292|Incidence|38220512|Hispanic|Female|Bones and Joints|2003-2007|0.7|0.9|0.8
0-19|0.7|1.2|1.0|67|Incidence|7525687|Hispanic|Female|Bones and Joints|2004|0.7|1.1|0.9
0-19|0.6|1.1|0.8|61|Incidence|7773221|Hispanic|Female|Bones and Joints|2005|0.6|1.0|0.8
0-19|0.6|1.1|0.8|63|Incidence|8040036|Hispanic|Female|Bones and Joints|2006|0.6|1.0|0.8
0-19|0.5|0.8|0.6|48|Incidence|8194088|Hispanic|Female|Bones and Joints|2007|0.4|0.8|0.6
0-19|1.9|2.6|2.2|144|Incidence|6236914|Hispanic|Female|Brain and Other Nervous System|1999|1.9|2.7|2.3
0-19|2.0|2.7|2.3|154|Incidence|6496738|Hispanic|Female|Brain and Other Nervous System|2000|2.0|2.8|2.4
0-19|2.0|2.7|2.4|165|Incidence|6777500|Hispanic|Female|Brain and Other Nervous System|2001|2.1|2.8|2.4
0-19|1.9|2.6|2.2|162|Incidence|6971829|Hispanic|Female|Brain and Other Nervous System|2002|2.0|2.7|2.3
0-19|2.1|2.8|2.5|186|Incidence|7264806|Hispanic|Female|Brain and Other Nervous System|2003|2.2|3.0|2.6
0-19|2.4|2.7|2.5|995|Incidence|38220512|Hispanic|Female|Brain and Other Nervous System|2003-2007|2.4|2.8|2.6
0-19|2.7|3.5|3.1|234|Incidence|7525687|Hispanic|Female|Brain and Other Nervous System|2004|2.7|3.5|3.1
0-19|1.9|2.6|2.3|181|Incidence|7773221|Hispanic|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|2.0|2.7|2.3|188|Incidence|8040036|Hispanic|Female|Brain and Other Nervous System|2006|2.0|2.7|2.3
0-19|2.3|3.0|2.6|220|Incidence|8194088|Hispanic|Female|Brain and Other Nervous System|2007|2.3|3.1|2.7
0-19|0.5|1.0|0.7|41|Incidence|6236914|Hispanic|Female|Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|49|Incidence|6496738|Hispanic|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.7|1.2|0.9|57|Incidence|6777500|Hispanic|Female|Hodgkin Lymphoma|2001|0.6|1.1|0.8
0-19|0.6|1.0|0.8|49|Incidence|6971829|Hispanic|Female|Hodgkin Lymphoma|2002|0.5|0.9|0.7
0-19|0.6|1.1|0.9|56|Incidence|7264806|Hispanic|Female|Hodgkin Lymphoma|2003|0.6|1.0|0.8
0-19|0.9|1.1|1.0|328|Incidence|38220512|Hispanic|Female|Hodgkin Lymphoma|2003-2007|0.8|1.0|0.9
0-19|0.8|1.3|1.0|70|Incidence|7525687|Hispanic|Female|Hodgkin Lymphoma|2004|0.7|1.2|0.9
0-19|0.8|1.2|1.0|68|Incidence|7773221|Hispanic|Female|Hodgkin Lymphoma|2005|0.7|1.1|0.9
0-19|0.8|1.3|1.1|76|Incidence|8040036|Hispanic|Female|Hodgkin Lymphoma|2006|0.7|1.2|0.9
0-19|0.7|1.1|0.9|62|Incidence|8194088|Hispanic|Female|Hodgkin Lymphoma|2007|0.6|1.0|0.8
0-19|0.5|0.9|0.6|44|Incidence|6236914|Hispanic|Female|Kidney and Renal Pelvis|1999|0.5|0.9|0.7
0-19|0.3|0.6|0.4|30|Incidence|6496738|Hispanic|Female|Kidney and Renal Pelvis|2000|0.3|0.7|0.5
0-19|0.4|0.8|0.6|45|Incidence|6777500|Hispanic|Female|Kidney and Renal Pelvis|2001|0.5|0.9|0.7
0-19|0.4|0.7|0.5|41|Incidence|6971829|Hispanic|Female|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.5|0.8|0.6|51|Incidence|7264806|Hispanic|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.5|0.6|0.6|245|Incidence|38220512|Hispanic|Female|Kidney and Renal Pelvis|2003-2007|0.6|0.7|0.6
0-19|0.4|0.8|0.6|49|Incidence|7525687|Hispanic|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.3|0.6|0.4|34|Incidence|7773221|Hispanic|Female|Kidney and Renal Pelvis|2005|0.3|0.6|0.4
0-19|0.4|0.7|0.6|53|Incidence|8040036|Hispanic|Female|Kidney and Renal Pelvis|2006|0.5|0.9|0.7
0-19|0.5|0.9|0.7|63|Incidence|8194088|Hispanic|Female|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|3.7|4.7|4.2|273|Incidence|6236914|Hispanic|Female|Leukemia|1999|3.9|4.9|4.4
0-19|4.5|5.6|5.1|338|Incidence|6496738|Hispanic|Female|Leukemia|2000|4.7|5.8|5.2
0-19|4.2|5.2|4.7|328|Incidence|6777500|Hispanic|Female|Leukemia|2001|4.3|5.4|4.8
0-19|4.5|5.5|5.0|360|Incidence|6971829|Hispanic|Female|Leukemia|2002|4.6|5.7|5.2
0-19|4.1|5.1|4.6|349|Incidence|7264806|Hispanic|Female|Leukemia|2003|4.3|5.3|4.8
0-19|4.4|4.8|4.6|1844|Incidence|38220512|Hispanic|Female|Leukemia|2003-2007|4.6|5.0|4.8
0-19|4.1|5.1|4.6|360|Incidence|7525687|Hispanic|Female|Leukemia|2004|4.3|5.3|4.8
0-19|4.0|4.9|4.5|364|Incidence|7773221|Hispanic|Female|Leukemia|2005|4.2|5.2|4.7
0-19|4.2|5.2|4.7|390|Incidence|8040036|Hispanic|Female|Leukemia|2006|4.4|5.4|4.9
0-19|4.3|5.3|4.8|404|Incidence|8194088|Hispanic|Female|Leukemia|2007|4.5|5.4|4.9
0-19|0.5|1.0|0.7|44|Incidence|6236914|Hispanic|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.5|1.0|0.7|45|Incidence|6496738|Hispanic|Female|Non-Hodgkin Lymphoma|2000|0.5|0.9|0.7
0-19|0.5|0.9|0.6|42|Incidence|6777500|Hispanic|Female|Non-Hodgkin Lymphoma|2001|0.4|0.8|0.6
0-19|0.6|1.1|0.8|55|Incidence|6971829|Hispanic|Female|Non-Hodgkin Lymphoma|2002|0.6|1.0|0.8
0-19|0.4|0.8|0.6|43|Incidence|7264806|Hispanic|Female|Non-Hodgkin Lymphoma|2003|0.4|0.8|0.6
0-19|0.6|0.8|0.7|263|Incidence|38220512|Hispanic|Female|Non-Hodgkin Lymphoma|2003-2007|0.6|0.8|0.7
0-19|0.5|0.9|0.7|49|Incidence|7525687|Hispanic|Female|Non-Hodgkin Lymphoma|2004|0.5|0.9|0.7
0-19|0.6|1.1|0.8|62|Incidence|7773221|Hispanic|Female|Non-Hodgkin Lymphoma|2005|0.6|1.0|0.8
0-19|0.5|0.9|0.7|54|Incidence|8040036|Hispanic|Female|Non-Hodgkin Lymphoma|2006|0.5|0.9|0.7
0-19|0.5|0.9|0.7|55|Incidence|8194088|Hispanic|Female|Non-Hodgkin Lymphoma|2007|0.5|0.9|0.7
0-19|3.2|4.1|3.6|222|Incidence|6236914|Hispanic|Female|Other|1999|3.1|4.1|3.6
0-19|3.6|4.7|4.1|262|Incidence|6496738|Hispanic|Female|Other|2000|3.6|4.6|4.0
0-19|3.6|4.6|4.1|278|Incidence|6777500|Hispanic|Female|Other|2001|3.6|4.6|4.1
0-19|3.6|4.6|4.0|275|Incidence|6971829|Hispanic|Female|Other|2002|3.5|4.4|3.9
0-19|3.7|4.7|4.2|297|Incidence|7264806|Hispanic|Female|Other|2003|3.6|4.6|4.1
0-19|4.2|4.6|4.4|1645|Incidence|38220512|Hispanic|Female|Other|2003-2007|4.1|4.5|4.3
0-19|4.2|5.2|4.7|353|Incidence|7525687|Hispanic|Female|Other|2004|4.2|5.2|4.7
0-19|4.0|5.0|4.5|343|Incidence|7773221|Hispanic|Female|Other|2005|4.0|4.9|4.4
0-19|3.9|4.8|4.3|339|Incidence|8040036|Hispanic|Female|Other|2006|3.8|4.7|4.2
0-19|3.8|4.7|4.2|340|Incidence|8194088|Hispanic|Female|Other|2007|3.7|4.6|4.1
0-19|0.5|1.0|0.7|47|Incidence|6236914|Hispanic|Female|Soft Tissue|1999|0.6|1.0|0.8
0-19|0.6|1.1|0.9|55|Incidence|6496738|Hispanic|Female|Soft Tissue|2000|0.6|1.1|0.8
0-19|0.7|1.1|0.9|60|Incidence|6777500|Hispanic|Female|Soft Tissue|2001|0.7|1.1|0.9
0-19|0.7|1.1|0.9|61|Incidence|6971829|Hispanic|Female|Soft Tissue|2002|0.7|1.1|0.9
0-19|1.0|1.5|1.2|91|Incidence|7264806|Hispanic|Female|Soft Tissue|2003|1.0|1.5|1.3
0-19|0.9|1.1|1.0|399|Incidence|38220512|Hispanic|Female|Soft Tissue|2003-2007|0.9|1.2|1.0
0-19|0.8|1.2|1.0|74|Incidence|7525687|Hispanic|Female|Soft Tissue|2004|0.8|1.2|1.0
0-19|0.8|1.3|1.0|79|Incidence|7773221|Hispanic|Female|Soft Tissue|2005|0.8|1.3|1.0
0-19|0.8|1.3|1.0|83|Incidence|8040036|Hispanic|Female|Soft Tissue|2006|0.8|1.3|1.0
0-19|0.7|1.1|0.9|76|Incidence|8194088|Hispanic|Female|Soft Tissue|2007|0.7|1.2|0.9
0-19|3.8|4.8|4.3|295|Incidence|6635632|Hispanic|Male|Acute Lymphocytic|1999|4.0|5.0|4.4
0-19|3.9|4.9|4.4|314|Incidence|6905637|Hispanic|Male|Acute Lymphocytic|2000|4.1|5.1|4.5
0-19|3.9|4.8|4.3|319|Incidence|7181644|Hispanic|Male|Acute Lymphocytic|2001|4.0|5.0|4.4
0-19|4.2|5.1|4.6|351|Incidence|7355503|Hispanic|Male|Acute Lymphocytic|2002|4.3|5.3|4.8
0-19|3.6|4.5|4.0|317|Incidence|7637910|Hispanic|Male|Acute Lymphocytic|2003|3.7|4.6|4.2
0-19|4.4|4.8|4.6|1908|Incidence|40095983|Hispanic|Male|Acute Lymphocytic|2003-2007|4.5|5.0|4.8
0-19|4.1|5.0|4.5|373|Incidence|7896624|Hispanic|Male|Acute Lymphocytic|2004|4.3|5.2|4.7
0-19|4.1|5.0|4.6|384|Incidence|8152179|Hispanic|Male|Acute Lymphocytic|2005|4.3|5.2|4.7
0-19|4.3|5.2|4.8|411|Incidence|8428638|Hispanic|Male|Acute Lymphocytic|2006|4.4|5.4|4.9
0-19|4.6|5.5|5.0|449|Incidence|8590364|Hispanic|Male|Acute Lymphocytic|2007|4.8|5.7|5.2
0-19|0.8|1.3|1.0|65|Incidence|6635632|Hispanic|Male|Acute Myeloid|1999|0.8|1.2|1.0
0-19|0.5|0.9|0.7|46|Incidence|6905637|Hispanic|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.6|1.1|0.8|62|Incidence|7181644|Hispanic|Male|Acute Myeloid|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|56|Incidence|7355503|Hispanic|Male|Acute Myeloid|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|54|Incidence|7637910|Hispanic|Male|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.7|0.9|0.8|328|Incidence|40095983|Hispanic|Male|Acute Myeloid|2003-2007|0.7|0.9|0.8
0-19|0.8|1.3|1.0|81|Incidence|7896624|Hispanic|Male|Acute Myeloid|2004|0.8|1.3|1.0
0-19|0.7|1.1|0.8|70|Incidence|8152179|Hispanic|Male|Acute Myeloid|2005|0.7|1.1|0.9
0-19|0.6|0.9|0.7|63|Incidence|8428638|Hispanic|Male|Acute Myeloid|2006|0.6|1.0|0.7
0-19|0.6|0.9|0.7|64|Incidence|8590364|Hispanic|Male|Acute Myeloid|2007|0.6|1.0|0.7
0-19|16.0|18.0|17.0|1141|Incidence|6635632|Hispanic|Male|All Cancer Sites Combined|1999|16.2|18.2|17.2
0-19|15.2|17.2|16.2|1125|Incidence|6905637|Hispanic|Male|All Cancer Sites Combined|2000|15.4|17.3|16.3
0-19|17.1|19.1|18.1|1309|Incidence|7181644|Hispanic|Male|All Cancer Sites Combined|2001|17.3|19.2|18.2
0-19|17.6|19.6|18.6|1368|Incidence|7355503|Hispanic|Male|All Cancer Sites Combined|2002|17.6|19.6|18.6
0-19|15.5|17.4|16.4|1260|Incidence|7637910|Hispanic|Male|All Cancer Sites Combined|2003|15.6|17.4|16.5
0-19|17.2|18.1|17.6|7118|Incidence|40095983|Hispanic|Male|All Cancer Sites Combined|2003-2007|17.3|18.2|17.8
0-19|16.8|18.7|17.7|1413|Incidence|7896624|Hispanic|Male|All Cancer Sites Combined|2004|17.0|18.9|17.9
0-19|16.7|18.6|17.6|1450|Incidence|8152179|Hispanic|Male|All Cancer Sites Combined|2005|16.9|18.7|17.8
0-19|17.4|19.3|18.3|1541|Incidence|8428638|Hispanic|Male|All Cancer Sites Combined|2006|17.4|19.2|18.3
0-19|17.0|18.8|17.9|1555|Incidence|8590364|Hispanic|Male|All Cancer Sites Combined|2007|17.2|19.0|18.1
0-19|0.5|0.9|0.7|45|Incidence|6635632|Hispanic|Male|Bones and Joints|1999|0.5|0.9|0.7
0-19|0.7|1.1|0.9|59|Incidence|6905637|Hispanic|Male|Bones and Joints|2000|0.7|1.1|0.9
0-19|0.9|1.4|1.2|79|Incidence|7181644|Hispanic|Male|Bones and Joints|2001|0.9|1.4|1.1
0-19|1.0|1.5|1.2|82|Incidence|7355503|Hispanic|Male|Bones and Joints|2002|0.9|1.4|1.1
0-19|0.8|1.2|1.0|68|Incidence|7637910|Hispanic|Male|Bones and Joints|2003|0.7|1.1|0.9
0-19|0.9|1.2|1.0|387|Incidence|40095983|Hispanic|Male|Bones and Joints|2003-2007|0.9|1.1|1.0
0-19|0.8|1.3|1.0|73|Incidence|7896624|Hispanic|Male|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.8|1.2|1.0|75|Incidence|8152179|Hispanic|Male|Bones and Joints|2005|0.7|1.2|0.9
0-19|1.0|1.5|1.2|94|Incidence|8428638|Hispanic|Male|Bones and Joints|2006|0.9|1.4|1.1
0-19|0.8|1.3|1.0|82|Incidence|8590364|Hispanic|Male|Bones and Joints|2007|0.8|1.2|1.0
0-19|2.6|3.5|3.0|203|Incidence|6635632|Hispanic|Male|Brain and Other Nervous System|1999|2.7|3.5|3.1
0-19|2.3|3.1|2.7|186|Incidence|6905637|Hispanic|Male|Brain and Other Nervous System|2000|2.3|3.1|2.7
0-19|2.5|3.3|2.9|214|Incidence|7181644|Hispanic|Male|Brain and Other Nervous System|2001|2.6|3.4|3.0
0-19|2.5|3.3|2.9|218|Incidence|7355503|Hispanic|Male|Brain and Other Nervous System|2002|2.6|3.4|3.0
0-19|2.3|3.0|2.7|207|Incidence|7637910|Hispanic|Male|Brain and Other Nervous System|2003|2.4|3.1|2.7
0-19|2.5|2.9|2.7|1112|Incidence|40095983|Hispanic|Male|Brain and Other Nervous System|2003-2007|2.6|2.9|2.8
0-19|2.2|2.9|2.5|207|Incidence|7896624|Hispanic|Male|Brain and Other Nervous System|2004|2.3|3.0|2.6
0-19|2.4|3.2|2.8|234|Incidence|8152179|Hispanic|Male|Brain and Other Nervous System|2005|2.5|3.3|2.9
0-19|2.5|3.3|2.9|247|Incidence|8428638|Hispanic|Male|Brain and Other Nervous System|2006|2.6|3.3|2.9
0-19|2.3|3.0|2.6|230|Incidence|8590364|Hispanic|Male|Brain and Other Nervous System|2007|2.3|3.0|2.7
0-19|0.9|1.4|1.1|72|Incidence|6635632|Hispanic|Male|Hodgkin Lymphoma|1999|0.8|1.4|1.1
0-19|0.8|1.4|1.1|72|Incidence|6905637|Hispanic|Male|Hodgkin Lymphoma|2000|0.8|1.3|1.0
0-19|1.1|1.7|1.4|95|Incidence|7181644|Hispanic|Male|Hodgkin Lymphoma|2001|1.1|1.6|1.3
0-19|0.9|1.4|1.1|77|Incidence|7355503|Hispanic|Male|Hodgkin Lymphoma|2002|0.8|1.3|1.0
0-19|1.2|1.8|1.5|105|Incidence|7637910|Hispanic|Male|Hodgkin Lymphoma|2003|1.1|1.7|1.4
0-19|1.1|1.3|1.2|453|Incidence|40095983|Hispanic|Male|Hodgkin Lymphoma|2003-2007|1.0|1.2|1.1
0-19|0.8|1.2|1.0|70|Incidence|7896624|Hispanic|Male|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.9|1.4|1.2|87|Incidence|8152179|Hispanic|Male|Hodgkin Lymphoma|2005|0.9|1.3|1.1
0-19|1.1|1.6|1.3|100|Incidence|8428638|Hispanic|Male|Hodgkin Lymphoma|2006|1.0|1.4|1.2
0-19|1.0|1.5|1.2|95|Incidence|8590364|Hispanic|Male|Hodgkin Lymphoma|2007|0.9|1.4|1.1
0-19|0.4|0.7|0.5|38|Incidence|6635632|Hispanic|Male|Kidney and Renal Pelvis|1999|0.4|0.8|0.6
0-19|0.3|0.6|0.5|34|Incidence|6905637|Hispanic|Male|Kidney and Renal Pelvis|2000|0.3|0.7|0.5
0-19|0.4|0.7|0.5|42|Incidence|7181644|Hispanic|Male|Kidney and Renal Pelvis|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7355503|Hispanic|Male|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.4|0.7|0.5|41|Incidence|7637910|Hispanic|Male|Kidney and Renal Pelvis|2003|0.4|0.7|0.5
0-19|0.4|0.5|0.5|209|Incidence|40095983|Hispanic|Male|Kidney and Renal Pelvis|2003-2007|0.5|0.6|0.5
0-19|0.3|0.6|0.4|38|Incidence|7896624|Hispanic|Male|Kidney and Renal Pelvis|2004|0.3|0.7|0.5
0-19|0.3|0.6|0.5|42|Incidence|8152179|Hispanic|Male|Kidney and Renal Pelvis|2005|0.4|0.7|0.5
0-19|0.3|0.5|0.4|38|Incidence|8428638|Hispanic|Male|Kidney and Renal Pelvis|2006|0.3|0.6|0.5
0-19|0.4|0.7|0.5|51|Incidence|8590364|Hispanic|Male|Kidney and Renal Pelvis|2007|0.4|0.8|0.6
0-19|5.2|6.4|5.8|393|Incidence|6635632|Hispanic|Male|Leukemia|1999|5.4|6.5|5.9
0-19|5.0|6.1|5.5|388|Incidence|6905637|Hispanic|Male|Leukemia|2000|5.1|6.2|5.6
0-19|5.2|6.4|5.8|424|Incidence|7181644|Hispanic|Male|Leukemia|2001|5.4|6.5|5.9
0-19|5.4|6.5|5.9|445|Incidence|7355503|Hispanic|Male|Leukemia|2002|5.5|6.6|6.0
0-19|4.6|5.6|5.1|397|Incidence|7637910|Hispanic|Male|Leukemia|2003|4.7|5.7|5.2
0-19|5.6|6.1|5.9|2428|Incidence|40095983|Hispanic|Male|Leukemia|2003-2007|5.8|6.3|6.1
0-19|5.5|6.6|6.0|492|Incidence|7896624|Hispanic|Male|Leukemia|2004|5.7|6.8|6.2
0-19|5.4|6.4|5.9|496|Incidence|8152179|Hispanic|Male|Leukemia|2005|5.6|6.6|6.1
0-19|5.5|6.6|6.0|520|Incidence|8428638|Hispanic|Male|Leukemia|2006|5.7|6.7|6.2
0-19|5.7|6.8|6.2|555|Incidence|8590364|Hispanic|Male|Leukemia|2007|5.9|7.0|6.5
0-19|0.9|1.4|1.1|72|Incidence|6635632|Hispanic|Male|Non-Hodgkin Lymphoma|1999|0.8|1.4|1.1
0-19|1.0|1.6|1.3|88|Incidence|6905637|Hispanic|Male|Non-Hodgkin Lymphoma|2000|1.0|1.6|1.3
0-19|1.0|1.5|1.2|84|Incidence|7181644|Hispanic|Male|Non-Hodgkin Lymphoma|2001|0.9|1.4|1.2
0-19|1.4|2.0|1.7|118|Incidence|7355503|Hispanic|Male|Non-Hodgkin Lymphoma|2002|1.3|1.9|1.6
0-19|0.9|1.4|1.1|83|Incidence|7637910|Hispanic|Male|Non-Hodgkin Lymphoma|2003|0.9|1.3|1.1
0-19|1.1|1.4|1.2|477|Incidence|40095983|Hispanic|Male|Non-Hodgkin Lymphoma|2003-2007|1.1|1.3|1.2
0-19|1.2|1.8|1.5|113|Incidence|7896624|Hispanic|Male|Non-Hodgkin Lymphoma|2004|1.2|1.7|1.4
0-19|1.1|1.6|1.3|100|Incidence|8152179|Hispanic|Male|Non-Hodgkin Lymphoma|2005|1.0|1.5|1.2
0-19|1.0|1.5|1.2|96|Incidence|8428638|Hispanic|Male|Non-Hodgkin Lymphoma|2006|0.9|1.4|1.1
0-19|0.9|1.4|1.1|92|Incidence|8590364|Hispanic|Male|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|3.4|4.3|3.8|260|Incidence|6635632|Hispanic|Male|Other|1999|3.5|4.4|3.9
0-19|2.9|3.7|3.3|229|Incidence|6905637|Hispanic|Male|Other|2000|2.9|3.8|3.3
0-19|3.8|4.7|4.2|306|Incidence|7181644|Hispanic|Male|Other|2001|3.8|4.8|4.3
0-19|3.7|4.7|4.2|305|Incidence|7355503|Hispanic|Male|Other|2002|3.7|4.6|4.1
0-19|3.5|4.4|3.9|300|Incidence|7637910|Hispanic|Male|Other|2003|3.5|4.4|3.9
0-19|4.0|4.4|4.2|1696|Incidence|40095983|Hispanic|Male|Other|2003-2007|4.0|4.4|4.2
0-19|3.8|4.7|4.2|339|Incidence|7896624|Hispanic|Male|Other|2004|3.8|4.8|4.3
0-19|3.8|4.7|4.3|348|Incidence|8152179|Hispanic|Male|Other|2005|3.8|4.7|4.3
0-19|3.9|4.8|4.4|367|Incidence|8428638|Hispanic|Male|Other|2006|3.9|4.8|4.4
0-19|3.9|4.8|4.3|374|Incidence|8590364|Hispanic|Male|Other|2007|3.9|4.8|4.4
0-19|0.6|1.1|0.9|58|Incidence|6635632|Hispanic|Male|Soft Tissue|1999|0.7|1.1|0.9
0-19|0.8|1.3|1.0|69|Incidence|6905637|Hispanic|Male|Soft Tissue|2000|0.8|1.3|1.0
0-19|0.7|1.2|0.9|65|Incidence|7181644|Hispanic|Male|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.8|1.3|1.1|79|Incidence|7355503|Hispanic|Male|Soft Tissue|2002|0.9|1.3|1.1
0-19|0.6|1.0|0.7|59|Incidence|7637910|Hispanic|Male|Soft Tissue|2003|0.6|1.0|0.8
0-19|0.8|1.0|0.9|356|Incidence|40095983|Hispanic|Male|Soft Tissue|2003-2007|0.8|1.0|0.9
0-19|0.8|1.3|1.0|81|Incidence|7896624|Hispanic|Male|Soft Tissue|2004|0.8|1.3|1.0
0-19|0.6|1.0|0.8|68|Incidence|8152179|Hispanic|Male|Soft Tissue|2005|0.6|1.1|0.8
0-19|0.7|1.2|0.9|79|Incidence|8428638|Hispanic|Male|Soft Tissue|2006|0.7|1.2|0.9
0-19|0.7|1.1|0.9|76|Incidence|8590364|Hispanic|Male|Soft Tissue|2007|0.7|1.1|0.9
0-19|3.4|4.1|3.8|503|Incidence|12872546|Hispanic|Male and Female|Acute Lymphocytic|1999|3.6|4.3|3.9
0-19|3.8|4.5|4.1|569|Incidence|13402375|Hispanic|Male and Female|Acute Lymphocytic|2000|3.9|4.6|4.2
0-19|3.7|4.3|4.0|573|Incidence|13959144|Hispanic|Male and Female|Acute Lymphocytic|2001|3.8|4.5|4.1
0-19|3.8|4.5|4.2|621|Incidence|14327332|Hispanic|Male and Female|Acute Lymphocytic|2002|4.0|4.7|4.3
0-19|3.4|4.1|3.7|584|Incidence|14902716|Hispanic|Male and Female|Acute Lymphocytic|2003|3.6|4.2|3.9
0-19|3.9|4.2|4.0|3304|Incidence|78316495|Hispanic|Male and Female|Acute Lymphocytic|2003-2007|4.1|4.4|4.2
0-19|3.7|4.3|4.0|644|Incidence|15422311|Hispanic|Male and Female|Acute Lymphocytic|2004|3.9|4.5|4.2
0-19|3.6|4.3|3.9|657|Incidence|15925400|Hispanic|Male and Female|Acute Lymphocytic|2005|3.8|4.5|4.1
0-19|3.9|4.5|4.2|716|Incidence|16468674|Hispanic|Male and Female|Acute Lymphocytic|2006|4.0|4.7|4.3
0-19|4.0|4.6|4.3|745|Incidence|16784452|Hispanic|Male and Female|Acute Lymphocytic|2007|4.1|4.8|4.4
0-19|0.7|1.0|0.8|106|Incidence|12872546|Hispanic|Male and Female|Acute Myeloid|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.7|98|Incidence|13402375|Hispanic|Male and Female|Acute Myeloid|2000|0.6|0.9|0.7
0-19|0.6|0.9|0.7|106|Incidence|13959144|Hispanic|Male and Female|Acute Myeloid|2001|0.6|0.9|0.8
0-19|0.6|0.9|0.7|105|Incidence|14327332|Hispanic|Male and Female|Acute Myeloid|2002|0.6|0.9|0.7
0-19|0.6|0.8|0.7|104|Incidence|14902716|Hispanic|Male and Female|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.7|0.8|0.8|616|Incidence|78316495|Hispanic|Male and Female|Acute Myeloid|2003-2007|0.7|0.9|0.8
0-19|0.8|1.1|0.9|142|Incidence|15422311|Hispanic|Male and Female|Acute Myeloid|2004|0.8|1.1|0.9
0-19|0.6|0.9|0.8|126|Incidence|15925400|Hispanic|Male and Female|Acute Myeloid|2005|0.7|0.9|0.8
0-19|0.6|0.9|0.7|119|Incidence|16468674|Hispanic|Male and Female|Acute Myeloid|2006|0.6|0.9|0.7
0-19|0.7|0.9|0.8|135|Incidence|16784452|Hispanic|Male and Female|Acute Myeloid|2007|0.7|1.0|0.8
0-19|14.7|16.1|15.4|2008|Incidence|12872546|Hispanic|Male and Female|All Cancer Sites Combined|1999|14.9|16.3|15.6
0-19|15.0|16.4|15.7|2114|Incidence|13402375|Hispanic|Male and Female|All Cancer Sites Combined|2000|15.1|16.5|15.8
0-19|15.9|17.2|16.5|2330|Incidence|13959144|Hispanic|Male and Female|All Cancer Sites Combined|2001|16.0|17.4|16.7
0-19|16.2|17.5|16.8|2419|Incidence|14327332|Hispanic|Male and Female|All Cancer Sites Combined|2002|16.2|17.6|16.9
0-19|15.3|16.6|15.9|2392|Incidence|14902716|Hispanic|Male and Female|All Cancer Sites Combined|2003|15.4|16.7|16.1
0-19|16.4|16.9|16.7|13129|Incidence|78316495|Hispanic|Male and Female|All Cancer Sites Combined|2003-2007|16.5|17.1|16.8
0-19|16.5|17.8|17.2|2669|Incidence|15422311|Hispanic|Male and Female|All Cancer Sites Combined|2004|16.7|18.0|17.3
0-19|15.9|17.1|16.5|2642|Incidence|15925400|Hispanic|Male and Female|All Cancer Sites Combined|2005|16.0|17.2|16.6
0-19|16.3|17.6|16.9|2787|Incidence|16468674|Hispanic|Male and Female|All Cancer Sites Combined|2006|16.3|17.6|16.9
0-19|16.1|17.3|16.7|2823|Incidence|16784452|Hispanic|Male and Female|All Cancer Sites Combined|2007|16.2|17.5|16.8
0-19|0.6|1.0|0.8|97|Incidence|12872546|Hispanic|Male and Female|Bones and Joints|1999|0.6|0.9|0.8
0-19|0.7|1.1|0.9|115|Incidence|13402375|Hispanic|Male and Female|Bones and Joints|2000|0.7|1.0|0.9
0-19|0.8|1.1|1.0|125|Incidence|13959144|Hispanic|Male and Female|Bones and Joints|2001|0.7|1.1|0.9
0-19|0.8|1.2|1.0|130|Incidence|14327332|Hispanic|Male and Female|Bones and Joints|2002|0.8|1.1|0.9
0-19|0.8|1.1|0.9|127|Incidence|14902716|Hispanic|Male and Female|Bones and Joints|2003|0.7|1.0|0.9
0-19|0.9|1.0|0.9|679|Incidence|78316495|Hispanic|Male and Female|Bones and Joints|2003-2007|0.8|0.9|0.9
0-19|0.8|1.2|1.0|140|Incidence|15422311|Hispanic|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.8|1.1|0.9|136|Incidence|15925400|Hispanic|Male and Female|Bones and Joints|2005|0.7|1.0|0.9
0-19|0.9|1.2|1.0|157|Incidence|16468674|Hispanic|Male and Female|Bones and Joints|2006|0.8|1.1|1.0
0-19|0.7|1.0|0.8|130|Incidence|16784452|Hispanic|Male and Female|Bones and Joints|2007|0.6|0.9|0.8
0-19|2.4|2.9|2.6|347|Incidence|12872546|Hispanic|Male and Female|Brain and Other Nervous System|1999|2.4|3.0|2.7
0-19|2.2|2.8|2.5|340|Incidence|13402375|Hispanic|Male and Female|Brain and Other Nervous System|2000|2.3|2.8|2.5
0-19|2.4|2.9|2.6|379|Incidence|13959144|Hispanic|Male and Female|Brain and Other Nervous System|2001|2.4|3.0|2.7
0-19|2.3|2.9|2.6|380|Incidence|14327332|Hispanic|Male and Female|Brain and Other Nervous System|2002|2.4|2.9|2.7
0-19|2.3|2.8|2.6|393|Incidence|14902716|Hispanic|Male and Female|Brain and Other Nervous System|2003|2.4|2.9|2.6
0-19|2.5|2.7|2.6|2107|Incidence|78316495|Hispanic|Male and Female|Brain and Other Nervous System|2003-2007|2.6|2.8|2.7
0-19|2.5|3.1|2.8|441|Incidence|15422311|Hispanic|Male and Female|Brain and Other Nervous System|2004|2.6|3.1|2.9
0-19|2.3|2.8|2.5|415|Incidence|15925400|Hispanic|Male and Female|Brain and Other Nervous System|2005|2.4|2.9|2.6
0-19|2.4|2.9|2.6|435|Incidence|16468674|Hispanic|Male and Female|Brain and Other Nervous System|2006|2.4|2.9|2.6
0-19|2.4|2.9|2.6|450|Incidence|16784452|Hispanic|Male and Female|Brain and Other Nervous System|2007|2.4|2.9|2.7
0-19|0.8|1.1|0.9|113|Incidence|12872546|Hispanic|Male and Female|Hodgkin Lymphoma|1999|0.7|1.1|0.9
0-19|0.8|1.1|1.0|121|Incidence|13402375|Hispanic|Male and Female|Hodgkin Lymphoma|2000|0.7|1.1|0.9
0-19|1.0|1.4|1.2|152|Incidence|13959144|Hispanic|Male and Female|Hodgkin Lymphoma|2001|0.9|1.3|1.1
0-19|0.8|1.1|1.0|126|Incidence|14327332|Hispanic|Male and Female|Hodgkin Lymphoma|2002|0.7|1.0|0.9
0-19|1.0|1.4|1.2|161|Incidence|14902716|Hispanic|Male and Female|Hodgkin Lymphoma|2003|0.9|1.3|1.1
0-19|1.0|1.2|1.1|781|Incidence|78316495|Hispanic|Male and Female|Hodgkin Lymphoma|2003-2007|0.9|1.1|1.0
0-19|0.8|1.2|1.0|140|Incidence|15422311|Hispanic|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|0.9|1.3|1.1|155|Incidence|15925400|Hispanic|Male and Female|Hodgkin Lymphoma|2005|0.8|1.1|1.0
0-19|1.0|1.4|1.2|176|Incidence|16468674|Hispanic|Male and Female|Hodgkin Lymphoma|2006|0.9|1.2|1.1
0-19|0.9|1.2|1.0|157|Incidence|16784452|Hispanic|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.5|0.7|0.6|82|Incidence|12872546|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|0.5|0.8|0.6
0-19|0.3|0.6|0.4|64|Incidence|13402375|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|0.4|0.6|0.5
0-19|0.5|0.7|0.6|87|Incidence|13959144|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|0.5|0.8|0.6
0-19|0.4|0.7|0.5|85|Incidence|14327332|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.4|0.7|0.5|92|Incidence|14902716|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|0.5|0.8|0.6
0-19|0.5|0.6|0.5|454|Incidence|78316495|Hispanic|Male and Female|Kidney and Renal Pelvis|2003-2007|0.5|0.6|0.6
0-19|0.4|0.6|0.5|87|Incidence|15422311|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.3|0.5|0.4|76|Incidence|15925400|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|91|Incidence|16468674|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|0.4|0.7|0.6
0-19|0.5|0.7|0.6|114|Incidence|16784452|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|4.6|5.4|5.0|666|Incidence|12872546|Hispanic|Male and Female|Leukemia|1999|4.8|5.6|5.2
0-19|4.9|5.7|5.3|726|Incidence|13402375|Hispanic|Male and Female|Leukemia|2000|5.0|5.8|5.4
0-19|4.9|5.6|5.2|752|Incidence|13959144|Hispanic|Male and Female|Leukemia|2001|5.0|5.8|5.4
0-19|5.1|5.8|5.4|805|Incidence|14327332|Hispanic|Male and Female|Leukemia|2002|5.2|6.0|5.6
0-19|4.5|5.2|4.8|746|Incidence|14902716|Hispanic|Male and Female|Leukemia|2003|4.7|5.4|5.0
0-19|5.1|5.4|5.3|4272|Incidence|78316495|Hispanic|Male and Female|Leukemia|2003-2007|5.3|5.6|5.5
0-19|5.0|5.7|5.3|852|Incidence|15422311|Hispanic|Male and Female|Leukemia|2004|5.2|5.9|5.5
0-19|4.8|5.6|5.2|860|Incidence|15925400|Hispanic|Male and Female|Leukemia|2005|5.0|5.8|5.4
0-19|5.0|5.7|5.4|910|Incidence|16468674|Hispanic|Male and Female|Leukemia|2006|5.2|5.9|5.5
0-19|5.2|5.9|5.5|959|Incidence|16784452|Hispanic|Male and Female|Leukemia|2007|5.4|6.1|5.7
0-19|0.8|1.1|0.9|116|Incidence|12872546|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|0.7|1.1|0.9
0-19|0.9|1.2|1.0|133|Incidence|13402375|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|0.8|1.2|1.0
0-19|0.8|1.1|0.9|126|Incidence|13959144|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.1|0.9
0-19|1.1|1.5|1.3|173|Incidence|14327332|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.4|1.2
0-19|0.7|1.0|0.9|126|Incidence|14902716|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.0|0.8
0-19|0.9|1.1|1.0|740|Incidence|78316495|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.9|1.0|0.9
0-19|0.9|1.3|1.1|162|Incidence|15422311|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.9|1.2|1.1
0-19|0.9|1.3|1.1|162|Incidence|15925400|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|0.9|1.2|1.0
0-19|0.8|1.1|1.0|150|Incidence|16468674|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|0.9|147|Incidence|16784452|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.7|1.0|0.9
0-19|3.4|4.1|3.7|482|Incidence|12872546|Hispanic|Male and Female|Other|1999|3.4|4.1|3.7
0-19|3.4|4.0|3.7|491|Incidence|13402375|Hispanic|Male and Female|Other|2000|3.3|4.0|3.7
0-19|3.8|4.5|4.2|584|Incidence|13959144|Hispanic|Male and Female|Other|2001|3.9|4.5|4.2
0-19|3.8|4.5|4.1|580|Incidence|14327332|Hispanic|Male and Female|Other|2002|3.7|4.4|4.0
0-19|3.7|4.4|4.0|597|Incidence|14902716|Hispanic|Male and Female|Other|2003|3.7|4.3|4.0
0-19|4.1|4.4|4.3|3341|Incidence|78316495|Hispanic|Male and Female|Other|2003-2007|4.1|4.4|4.3
0-19|4.1|4.8|4.5|692|Incidence|15422311|Hispanic|Male and Female|Other|2004|4.2|4.8|4.5
0-19|4.1|4.7|4.4|691|Incidence|15925400|Hispanic|Male and Female|Other|2005|4.0|4.7|4.3
0-19|4.0|4.7|4.3|706|Incidence|16468674|Hispanic|Male and Female|Other|2006|4.0|4.6|4.3
0-19|3.9|4.6|4.3|714|Incidence|16784452|Hispanic|Male and Female|Other|2007|3.9|4.6|4.3
0-19|0.7|1.0|0.8|105|Incidence|12872546|Hispanic|Male and Female|Soft Tissue|1999|0.7|1.0|0.8
0-19|0.8|1.1|0.9|124|Incidence|13402375|Hispanic|Male and Female|Soft Tissue|2000|0.8|1.1|0.9
0-19|0.7|1.1|0.9|125|Incidence|13959144|Hispanic|Male and Female|Soft Tissue|2001|0.7|1.1|0.9
0-19|0.8|1.1|1.0|140|Incidence|14327332|Hispanic|Male and Female|Soft Tissue|2002|0.8|1.2|1.0
0-19|0.8|1.2|1.0|150|Incidence|14902716|Hispanic|Male and Female|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.9|1.0|0.9|755|Incidence|78316495|Hispanic|Male and Female|Soft Tissue|2003-2007|0.9|1.0|1.0
0-19|0.8|1.2|1.0|155|Incidence|15422311|Hispanic|Male and Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.8|1.1|0.9|147|Incidence|15925400|Hispanic|Male and Female|Soft Tissue|2005|0.8|1.1|0.9
0-19|0.8|1.1|1.0|162|Incidence|16468674|Hispanic|Male and Female|Soft Tissue|2006|0.8|1.1|1.0
0-19|0.7|1.0|0.9|152|Incidence|16784452|Hispanic|Male and Female|Soft Tissue|2007|0.8|1.1|0.9
0-19|2.7|3.1|2.9|800|Incidence|27890317|White|Female|Acute Lymphocytic|1999|2.7|3.1|2.9
0-19|2.9|3.3|3.1|861|Incidence|27994447|White|Female|Acute Lymphocytic|2000|2.9|3.3|3.1
0-19|2.9|3.4|3.1|910|Incidence|29165264|White|Female|Acute Lymphocytic|2001|2.9|3.3|3.1
0-19|2.8|3.2|3.0|863|Incidence|29197702|White|Female|Acute Lymphocytic|2002|2.8|3.2|3.0
0-19|2.7|3.1|2.9|882|Incidence|30181861|White|Female|Acute Lymphocytic|2003|2.7|3.1|2.9
0-19|2.9|3.1|3.0|4531|Incidence|150326854|White|Female|Acute Lymphocytic|2003-2007|2.9|3.1|3.0
0-19|2.8|3.2|3.0|920|Incidence|30857914|White|Female|Acute Lymphocytic|2004|2.8|3.2|3.0
0-19|2.8|3.2|3.0|919|Incidence|30906558|White|Female|Acute Lymphocytic|2005|2.8|3.2|3.0
0-19|2.9|3.3|3.1|950|Incidence|30977009|White|Female|Acute Lymphocytic|2006|2.9|3.3|3.1
0-19|2.9|3.3|3.1|957|Incidence|30810937|White|Female|Acute Lymphocytic|2007|2.9|3.3|3.1
0-19|0.6|0.8|0.7|183|Incidence|27890317|White|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|188|Incidence|27994447|White|Female|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|201|Incidence|29165264|White|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|194|Incidence|29197702|White|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|181|Incidence|30181861|White|Female|Acute Myeloid|2003|0.5|0.7|0.6
0-19|0.6|0.7|0.6|958|Incidence|150326854|White|Female|Acute Myeloid|2003-2007|0.6|0.7|0.6
0-19|0.5|0.7|0.6|189|Incidence|30857914|White|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|202|Incidence|30906558|White|Female|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.6|201|Incidence|30977009|White|Female|Acute Myeloid|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|208|Incidence|30810937|White|Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|14.9|15.9|15.4|4290|Incidence|27890317|White|Female|All Cancer Sites Combined|1999|14.9|15.8|15.4
0-19|15.8|16.8|16.3|4555|Incidence|27994447|White|Female|All Cancer Sites Combined|2000|15.8|16.8|16.3
0-19|16.5|17.4|16.9|4937|Incidence|29165264|White|Female|All Cancer Sites Combined|2001|16.5|17.4|16.9
0-19|15.9|16.8|16.3|4773|Incidence|29197702|White|Female|All Cancer Sites Combined|2002|15.9|16.8|16.3
0-19|16.3|17.3|16.8|5089|Incidence|30181861|White|Female|All Cancer Sites Combined|2003|16.4|17.3|16.9
0-19|16.5|16.9|16.7|25341|Incidence|150326854|White|Female|All Cancer Sites Combined|2003-2007|16.7|17.1|16.9
0-19|16.5|17.4|16.9|5263|Incidence|30857914|White|Female|All Cancer Sites Combined|2004|16.6|17.5|17.1
0-19|16.2|17.1|16.7|5199|Incidence|30906558|White|Female|All Cancer Sites Combined|2005|16.4|17.3|16.8
0-19|15.9|16.8|16.4|5117|Incidence|30977009|White|Female|All Cancer Sites Combined|2006|16.1|17.0|16.5
0-19|16.3|17.2|16.7|5207|Incidence|30810937|White|Female|All Cancer Sites Combined|2007|16.4|17.4|16.9
0-19|0.7|0.9|0.8|222|Incidence|27890317|White|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|1.0|0.8|237|Incidence|27994447|White|Female|Bones and Joints|2000|0.7|1.0|0.8
0-19|0.7|1.0|0.8|249|Incidence|29165264|White|Female|Bones and Joints|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|242|Incidence|29197702|White|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|1.0|0.9|276|Incidence|30181861|White|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1268|Incidence|150326854|White|Female|Bones and Joints|2003-2007|0.8|0.9|0.8
0-19|0.8|1.0|0.9|275|Incidence|30857914|White|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|0.9|0.8|259|Incidence|30906558|White|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|256|Incidence|30977009|White|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|230|Incidence|30810937|White|Female|Bones and Joints|2007|0.7|0.8|0.7
0-19|2.7|3.1|2.9|817|Incidence|27890317|White|Female|Brain and Other Nervous System|1999|2.7|3.1|2.9
0-19|2.8|3.2|3.0|833|Incidence|27994447|White|Female|Brain and Other Nervous System|2000|2.8|3.2|3.0
0-19|2.8|3.2|3.0|863|Incidence|29165264|White|Female|Brain and Other Nervous System|2001|2.8|3.2|3.0
0-19|2.7|3.1|2.9|851|Incidence|29197702|White|Female|Brain and Other Nervous System|2002|2.7|3.1|2.9
0-19|2.9|3.3|3.1|934|Incidence|30181861|White|Female|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.0|3.2|3.1|4610|Incidence|150326854|White|Female|Brain and Other Nervous System|2003-2007|3.0|3.2|3.1
0-19|3.0|3.4|3.2|992|Incidence|30857914|White|Female|Brain and Other Nervous System|2004|3.0|3.4|3.2
0-19|2.7|3.1|2.9|906|Incidence|30906558|White|Female|Brain and Other Nervous System|2005|2.7|3.1|2.9
0-19|2.7|3.1|2.9|905|Incidence|30977009|White|Female|Brain and Other Nervous System|2006|2.7|3.1|2.9
0-19|2.9|3.3|3.1|965|Incidence|30810937|White|Female|Brain and Other Nervous System|2007|2.9|3.3|3.1
0-19|1.1|1.3|1.2|329|Incidence|27890317|White|Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.5|1.3|371|Incidence|27994447|White|Female|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.2|1.5|1.3|390|Incidence|29165264|White|Female|Hodgkin Lymphoma|2001|1.2|1.5|1.3
0-19|1.2|1.4|1.3|378|Incidence|29197702|White|Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.1|1.4|1.2|376|Incidence|30181861|White|Female|Hodgkin Lymphoma|2003|1.1|1.4|1.2
0-19|1.2|1.3|1.2|1904|Incidence|150326854|White|Female|Hodgkin Lymphoma|2003-2007|1.2|1.3|1.3
0-19|1.2|1.4|1.3|399|Incidence|30857914|White|Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.1|1.4|1.3|394|Incidence|30906558|White|Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.1|1.4|1.3|396|Incidence|30977009|White|Female|Hodgkin Lymphoma|2006|1.2|1.4|1.3
0-19|1.1|1.3|1.2|375|Incidence|30810937|White|Female|Hodgkin Lymphoma|2007|1.1|1.3|1.2
0-19|0.6|0.8|0.7|190|Incidence|27890317|White|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|194|Incidence|27994447|White|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|224|Incidence|29165264|White|Female|Kidney and Renal Pelvis|2001|0.7|0.9|0.8
0-19|0.5|0.7|0.6|177|Incidence|29197702|White|Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.7|0.9|0.8|239|Incidence|30181861|White|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1098|Incidence|150326854|White|Female|Kidney and Renal Pelvis|2003-2007|0.7|0.8|0.7
0-19|0.6|0.8|0.7|208|Incidence|30857914|White|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|219|Incidence|30906558|White|Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|218|Incidence|30977009|White|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|237|Incidence|30810937|White|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|3.6|4.0|3.8|1060|Incidence|27890317|White|Female|Leukemia|1999|3.6|4.0|3.8
0-19|3.9|4.4|4.1|1149|Incidence|27994447|White|Female|Leukemia|2000|3.9|4.3|4.1
0-19|4.0|4.5|4.2|1228|Incidence|29165264|White|Female|Leukemia|2001|4.0|4.5|4.2
0-19|3.8|4.3|4.0|1172|Incidence|29197702|White|Female|Leukemia|2002|3.8|4.3|4.0
0-19|3.7|4.1|3.9|1169|Incidence|30181861|White|Female|Leukemia|2003|3.7|4.1|3.9
0-19|3.9|4.1|4.0|6031|Incidence|150326854|White|Female|Leukemia|2003-2007|3.9|4.1|4.0
0-19|3.7|4.2|3.9|1215|Incidence|30857914|White|Female|Leukemia|2004|3.7|4.2|3.9
0-19|3.8|4.2|4.0|1235|Incidence|30906558|White|Female|Leukemia|2005|3.8|4.2|4.0
0-19|3.9|4.3|4.1|1270|Incidence|30977009|White|Female|Leukemia|2006|3.9|4.3|4.1
0-19|3.9|4.3|4.1|1275|Incidence|30810937|White|Female|Leukemia|2007|3.9|4.4|4.1
0-19|0.6|0.8|0.7|195|Incidence|27890317|White|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|217|Incidence|27994447|White|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|229|Incidence|29165264|White|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|226|Incidence|29197702|White|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|224|Incidence|30181861|White|Female|Non-Hodgkin Lymphoma|2003|0.6|0.8|0.7
0-19|0.7|0.8|0.8|1136|Incidence|150326854|White|Female|Non-Hodgkin Lymphoma|2003-2007|0.7|0.8|0.8
0-19|0.7|0.9|0.8|236|Incidence|30857914|White|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|233|Incidence|30906558|White|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.6|0.8|0.7|220|Incidence|30977009|White|Female|Non-Hodgkin Lymphoma|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|238|Incidence|30810937|White|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|4.1|4.6|4.4|1221|Incidence|27890317|White|Female|Other|1999|4.1|4.6|4.4
0-19|4.3|4.8|4.6|1276|Incidence|27994447|White|Female|Other|2000|4.3|4.8|4.6
0-19|4.7|5.2|4.9|1443|Incidence|29165264|White|Female|Other|2001|4.7|5.2|4.9
0-19|4.7|5.2|4.9|1443|Incidence|29197702|White|Female|Other|2002|4.7|5.2|4.9
0-19|4.8|5.3|5.1|1544|Incidence|30181861|White|Female|Other|2003|4.9|5.4|5.1
0-19|4.9|5.2|5.1|7719|Incidence|150326854|White|Female|Other|2003-2007|5.0|5.3|5.1
0-19|4.9|5.4|5.2|1619|Incidence|30857914|White|Female|Other|2004|5.0|5.5|5.2
0-19|5.0|5.5|5.2|1638|Incidence|30906558|White|Female|Other|2005|5.0|5.6|5.3
0-19|4.7|5.1|4.9|1545|Incidence|30977009|White|Female|Other|2006|4.7|5.2|5.0
0-19|4.7|5.2|4.9|1545|Incidence|30810937|White|Female|Other|2007|4.8|5.3|5.0
0-19|0.8|1.0|0.9|256|Incidence|27890317|White|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|278|Incidence|27994447|White|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.2|1.1|311|Incidence|29165264|White|Female|Soft Tissue|2001|1.0|1.2|1.1
0-19|0.9|1.1|1.0|284|Incidence|29197702|White|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|1.0|1.2|1.1|327|Incidence|30181861|White|Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|1.0|1.1|1.0|1575|Incidence|150326854|White|Female|Soft Tissue|2003-2007|1.0|1.1|1.0
0-19|0.9|1.1|1.0|319|Incidence|30857914|White|Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.9|1.1|1.0|315|Incidence|30906558|White|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|307|Incidence|30977009|White|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|342|Incidence|30810937|White|Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|3.5|3.9|3.7|1079|Incidence|29466007|White|Male|Acute Lymphocytic|1999|3.4|3.9|3.7
0-19|3.6|4.0|3.8|1118|Incidence|29575302|White|Male|Acute Lymphocytic|2000|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1192|Incidence|30812759|White|Male|Acute Lymphocytic|2001|3.7|4.1|3.9
0-19|3.6|4.0|3.8|1160|Incidence|30823248|White|Male|Acute Lymphocytic|2002|3.5|4.0|3.8
0-19|3.4|3.9|3.6|1157|Incidence|31823386|White|Male|Acute Lymphocytic|2003|3.4|3.9|3.6
0-19|3.7|3.9|3.8|6083|Incidence|158321814|White|Male|Acute Lymphocytic|2003-2007|3.7|3.9|3.8
0-19|3.8|4.3|4.1|1318|Incidence|32512352|White|Male|Acute Lymphocytic|2004|3.8|4.3|4.1
0-19|3.5|3.9|3.7|1213|Incidence|32548989|White|Male|Acute Lymphocytic|2005|3.5|3.9|3.7
0-19|3.7|4.2|3.9|1287|Incidence|32612779|White|Male|Acute Lymphocytic|2006|3.7|4.2|3.9
0-19|3.6|4.1|3.8|1251|Incidence|32425414|White|Male|Acute Lymphocytic|2007|3.6|4.1|3.9
0-19|0.7|0.9|0.8|226|Incidence|29466007|White|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|198|Incidence|29575302|White|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|239|Incidence|30812759|White|Male|Acute Myeloid|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|236|Incidence|30823248|White|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|225|Incidence|31823386|White|Male|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1160|Incidence|158321814|White|Male|Acute Myeloid|2003-2007|0.7|0.8|0.7
0-19|0.8|1.0|0.9|283|Incidence|32512352|White|Male|Acute Myeloid|2004|0.8|1.0|0.9
0-19|0.6|0.7|0.6|213|Incidence|32548989|White|Male|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|226|Incidence|32612779|White|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|233|Incidence|32425414|White|Male|Acute Myeloid|2007|0.6|0.8|0.7
0-19|17.3|18.3|17.8|5231|Incidence|29466007|White|Male|All Cancer Sites Combined|1999|17.3|18.2|17.8
0-19|17.6|18.6|18.1|5345|Incidence|29575302|White|Male|All Cancer Sites Combined|2000|17.6|18.6|18.1
0-19|18.3|19.2|18.8|5783|Incidence|30812759|White|Male|All Cancer Sites Combined|2001|18.3|19.3|18.8
0-19|18.8|19.7|19.2|5941|Incidence|30823248|White|Male|All Cancer Sites Combined|2002|18.8|19.8|19.3
0-19|17.6|18.5|18.0|5754|Incidence|31823386|White|Male|All Cancer Sites Combined|2003|17.6|18.6|18.1
0-19|18.4|18.9|18.7|29764|Incidence|158321814|White|Male|All Cancer Sites Combined|2003-2007|18.6|19.0|18.8
0-19|18.6|19.6|19.1|6248|Incidence|32512352|White|Male|All Cancer Sites Combined|2004|18.7|19.7|19.2
0-19|18.0|18.9|18.4|6045|Incidence|32548989|White|Male|All Cancer Sites Combined|2005|18.1|19.0|18.6
0-19|18.4|19.4|18.9|6217|Incidence|32612779|White|Male|All Cancer Sites Combined|2006|18.6|19.5|19.1
0-19|18.3|19.2|18.7|6144|Incidence|32425414|White|Male|All Cancer Sites Combined|2007|18.5|19.4|18.9
0-19|0.9|1.2|1.1|313|Incidence|29466007|White|Male|Bones and Joints|1999|0.9|1.2|1.1
0-19|0.9|1.1|1.0|290|Incidence|29575302|White|Male|Bones and Joints|2000|0.9|1.1|1.0
0-19|1.1|1.3|1.2|366|Incidence|30812759|White|Male|Bones and Joints|2001|1.1|1.3|1.2
0-19|1.0|1.3|1.1|352|Incidence|30823248|White|Male|Bones and Joints|2002|1.0|1.3|1.1
0-19|0.9|1.1|1.0|312|Incidence|31823386|White|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|1.0|1.1|1.0|1645|Incidence|158321814|White|Male|Bones and Joints|2003-2007|1.0|1.1|1.0
0-19|0.9|1.1|1.0|316|Incidence|32512352|White|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|324|Incidence|32548989|White|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.3|1.1|372|Incidence|32612779|White|Male|Bones and Joints|2006|1.0|1.3|1.1
0-19|1.0|1.2|1.1|358|Incidence|32425414|White|Male|Bones and Joints|2007|1.0|1.2|1.1
0-19|3.1|3.5|3.3|964|Incidence|29466007|White|Male|Brain and Other Nervous System|1999|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1040|Incidence|29575302|White|Male|Brain and Other Nervous System|2000|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1038|Incidence|30812759|White|Male|Brain and Other Nervous System|2001|3.2|3.6|3.4
0-19|3.5|4.0|3.7|1147|Incidence|30823248|White|Male|Brain and Other Nervous System|2002|3.5|3.9|3.7
0-19|3.1|3.5|3.3|1050|Incidence|31823386|White|Male|Brain and Other Nervous System|2003|3.1|3.5|3.3
0-19|3.3|3.5|3.4|5397|Incidence|158321814|White|Male|Brain and Other Nervous System|2003-2007|3.3|3.5|3.4
0-19|3.3|3.7|3.5|1126|Incidence|32512352|White|Male|Brain and Other Nervous System|2004|3.3|3.7|3.5
0-19|3.1|3.5|3.3|1064|Incidence|32548989|White|Male|Brain and Other Nervous System|2005|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1150|Incidence|32612779|White|Male|Brain and Other Nervous System|2006|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1109|Incidence|32425414|White|Male|Brain and Other Nervous System|2007|3.2|3.6|3.4
0-19|1.2|1.5|1.4|405|Incidence|29466007|White|Male|Hodgkin Lymphoma|1999|1.2|1.5|1.4
0-19|1.2|1.4|1.3|389|Incidence|29575302|White|Male|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.3|1.5|1.4|430|Incidence|30812759|White|Male|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|401|Incidence|30823248|White|Male|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.3|1.5|1.4|452|Incidence|31823386|White|Male|Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.3|1.4|1.4|2208|Incidence|158321814|White|Male|Hodgkin Lymphoma|2003-2007|1.3|1.5|1.4
0-19|1.1|1.4|1.3|414|Incidence|32512352|White|Male|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.3|1.5|1.4|456|Incidence|32548989|White|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.3|1.6|1.4|473|Incidence|32612779|White|Male|Hodgkin Lymphoma|2006|1.3|1.6|1.5
0-19|1.3|1.5|1.4|457|Incidence|32425414|White|Male|Hodgkin Lymphoma|2007|1.3|1.5|1.4
0-19|0.5|0.7|0.6|179|Incidence|29466007|White|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.5|0.7|0.6|184|Incidence|29575302|White|Male|Kidney and Renal Pelvis|2000|0.5|0.7|0.6
0-19|0.5|0.7|0.6|191|Incidence|30812759|White|Male|Kidney and Renal Pelvis|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|210|Incidence|30823248|White|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|183|Incidence|31823386|White|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.6|0.6|954|Incidence|158321814|White|Male|Kidney and Renal Pelvis|2003-2007|0.6|0.6|0.6
0-19|0.5|0.7|0.6|204|Incidence|32512352|White|Male|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.5|0.7|0.6|206|Incidence|32548989|White|Male|Kidney and Renal Pelvis|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|203|Incidence|32612779|White|Male|Kidney and Renal Pelvis|2006|0.5|0.7|0.6
0-19|0.5|0.6|0.5|179|Incidence|32425414|White|Male|Kidney and Renal Pelvis|2007|0.5|0.6|0.6
0-19|4.6|5.1|4.8|1423|Incidence|29466007|White|Male|Leukemia|1999|4.6|5.1|4.8
0-19|4.6|5.1|4.8|1418|Incidence|29575302|White|Male|Leukemia|2000|4.5|5.1|4.8
0-19|4.9|5.4|5.1|1562|Incidence|30812759|White|Male|Leukemia|2001|4.8|5.3|5.1
0-19|4.7|5.2|5.0|1529|Incidence|30823248|White|Male|Leukemia|2002|4.7|5.2|5.0
0-19|4.5|5.0|4.7|1499|Incidence|31823386|White|Male|Leukemia|2003|4.5|5.0|4.7
0-19|4.9|5.1|5.0|7935|Incidence|158321814|White|Male|Leukemia|2003-2007|4.9|5.1|5.0
0-19|5.1|5.6|5.3|1739|Incidence|32512352|White|Male|Leukemia|2004|5.1|5.6|5.3
0-19|4.6|5.1|4.8|1580|Incidence|32548989|White|Male|Leukemia|2005|4.6|5.1|4.9
0-19|4.9|5.3|5.1|1671|Incidence|32612779|White|Male|Leukemia|2006|4.9|5.4|5.1
0-19|4.7|5.2|5.0|1625|Incidence|32425414|White|Male|Leukemia|2007|4.8|5.3|5.0
0-19|1.3|1.6|1.4|421|Incidence|29466007|White|Male|Non-Hodgkin Lymphoma|1999|1.3|1.6|1.4
0-19|1.4|1.7|1.5|449|Incidence|29575302|White|Male|Non-Hodgkin Lymphoma|2000|1.4|1.7|1.5
0-19|1.3|1.6|1.5|453|Incidence|30812759|White|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.5
0-19|1.4|1.7|1.5|474|Incidence|30823248|White|Male|Non-Hodgkin Lymphoma|2002|1.4|1.7|1.5
0-19|1.3|1.6|1.4|457|Incidence|31823386|White|Male|Non-Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.4|1.5|1.5|2337|Incidence|158321814|White|Male|Non-Hodgkin Lymphoma|2003-2007|1.4|1.5|1.5
0-19|1.3|1.6|1.4|463|Incidence|32512352|White|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.3|1.6|1.5|483|Incidence|32548989|White|Male|Non-Hodgkin Lymphoma|2005|1.4|1.6|1.5
0-19|1.4|1.6|1.5|483|Incidence|32612779|White|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.6|1.5|488|Incidence|32425414|White|Male|Non-Hodgkin Lymphoma|2007|1.4|1.6|1.5
0-19|4.1|4.6|4.3|1270|Incidence|29466007|White|Male|Other|1999|4.1|4.6|4.3
0-19|4.0|4.5|4.2|1248|Incidence|29575302|White|Male|Other|2000|4.0|4.5|4.2
0-19|4.4|4.9|4.6|1435|Incidence|30812759|White|Male|Other|2001|4.4|4.9|4.7
0-19|4.5|5.0|4.8|1486|Incidence|30823248|White|Male|Other|2002|4.6|5.1|4.8
0-19|4.3|4.8|4.5|1461|Incidence|31823386|White|Male|Other|2003|4.4|4.8|4.6
0-19|4.6|4.8|4.7|7584|Incidence|158321814|White|Male|Other|2003-2007|4.7|4.9|4.8
0-19|4.7|5.2|5.0|1644|Incidence|32512352|White|Male|Other|2004|4.8|5.3|5.1
0-19|4.5|4.9|4.7|1560|Incidence|32548989|White|Male|Other|2005|4.6|5.0|4.8
0-19|4.3|4.8|4.6|1523|Incidence|32612779|White|Male|Other|2006|4.4|4.9|4.7
0-19|4.5|5.0|4.8|1584|Incidence|32425414|White|Male|Other|2007|4.6|5.1|4.9
0-19|0.8|1.0|0.9|256|Incidence|29466007|White|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|327|Incidence|29575302|White|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|308|Incidence|30812759|White|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|342|Incidence|30823248|White|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|1.0|1.2|1.1|340|Incidence|31823386|White|Male|Soft Tissue|2003|1.0|1.2|1.1
0-19|1.0|1.1|1.1|1704|Incidence|158321814|White|Male|Soft Tissue|2003-2007|1.0|1.1|1.1
0-19|0.9|1.2|1.0|342|Incidence|32512352|White|Male|Soft Tissue|2004|0.9|1.2|1.1
0-19|1.0|1.3|1.1|372|Incidence|32548989|White|Male|Soft Tissue|2005|1.0|1.3|1.1
0-19|0.9|1.2|1.0|342|Incidence|32612779|White|Male|Soft Tissue|2006|0.9|1.2|1.0
0-19|0.9|1.2|1.0|344|Incidence|32425414|White|Male|Soft Tissue|2007|1.0|1.2|1.1
0-19|3.1|3.4|3.3|1879|Incidence|57356324|White|Male and Female|Acute Lymphocytic|1999|3.1|3.4|3.3
0-19|3.3|3.6|3.5|1979|Incidence|57569749|White|Male and Female|Acute Lymphocytic|2000|3.3|3.6|3.4
0-19|3.4|3.7|3.5|2102|Incidence|59978023|White|Male and Female|Acute Lymphocytic|2001|3.4|3.7|3.5
0-19|3.2|3.5|3.4|2023|Incidence|60020950|White|Male and Female|Acute Lymphocytic|2002|3.2|3.5|3.4
0-19|3.2|3.4|3.3|2039|Incidence|62005247|White|Male and Female|Acute Lymphocytic|2003|3.1|3.4|3.3
0-19|3.4|3.5|3.4|10614|Incidence|308648668|White|Male and Female|Acute Lymphocytic|2003-2007|3.4|3.5|3.4
0-19|3.4|3.7|3.5|2238|Incidence|63370266|White|Male and Female|Acute Lymphocytic|2004|3.4|3.7|3.5
0-19|3.2|3.5|3.3|2132|Incidence|63455547|White|Male and Female|Acute Lymphocytic|2005|3.2|3.5|3.4
0-19|3.4|3.7|3.5|2237|Incidence|63589788|White|Male and Female|Acute Lymphocytic|2006|3.4|3.7|3.5
0-19|3.3|3.6|3.5|2208|Incidence|63236351|White|Male and Female|Acute Lymphocytic|2007|3.3|3.6|3.5
0-19|0.6|0.8|0.7|409|Incidence|57356324|White|Male and Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.7|386|Incidence|57569749|White|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.7|0.8|0.7|440|Incidence|59978023|White|Male and Female|Acute Myeloid|2001|0.7|0.8|0.7
0-19|0.6|0.8|0.7|430|Incidence|60020950|White|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.7|406|Incidence|62005247|White|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2118|Incidence|308648668|White|Male and Female|Acute Myeloid|2003-2007|0.7|0.7|0.7
0-19|0.7|0.8|0.7|472|Incidence|63370266|White|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.6|415|Incidence|63455547|White|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|427|Incidence|63589788|White|Male and Female|Acute Myeloid|2006|0.6|0.7|0.7
0-19|0.6|0.8|0.7|441|Incidence|63236351|White|Male and Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|16.3|17.0|16.6|9521|Incidence|57356324|White|Male and Female|All Cancer Sites Combined|1999|16.3|16.9|16.6
0-19|16.9|17.6|17.2|9900|Incidence|57569749|White|Male and Female|All Cancer Sites Combined|2000|16.9|17.5|17.2
0-19|17.5|18.2|17.9|10720|Incidence|59978023|White|Male and Female|All Cancer Sites Combined|2001|17.5|18.2|17.9
0-19|17.5|18.2|17.8|10714|Incidence|60020950|White|Male and Female|All Cancer Sites Combined|2002|17.5|18.2|17.9
0-19|17.1|17.8|17.4|10843|Incidence|62005247|White|Male and Female|All Cancer Sites Combined|2003|17.2|17.8|17.5
0-19|17.6|17.9|17.7|55105|Incidence|308648668|White|Male and Female|All Cancer Sites Combined|2003-2007|17.7|18.0|17.9
0-19|17.7|18.4|18.1|11511|Incidence|63370266|White|Male and Female|All Cancer Sites Combined|2004|17.8|18.5|18.2
0-19|17.2|17.9|17.6|11244|Incidence|63455547|White|Male and Female|All Cancer Sites Combined|2005|17.4|18.1|17.7
0-19|17.3|18.0|17.7|11334|Incidence|63589788|White|Male and Female|All Cancer Sites Combined|2006|17.5|18.2|17.8
0-19|17.4|18.1|17.8|11351|Incidence|63236351|White|Male and Female|All Cancer Sites Combined|2007|17.6|18.3|18.0
0-19|0.9|1.0|0.9|535|Incidence|57356324|White|Male and Female|Bones and Joints|1999|0.9|1.0|0.9
0-19|0.8|1.0|0.9|527|Incidence|57569749|White|Male and Female|Bones and Joints|2000|0.8|1.0|0.9
0-19|0.9|1.1|1.0|615|Incidence|59978023|White|Male and Female|Bones and Joints|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|594|Incidence|60020950|White|Male and Female|Bones and Joints|2002|0.9|1.1|1.0
0-19|0.9|1.0|0.9|588|Incidence|62005247|White|Male and Female|Bones and Joints|2003|0.9|1.0|0.9
0-19|0.9|1.0|0.9|2913|Incidence|308648668|White|Male and Female|Bones and Joints|2003-2007|0.9|1.0|0.9
0-19|0.9|1.0|0.9|591|Incidence|63370266|White|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.8|1.0|0.9|583|Incidence|63455547|White|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.1|1.0|628|Incidence|63589788|White|Male and Female|Bones and Joints|2006|0.9|1.1|1.0
0-19|0.9|1.0|0.9|588|Incidence|63236351|White|Male and Female|Bones and Joints|2007|0.9|1.0|0.9
0-19|3.0|3.3|3.1|1781|Incidence|57356324|White|Male and Female|Brain and Other Nervous System|1999|3.0|3.3|3.1
0-19|3.1|3.4|3.3|1873|Incidence|57569749|White|Male and Female|Brain and Other Nervous System|2000|3.1|3.4|3.3
0-19|3.0|3.3|3.2|1901|Incidence|59978023|White|Male and Female|Brain and Other Nervous System|2001|3.0|3.3|3.2
0-19|3.2|3.5|3.3|1998|Incidence|60020950|White|Male and Female|Brain and Other Nervous System|2002|3.2|3.5|3.3
0-19|3.1|3.3|3.2|1984|Incidence|62005247|White|Male and Female|Brain and Other Nervous System|2003|3.1|3.3|3.2
0-19|3.2|3.3|3.2|10007|Incidence|308648668|White|Male and Female|Brain and Other Nervous System|2003-2007|3.2|3.3|3.2
0-19|3.2|3.5|3.3|2118|Incidence|63370266|White|Male and Female|Brain and Other Nervous System|2004|3.2|3.5|3.3
0-19|3.0|3.2|3.1|1970|Incidence|63455547|White|Male and Female|Brain and Other Nervous System|2005|3.0|3.2|3.1
0-19|3.1|3.4|3.2|2055|Incidence|63589788|White|Male and Female|Brain and Other Nervous System|2006|3.1|3.4|3.2
0-19|3.1|3.4|3.3|2074|Incidence|63236351|White|Male and Female|Brain and Other Nervous System|2007|3.1|3.4|3.3
0-19|1.2|1.4|1.3|734|Incidence|57356324|White|Male and Female|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.2|1.4|1.3|760|Incidence|57569749|White|Male and Female|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.3|1.5|1.4|820|Incidence|59978023|White|Male and Female|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|779|Incidence|60020950|White|Male and Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.2|1.4|1.3|828|Incidence|62005247|White|Male and Female|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.3|1.4|1.3|4112|Incidence|308648668|White|Male and Female|Hodgkin Lymphoma|2003-2007|1.3|1.4|1.3
0-19|1.2|1.4|1.3|813|Incidence|63370266|White|Male and Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.2|1.4|1.3|850|Incidence|63455547|White|Male and Female|Hodgkin Lymphoma|2005|1.3|1.4|1.3
0-19|1.3|1.4|1.3|869|Incidence|63589788|White|Male and Female|Hodgkin Lymphoma|2006|1.3|1.5|1.4
0-19|1.2|1.4|1.3|832|Incidence|63236351|White|Male and Female|Hodgkin Lymphoma|2007|1.2|1.4|1.3
0-19|0.6|0.7|0.6|369|Incidence|57356324|White|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.7|378|Incidence|57569749|White|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|415|Incidence|59978023|White|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.6|387|Incidence|60020950|White|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.6
0-19|0.6|0.7|0.7|422|Incidence|62005247|White|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.7|2052|Incidence|308648668|White|Male and Female|Kidney and Renal Pelvis|2003-2007|0.6|0.7|0.7
0-19|0.6|0.7|0.6|412|Incidence|63370266|White|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|425|Incidence|63455547|White|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|421|Incidence|63589788|White|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.7|0.7
0-19|0.6|0.7|0.6|416|Incidence|63236351|White|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.7|0.7
0-19|4.2|4.5|4.3|2483|Incidence|57356324|White|Male and Female|Leukemia|1999|4.2|4.5|4.3
0-19|4.3|4.7|4.5|2567|Incidence|57569749|White|Male and Female|Leukemia|2000|4.3|4.6|4.5
0-19|4.5|4.9|4.7|2790|Incidence|59978023|White|Male and Female|Leukemia|2001|4.5|4.8|4.7
0-19|4.3|4.7|4.5|2701|Incidence|60020950|White|Male and Female|Leukemia|2002|4.3|4.7|4.5
0-19|4.1|4.5|4.3|2668|Incidence|62005247|White|Male and Female|Leukemia|2003|4.1|4.5|4.3
0-19|4.4|4.6|4.5|13966|Incidence|308648668|White|Male and Female|Leukemia|2003-2007|4.5|4.6|4.5
0-19|4.5|4.8|4.6|2954|Incidence|63370266|White|Male and Female|Leukemia|2004|4.5|4.8|4.7
0-19|4.3|4.6|4.4|2815|Incidence|63455547|White|Male and Female|Leukemia|2005|4.3|4.6|4.4
0-19|4.4|4.8|4.6|2941|Incidence|63589788|White|Male and Female|Leukemia|2006|4.5|4.8|4.6
0-19|4.4|4.7|4.6|2900|Incidence|63236351|White|Male and Female|Leukemia|2007|4.4|4.8|4.6
0-19|1.0|1.2|1.1|616|Incidence|57356324|White|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.2|1.2|666|Incidence|57569749|White|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.2|1.2
0-19|1.1|1.2|1.1|682|Incidence|59978023|White|Male and Female|Non-Hodgkin Lymphoma|2001|1.1|1.2|1.1
0-19|1.1|1.3|1.2|700|Incidence|60020950|White|Male and Female|Non-Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.0|1.2|1.1|681|Incidence|62005247|White|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.1|1.2|1.1|3473|Incidence|308648668|White|Male and Female|Non-Hodgkin Lymphoma|2003-2007|1.1|1.2|1.1
0-19|1.0|1.2|1.1|699|Incidence|63370266|White|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.2|1.1
0-19|1.0|1.2|1.1|716|Incidence|63455547|White|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.2|1.1
0-19|1.0|1.2|1.1|703|Incidence|63589788|White|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|1.1|1.2|1.1|726|Incidence|63236351|White|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.2|1.1
0-19|4.2|4.5|4.4|2491|Incidence|57356324|White|Male and Female|Other|1999|4.2|4.5|4.3
0-19|4.2|4.6|4.4|2524|Incidence|57569749|White|Male and Female|Other|2000|4.2|4.6|4.4
0-19|4.6|5.0|4.8|2878|Incidence|59978023|White|Male and Female|Other|2001|4.6|5.0|4.8
0-19|4.7|5.0|4.9|2929|Incidence|60020950|White|Male and Female|Other|2002|4.7|5.1|4.9
0-19|4.6|5.0|4.8|3005|Incidence|62005247|White|Male and Female|Other|2003|4.7|5.0|4.8
0-19|4.8|5.0|4.9|15303|Incidence|308648668|White|Male and Female|Other|2003-2007|4.9|5.0|5.0
0-19|4.9|5.3|5.1|3263|Incidence|63370266|White|Male and Female|Other|2004|5.0|5.3|5.1
0-19|4.8|5.1|5.0|3198|Incidence|63455547|White|Male and Female|Other|2005|4.9|5.2|5.0
0-19|4.6|4.9|4.7|3068|Incidence|63589788|White|Male and Female|Other|2006|4.7|5.0|4.8
0-19|4.7|5.0|4.8|3129|Incidence|63236351|White|Male and Female|Other|2007|4.8|5.1|4.9
0-19|0.8|1.0|0.9|512|Incidence|57356324|White|Male and Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.1|1.1|605|Incidence|57569749|White|Male and Female|Soft Tissue|2000|1.0|1.1|1.1
0-19|0.9|1.1|1.0|619|Incidence|59978023|White|Male and Female|Soft Tissue|2001|1.0|1.1|1.0
0-19|1.0|1.1|1.0|626|Incidence|60020950|White|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|1.0|1.2|1.1|667|Incidence|62005247|White|Male and Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|1.0|1.1|1.1|3279|Incidence|308648668|White|Male and Female|Soft Tissue|2003-2007|1.0|1.1|1.1
0-19|1.0|1.1|1.0|661|Incidence|63370266|White|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.2|1.1|687|Incidence|63455547|White|Male and Female|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|649|Incidence|63589788|White|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|686|Incidence|63236351|White|Male and Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|0.2|0.3|0.3|109|Mortality|39015588|All Races|Female|Acute Lymphocytic|1999|0.2|0.3|0.3
0-19|0.3|0.4|0.3|126|Mortality|39256716|All Races|Female|Acute Lymphocytic|2000|0.3|0.4|0.3
0-19|0.3|0.4|0.3|120|Mortality|39361282|All Races|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.3|135|Mortality|39461821|All Races|Female|Acute Lymphocytic|2002|0.3|0.4|0.3
0-19|0.3|0.4|0.3|122|Mortality|39576402|All Races|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.3|0.3|0.3|557|Mortality|199295399|All Races|Female|Acute Lymphocytic|2003-2007|0.3|0.3|0.3
0-19|0.2|0.4|0.3|118|Mortality|39727610|All Races|Female|Acute Lymphocytic|2004|0.2|0.4|0.3
0-19|0.2|0.3|0.2|91|Mortality|39837382|All Races|Female|Acute Lymphocytic|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|108|Mortality|39976439|All Races|Female|Acute Lymphocytic|2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|118|Mortality|40177566|All Races|Female|Acute Lymphocytic|2007|0.2|0.4|0.3
0-19|0.2|0.3|0.3|106|Mortality|39015588|All Races|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|95|Mortality|39256716|All Races|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|113|Mortality|39361282|All Races|Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|100|Mortality|39461821|All Races|Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|94|Mortality|39576402|All Races|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|470|Mortality|199295399|All Races|Female|Acute Myeloid|2003-2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|96|Mortality|39727610|All Races|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|101|Mortality|39837382|All Races|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|90|Mortality|39976439|All Races|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|89|Mortality|40177566|All Races|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.4|2.7|2.5|977|Mortality|39015588|All Races|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.6|2.5|973|Mortality|39256716|All Races|Female|All Cancer Sites Combined|2000|2.3|2.6|2.5
0-19|2.4|2.7|2.5|986|Mortality|39361282|All Races|Female|All Cancer Sites Combined|2001|2.4|2.7|2.5
0-19|2.4|2.7|2.5|989|Mortality|39461821|All Races|Female|All Cancer Sites Combined|2002|2.4|2.7|2.5
0-19|2.2|2.5|2.4|943|Mortality|39576402|All Races|Female|All Cancer Sites Combined|2003|2.2|2.5|2.4
0-19|2.3|2.4|2.3|4642|Mortality|199295399|All Races|Female|All Cancer Sites Combined|2003-2007|2.3|2.4|2.3
0-19|2.3|2.6|2.4|967|Mortality|39727610|All Races|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.5|2.3|922|Mortality|39837382|All Races|Female|All Cancer Sites Combined|2005|2.2|2.5|2.3
0-19|2.0|2.3|2.2|866|Mortality|39976439|All Races|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|2.2|2.5|2.4|944|Mortality|40177566|All Races|Female|All Cancer Sites Combined|2007|2.2|2.5|2.3
0-19|0.2|0.3|0.2|92|Mortality|39015588|All Races|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.2|0.2|76|Mortality|39256716|All Races|Female|Bones and Joints|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|75|Mortality|39361282|All Races|Female|Bones and Joints|2001|0.1|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|39461821|All Races|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|64|Mortality|39576402|All Races|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.2|0.2|381|Mortality|199295399|All Races|Female|Bones and Joints|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39727610|All Races|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|91|Mortality|39837382|All Races|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|39976439|All Races|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.2|0.2|80|Mortality|40177566|All Races|Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.6|0.7|0.7|259|Mortality|39015588|All Races|Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.5|0.7|0.6|238|Mortality|39256716|All Races|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.6|252|Mortality|39361282|All Races|Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.5|0.7|0.6|244|Mortality|39461821|All Races|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|269|Mortality|39576402|All Races|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|1267|Mortality|199295399|All Races|Female|Brain and Other Nervous System|2003-2007|0.6|0.7|0.6
0-19|0.6|0.7|0.6|254|Mortality|39727610|All Races|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|246|Mortality|39837382|All Races|Female|Brain and Other Nervous System|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|237|Mortality|39976439|All Races|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.7|0.7|261|Mortality|40177566|All Races|Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.0|0.1|0.0|17|Mortality|39015588|All Races|Female|Hodgkin Lymphoma|1999|0.0|0.1|0.0
0-19|0.0|0.1|0.0|19|Mortality|39256716|All Races|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|39361282|All Races|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|39461821|All Races|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|39576402|All Races|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|0.0|0.0|0.0|50|Mortality|199295399|All Races|Female|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|39727610|All Races|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|39837382|All Races|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|39976439|All Races|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|40177566|All Races|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|0.1|0.1|0.1|30|Mortality|39015588|All Races|Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|39256716|All Races|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|39|Mortality|39361282|All Races|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39461821|All Races|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|34|Mortality|39576402|All Races|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|150|Mortality|199295399|All Races|Female|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39727610|All Races|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|39837382|All Races|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|25|Mortality|39976439|All Races|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|40177566|All Races|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.7|0.8|0.8|293|Mortality|39015588|All Races|Female|Leukemia|1999|0.7|0.8|0.8
0-19|0.7|0.9|0.8|302|Mortality|39256716|All Races|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|318|Mortality|39361282|All Races|Female|Leukemia|2001|0.7|0.9|0.8
0-19|0.7|0.8|0.8|296|Mortality|39461821|All Races|Female|Leukemia|2002|0.7|0.8|0.8
0-19|0.6|0.8|0.7|284|Mortality|39576402|All Races|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1357|Mortality|199295399|All Races|Female|Leukemia|2003-2007|0.6|0.7|0.7
0-19|0.6|0.8|0.7|278|Mortality|39727610|All Races|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.7|0.6|258|Mortality|39837382|All Races|Female|Leukemia|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.6|259|Mortality|39976439|All Races|Female|Leukemia|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|278|Mortality|40177566|All Races|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.1|0.1|0.1|37|Mortality|39015588|All Races|Female|Non-Hodgkin Lymphoma|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|36|Mortality|39256716|All Races|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39361282|All Races|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|40|Mortality|39461821|All Races|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|38|Mortality|39576402|All Races|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|142|Mortality|199295399|All Races|Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39727610|All Races|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|39837382|All Races|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|19|Mortality|39976439|All Races|Female|Non-Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|28|Mortality|40177566|All Races|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.4|0.6|0.5|189|Mortality|39015588|All Races|Female|Other|1999|0.4|0.6|0.5
0-19|0.5|0.6|0.5|207|Mortality|39256716|All Races|Female|Other|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|202|Mortality|39361282|All Races|Female|Other|2001|0.4|0.6|0.5
0-19|0.5|0.6|0.5|215|Mortality|39461821|All Races|Female|Other|2002|0.5|0.6|0.5
0-19|0.4|0.5|0.5|182|Mortality|39576402|All Races|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.5|0.5|941|Mortality|199295399|All Races|Female|Other|2003-2007|0.4|0.5|0.5
0-19|0.4|0.6|0.5|205|Mortality|39727610|All Races|Female|Other|2004|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|39837382|All Races|Female|Other|2005|0.4|0.5|0.4
0-19|0.4|0.5|0.5|188|Mortality|39976439|All Races|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|189|Mortality|40177566|All Races|Female|Other|2007|0.4|0.5|0.5
0-19|0.1|0.2|0.2|60|Mortality|39015588|All Races|Female|Soft Tissue|1999|0.1|0.2|0.2
0-19|0.1|0.2|0.2|69|Mortality|39256716|All Races|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|60|Mortality|39361282|All Races|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39461821|All Races|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|62|Mortality|39576402|All Races|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.2|0.2|0.2|354|Mortality|199295399|All Races|Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|81|Mortality|39727610|All Races|Female|Soft Tissue|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|87|Mortality|39837382|All Races|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|56|Mortality|39976439|All Races|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|68|Mortality|40177566|All Races|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.4|0.5|0.4|176|Mortality|41024382|All Races|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.4|0.6|0.5|206|Mortality|41282647|All Races|Male|Acute Lymphocytic|2000|0.4|0.6|0.5
0-19|0.4|0.5|0.5|193|Mortality|41402165|All Races|Male|Acute Lymphocytic|2001|0.4|0.5|0.5
0-19|0.4|0.5|0.5|188|Mortality|41481180|All Races|Male|Acute Lymphocytic|2002|0.4|0.5|0.5
0-19|0.4|0.6|0.5|206|Mortality|41556050|All Races|Male|Acute Lymphocytic|2003|0.4|0.6|0.5
0-19|0.4|0.5|0.4|893|Mortality|209079485|All Races|Male|Acute Lymphocytic|2003-2007|0.4|0.5|0.4
0-19|0.4|0.5|0.4|177|Mortality|41686807|All Races|Male|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.4|0.5|0.4|176|Mortality|41786904|All Races|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.4|0.4|158|Mortality|41922622|All Races|Male|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.4|0.5|0.4|176|Mortality|42127102|All Races|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.2|0.3|0.2|101|Mortality|41024382|All Races|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.3|0.4|0.3|127|Mortality|41282647|All Races|Male|Acute Myeloid|2000|0.3|0.4|0.3
0-19|0.2|0.3|0.3|114|Mortality|41402165|All Races|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|109|Mortality|41481180|All Races|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|113|Mortality|41556050|All Races|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|550|Mortality|209079485|All Races|Male|Acute Myeloid|2003-2007|0.2|0.3|0.3
0-19|0.2|0.3|0.3|115|Mortality|41686807|All Races|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|111|Mortality|41786904|All Races|Male|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|105|Mortality|41922622|All Races|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|106|Mortality|42127102|All Races|Male|Acute Myeloid|2007|0.2|0.3|0.3
0-19|2.9|3.3|3.1|1266|Mortality|41024382|All Races|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.3|3.1|1298|Mortality|41282647|All Races|Male|All Cancer Sites Combined|2000|3.0|3.3|3.1
0-19|2.8|3.2|3.0|1240|Mortality|41402165|All Races|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1282|Mortality|41481180|All Races|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|2.9|3.3|3.1|1290|Mortality|41556050|All Races|Male|All Cancer Sites Combined|2003|2.9|3.3|3.1
0-19|2.8|3.0|2.9|6100|Mortality|209079485|All Races|Male|All Cancer Sites Combined|2003-2007|2.8|3.0|2.9
0-19|2.9|3.2|3.0|1256|Mortality|41686807|All Races|Male|All Cancer Sites Combined|2004|2.8|3.2|3.0
0-19|2.8|3.2|3.0|1261|Mortality|41786904|All Races|Male|All Cancer Sites Combined|2005|2.9|3.2|3.0
0-19|2.6|2.9|2.8|1169|Mortality|41922622|All Races|Male|All Cancer Sites Combined|2006|2.6|3.0|2.8
0-19|2.5|2.8|2.7|1124|Mortality|42127102|All Races|Male|All Cancer Sites Combined|2007|2.5|2.8|2.7
0-19|0.2|0.3|0.3|117|Mortality|41024382|All Races|Male|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|105|Mortality|41282647|All Races|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|114|Mortality|41402165|All Races|Male|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|96|Mortality|41481180|All Races|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.3|122|Mortality|41556050|All Races|Male|Bones and Joints|2003|0.2|0.4|0.3
0-19|0.2|0.3|0.3|552|Mortality|209079485|All Races|Male|Bones and Joints|2003-2007|0.2|0.3|0.3
0-19|0.2|0.3|0.3|118|Mortality|41686807|All Races|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|121|Mortality|41786904|All Races|Male|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|99|Mortality|41922622|All Races|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|92|Mortality|42127102|All Races|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.6|0.8|0.7|287|Mortality|41024382|All Races|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.8|0.7|307|Mortality|41282647|All Races|Male|Brain and Other Nervous System|2000|0.7|0.8|0.7
0-19|0.6|0.7|0.6|268|Mortality|41402165|All Races|Male|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.9|0.8|327|Mortality|41481180|All Races|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|308|Mortality|41556050|All Races|Male|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.7|0.7|0.7|1454|Mortality|209079485|All Races|Male|Brain and Other Nervous System|2003-2007|0.7|0.7|0.7
0-19|0.6|0.8|0.7|301|Mortality|41686807|All Races|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|298|Mortality|41786904|All Races|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|287|Mortality|41922622|All Races|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|260|Mortality|42127102|All Races|Male|Brain and Other Nervous System|2007|0.5|0.7|0.6
0-19|0.0|0.1|0.1|24|Mortality|41024382|All Races|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|41282647|All Races|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|41402165|All Races|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|20|Mortality|41481180|All Races|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|41556050|All Races|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|0.0|0.0|0.0|58|Mortality|209079485|All Races|Male|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|41686807|All Races|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|41786904|All Races|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|41922622|All Races|Male|Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|42127102|All Races|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|0.1|0.1|0.1|32|Mortality|41024382|All Races|Male|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|28|Mortality|41282647|All Races|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|41402165|All Races|Male|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|41481180|All Races|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41556050|All Races|Male|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|137|Mortality|209079485|All Races|Male|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|41686807|All Races|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41786904|All Races|Male|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|41922622|All Races|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|20|Mortality|42127102|All Races|Male|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.8|1.0|0.9|379|Mortality|41024382|All Races|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|430|Mortality|41282647|All Races|Male|Leukemia|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Mortality|41402165|All Races|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.0|0.9|382|Mortality|41481180|All Races|Male|Leukemia|2002|0.8|1.0|0.9
0-19|0.9|1.1|1.0|404|Mortality|41556050|All Races|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.9|0.9|0.9|1897|Mortality|209079485|All Races|Male|Leukemia|2003-2007|0.9|0.9|0.9
0-19|0.8|1.0|0.9|387|Mortality|41686807|All Races|Male|Leukemia|2004|0.8|1.0|0.9
0-19|0.8|1.0|0.9|382|Mortality|41786904|All Races|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|0.9|0.9|359|Mortality|41922622|All Races|Male|Leukemia|2006|0.8|0.9|0.9
0-19|0.8|1.0|0.9|365|Mortality|42127102|All Races|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.1|0.2|0.2|69|Mortality|41024382|All Races|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.2|0.2|79|Mortality|41282647|All Races|Male|Non-Hodgkin Lymphoma|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|74|Mortality|41402165|All Races|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41481180|All Races|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|65|Mortality|41556050|All Races|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|339|Mortality|209079485|All Races|Male|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|67|Mortality|41686807|All Races|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41786904|All Races|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|70|Mortality|41922622|All Races|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|59|Mortality|42127102|All Races|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.6|0.7|0.6|266|Mortality|41024382|All Races|Male|Other|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.6|264|Mortality|41282647|All Races|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|242|Mortality|41402165|All Races|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.7|0.7|275|Mortality|41481180|All Races|Male|Other|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.6|265|Mortality|41556050|All Races|Male|Other|2003|0.6|0.7|0.6
0-19|0.6|0.6|0.6|1264|Mortality|209079485|All Races|Male|Other|2003-2007|0.6|0.6|0.6
0-19|0.6|0.7|0.6|263|Mortality|41686807|All Races|Male|Other|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|261|Mortality|41786904|All Races|Male|Other|2005|0.6|0.7|0.6
0-19|0.5|0.6|0.5|225|Mortality|41922622|All Races|Male|Other|2006|0.5|0.6|0.5
0-19|0.5|0.7|0.6|250|Mortality|42127102|All Races|Male|Other|2007|0.5|0.7|0.6
0-19|0.2|0.3|0.2|92|Mortality|41024382|All Races|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|41282647|All Races|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|41402165|All Races|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.2|0.2|0.2|82|Mortality|41481180|All Races|Male|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.3|0.2|84|Mortality|41556050|All Races|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|399|Mortality|209079485|All Races|Male|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.2|0.2|0.2|83|Mortality|41686807|All Races|Male|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.1|0.2|0.2|76|Mortality|41786904|All Races|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|41922622|All Races|Male|Soft Tissue|2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|72|Mortality|42127102|All Races|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.3|0.4|0.4|285|Mortality|80039970|All Races|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.4|332|Mortality|80539363|All Races|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.4
0-19|0.3|0.4|0.4|313|Mortality|80763447|All Races|Male and Female|Acute Lymphocytic|2001|0.3|0.4|0.4
0-19|0.4|0.4|0.4|323|Mortality|80943001|All Races|Male and Female|Acute Lymphocytic|2002|0.4|0.4|0.4
0-19|0.4|0.5|0.4|328|Mortality|81132452|All Races|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.3|0.4|0.4|1450|Mortality|408374884|All Races|Male and Female|Acute Lymphocytic|2003-2007|0.3|0.4|0.4
0-19|0.3|0.4|0.4|295|Mortality|81414417|All Races|Male and Female|Acute Lymphocytic|2004|0.3|0.4|0.4
0-19|0.3|0.4|0.3|267|Mortality|81624286|All Races|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.3
0-19|0.3|0.4|0.3|266|Mortality|81899061|All Races|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.4|294|Mortality|82304668|All Races|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.2|0.3|0.3|207|Mortality|80039970|All Races|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|222|Mortality|80539363|All Races|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|227|Mortality|80763447|All Races|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|209|Mortality|80943001|All Races|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|81132452|All Races|Male and Female|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.2|1020|Mortality|408374884|All Races|Male and Female|Acute Myeloid|2003-2007|0.2|0.3|0.2
0-19|0.2|0.3|0.3|211|Mortality|81414417|All Races|Male and Female|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|212|Mortality|81624286|All Races|Male and Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|195|Mortality|81899061|All Races|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|195|Mortality|82304668|All Races|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Races|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80539363|All Races|Male and Female|All Cancer Sites Combined|2000|2.7|2.9|2.8
0-19|2.6|2.9|2.8|2226|Mortality|80763447|All Races|Male and Female|All Cancer Sites Combined|2001|2.6|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80943001|All Races|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.6|2.9|2.8|2233|Mortality|81132452|All Races|Male and Female|All Cancer Sites Combined|2003|2.6|2.9|2.8
0-19|2.6|2.7|2.6|10742|Mortality|408374884|All Races|Male and Female|All Cancer Sites Combined|2003-2007|2.6|2.7|2.6
0-19|2.6|2.8|2.7|2223|Mortality|81414417|All Races|Male and Female|All Cancer Sites Combined|2004|2.6|2.8|2.7
0-19|2.6|2.8|2.7|2183|Mortality|81624286|All Races|Male and Female|All Cancer Sites Combined|2005|2.6|2.8|2.7
0-19|2.4|2.6|2.5|2035|Mortality|81899061|All Races|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.4|2.6|2.5|2068|Mortality|82304668|All Races|Male and Female|All Cancer Sites Combined|2007|2.4|2.6|2.5
0-19|0.2|0.3|0.3|209|Mortality|80039970|All Races|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|181|Mortality|80539363|All Races|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|80763447|All Races|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|179|Mortality|80943001|All Races|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|186|Mortality|81132452|All Races|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|933|Mortality|408374884|All Races|Male and Female|Bones and Joints|2003-2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|189|Mortality|81414417|All Races|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|212|Mortality|81624286|All Races|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|174|Mortality|81899061|All Races|Male and Female|Bones and Joints|2006|0.2|0.2|0.2
0-19|0.2|0.2|0.2|172|Mortality|82304668|All Races|Male and Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.6|0.7|0.7|546|Mortality|80039970|All Races|Male and Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Mortality|80539363|All Races|Male and Female|Brain and Other Nervous System|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.6|520|Mortality|80763447|All Races|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.8|0.7|571|Mortality|80943001|All Races|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|577|Mortality|81132452|All Races|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.7|0.7|2721|Mortality|408374884|All Races|Male and Female|Brain and Other Nervous System|2003-2007|0.6|0.7|0.7
0-19|0.6|0.7|0.7|555|Mortality|81414417|All Races|Male and Female|Brain and Other Nervous System|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|544|Mortality|81624286|All Races|Male and Female|Brain and Other Nervous System|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|524|Mortality|81899061|All Races|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.6|0.7|0.6|521|Mortality|82304668|All Races|Male and Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.0|0.1|0.1|41|Mortality|80039970|All Races|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|29|Mortality|80539363|All Races|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|31|Mortality|80763447|All Races|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|33|Mortality|80943001|All Races|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|21|Mortality|81132452|All Races|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|108|Mortality|408374884|All Races|Male and Female|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81414417|All Races|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|22|Mortality|81624286|All Races|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81899061|All Races|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|82304668|All Races|Male and Female|Hodgkin Lymphoma|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|62|Mortality|80039970|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|54|Mortality|80539363|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.1|0.1
0-19|0.1|0.1|0.1|66|Mortality|80763447|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|49|Mortality|80943001|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|65|Mortality|81132452|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|287|Mortality|408374884|All Races|Male and Female|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|59|Mortality|81414417|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|62|Mortality|81624286|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.1|0.1|0.1|54|Mortality|81899061|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|47|Mortality|82304668|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.8|0.9|0.8|672|Mortality|80039970|All Races|Male and Female|Leukemia|1999|0.8|0.9|0.8
0-19|0.8|1.0|0.9|732|Mortality|80539363|All Races|Male and Female|Leukemia|2000|0.8|1.0|0.9
0-19|0.8|1.0|0.9|728|Mortality|80763447|All Races|Male and Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.8|0.9|0.8|678|Mortality|80943001|All Races|Male and Female|Leukemia|2002|0.8|0.9|0.8
0-19|0.8|0.9|0.8|688|Mortality|81132452|All Races|Male and Female|Leukemia|2003|0.8|0.9|0.8
0-19|0.8|0.8|0.8|3254|Mortality|408374884|All Races|Male and Female|Leukemia|2003-2007|0.8|0.8|0.8
0-19|0.8|0.9|0.8|665|Mortality|81414417|All Races|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.8|0.8|640|Mortality|81624286|All Races|Male and Female|Leukemia|2005|0.7|0.8|0.8
0-19|0.7|0.8|0.7|618|Mortality|81899061|All Races|Male and Female|Leukemia|2006|0.7|0.8|0.8
0-19|0.7|0.8|0.8|643|Mortality|82304668|All Races|Male and Female|Leukemia|2007|0.7|0.8|0.8
0-19|0.1|0.2|0.1|106|Mortality|80039970|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|115|Mortality|80539363|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|101|Mortality|80763447|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|118|Mortality|80943001|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.2|0.1|103|Mortality|81132452|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.1|0.1|481|Mortality|408374884|All Races|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|100|Mortality|81414417|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.2|0.1|102|Mortality|81624286|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|89|Mortality|81899061|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|87|Mortality|82304668|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.5|0.6|0.6|455|Mortality|80039970|All Races|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|471|Mortality|80539363|All Races|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.6|444|Mortality|80763447|All Races|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.6|0.7|0.6|490|Mortality|80943001|All Races|Male and Female|Other|2002|0.6|0.7|0.6
0-19|0.5|0.6|0.6|447|Mortality|81132452|All Races|Male and Female|Other|2003|0.5|0.6|0.6
0-19|0.5|0.6|0.5|2205|Mortality|408374884|All Races|Male and Female|Other|2003-2007|0.5|0.6|0.5
0-19|0.5|0.6|0.6|468|Mortality|81414417|All Races|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|438|Mortality|81624286|All Races|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.5|0.6|0.5|413|Mortality|81899061|All Races|Male and Female|Other|2006|0.5|0.6|0.5
0-19|0.5|0.6|0.5|439|Mortality|82304668|All Races|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.2|0.2|0.2|152|Mortality|80039970|All Races|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|144|Mortality|80539363|All Races|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|147|Mortality|80763447|All Races|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|153|Mortality|80943001|All Races|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|146|Mortality|81132452|All Races|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|753|Mortality|408374884|All Races|Male and Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.2|0.2|0.2|164|Mortality|81414417|All Races|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|163|Mortality|81624286|All Races|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|81899061|All Races|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|82304668|All Races|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Acute Lymphocytic|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Acute Myeloid|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|~|~|~
0-19|0.8|1.7|1.2|34|Mortality|2853593|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003-2007|0.8|1.7|1.2
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Leukemia|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Other|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|558397|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|560790|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|562948|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|564439|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|2853593|American Indian/Alaska Native|Female|Soft Tissue|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|566574|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|569744|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|573581|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|579255|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Acute Lymphocytic|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Acute Myeloid|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|~|~|~
0-19|1.6|4.5|2.7|16|Mortality|579992|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|1.6|4.5|2.8
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|~|~|~
0-19|1.7|2.8|2.2|64|Mortality|2937507|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003-2007|1.7|2.8|2.2
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|0.4|1.0|0.6|18|Mortality|2937507|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003-2007|0.4|1.0|0.6
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Leukemia|2003|~|~|~
0-19|0.5|1.2|0.8|24|Mortality|2937507|American Indian/Alaska Native|Male|Leukemia|2003-2007|0.5|1.2|0.8
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Other|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|578342|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|579992|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|581015|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|581502|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|2937507|American Indian/Alaska Native|Male|Soft Tissue|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|583658|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|586324|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|590064|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|595959|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|5791100|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003-2007|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|~|~|~
0-19|1.0|2.6|1.7|19|Mortality|1136739|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|1.0|2.6|1.7
0-19|1.2|2.9|1.9|22|Mortality|1140782|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|1.2|2.9|1.9
0-19|1.4|3.2|2.2|25|Mortality|1143963|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|1.4|3.2|2.2
0-19|1.3|3.1|2.1|24|Mortality|1145941|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|1.3|3.1|2.1
0-19|1.4|2.1|1.7|98|Mortality|5791100|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003-2007|1.4|2.1|1.7
0-19|0.9|2.5|1.6|18|Mortality|1150232|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|0.9|2.5|1.6
0-19|0.9|2.4|1.5|18|Mortality|1156068|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|0.9|2.5|1.6
0-19|1.0|2.5|1.6|19|Mortality|1163645|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|1.0|2.5|1.6
0-19|1.0|2.5|1.6|19|Mortality|1175214|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|1.0|2.5|1.6
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|0.3|0.6|0.4|25|Mortality|5791100|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003-2007|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Leukemia|2003|~|~|~
0-19|0.4|0.9|0.6|37|Mortality|5791100|American Indian/Alaska Native|Male and Female|Leukemia|2003-2007|0.4|0.9|0.6
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Other|2003|~|~|~
0-19|0.2|0.5|0.3|17|Mortality|5791100|American Indian/Alaska Native|Male and Female|Other|2003-2007|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1136739|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1140782|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1143963|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1145941|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|5791100|American Indian/Alaska Native|Male and Female|Soft Tissue|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1150232|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1156068|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1163645|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1175214|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|~|~|~
0-19|0.1|0.3|0.2|20|Mortality|9315403|Asian/Pacific Islander|Female|Acute Lymphocytic|2003-2007|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|0.2|0.4|0.3|27|Mortality|9315403|Asian/Pacific Islander|Female|Acute Myeloid|2003-2007|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|1.7|3.3|2.4|39|Mortality|1642417|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|1.7|3.2|2.4
0-19|1.6|3.1|2.3|39|Mortality|1694064|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|1.6|3.1|2.3
0-19|1.5|3.0|2.1|37|Mortality|1721959|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|1.5|3.0|2.1
0-19|1.5|3.0|2.2|38|Mortality|1751755|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|1.5|3.0|2.2
0-19|1.4|2.7|2.0|35|Mortality|1786185|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|1.4|2.7|2.0
0-19|1.7|2.3|1.9|180|Mortality|9315403|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003-2007|1.7|2.2|1.9
0-19|1.3|2.6|1.9|34|Mortality|1822285|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|1.3|2.6|1.9
0-19|1.2|2.5|1.7|32|Mortality|1861345|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|1.2|2.4|1.7
0-19|1.6|2.9|2.2|41|Mortality|1901294|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|1.5|2.9|2.2
0-19|1.4|2.7|2.0|38|Mortality|1944294|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|1.4|2.7|2.0
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|9315403|Asian/Pacific Islander|Female|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|~|~|~
0-19|0.3|0.6|0.5|42|Mortality|9315403|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003-2007|0.3|0.6|0.5
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|9315403|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|9315403|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Leukemia|2001|~|~|~
0-19|0.6|1.6|1.0|18|Mortality|1751755|Asian/Pacific Islander|Female|Leukemia|2002|0.6|1.6|1.0
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Leukemia|2003|~|~|~
0-19|0.5|0.8|0.6|57|Mortality|9315403|Asian/Pacific Islander|Female|Leukemia|2003-2007|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|9315403|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Other|2003|~|~|~
0-19|0.4|0.7|0.5|46|Mortality|9315403|Asian/Pacific Islander|Female|Other|2003-2007|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1694064|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1721959|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1751755|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1786185|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|9315403|Asian/Pacific Islander|Female|Soft Tissue|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1822285|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1861345|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1901294|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1944294|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|~|~|~
0-19|0.3|0.5|0.4|37|Mortality|9735640|Asian/Pacific Islander|Male|Acute Lymphocytic|2003-2007|0.3|0.5|0.4
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|0.2|0.4|0.2|24|Mortality|9735640|Asian/Pacific Islander|Male|Acute Myeloid|2003-2007|0.2|0.4|0.2
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Acute Myeloid|2007|~|~|~
0-19|2.3|4.0|3.1|53|Mortality|1714818|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|2.3|4.0|3.1
0-19|2.0|3.5|2.7|47|Mortality|1764865|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|2.0|3.5|2.7
0-19|2.1|3.7|2.8|50|Mortality|1796741|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|2.1|3.7|2.8
0-19|2.2|3.8|2.9|53|Mortality|1828604|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|2.2|3.8|2.9
0-19|1.8|3.3|2.5|46|Mortality|1865772|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|1.8|3.3|2.5
0-19|2.3|2.9|2.6|248|Mortality|9735640|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003-2007|2.2|2.9|2.5
0-19|2.2|3.8|2.9|55|Mortality|1904159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|2.2|3.8|2.9
0-19|1.9|3.4|2.6|50|Mortality|1945619|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|1.9|3.4|2.6
0-19|1.8|3.2|2.4|48|Mortality|1987530|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|1.8|3.2|2.4
0-19|1.8|3.2|2.4|49|Mortality|2032560|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|1.8|3.2|2.4
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|9735640|Asian/Pacific Islander|Male|Bones and Joints|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|~|~|~
0-19|0.5|0.8|0.6|60|Mortality|9735640|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003-2007|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|9735640|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|9735640|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.5|1.5|0.9|16|Mortality|1714818|Asian/Pacific Islander|Male|Leukemia|1999|0.5|1.5|0.9
0-19|0.8|1.9|1.3|22|Mortality|1764865|Asian/Pacific Islander|Male|Leukemia|2000|0.8|1.9|1.2
0-19|0.6|1.7|1.1|19|Mortality|1796741|Asian/Pacific Islander|Male|Leukemia|2001|0.6|1.7|1.1
0-19|0.5|1.5|0.9|17|Mortality|1828604|Asian/Pacific Islander|Male|Leukemia|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.9|16|Mortality|1865772|Asian/Pacific Islander|Male|Leukemia|2003|0.5|1.4|0.9
0-19|0.7|1.1|0.9|84|Mortality|9735640|Asian/Pacific Islander|Male|Leukemia|2003-2007|0.7|1.1|0.9
0-19|0.5|1.5|0.9|18|Mortality|1904159|Asian/Pacific Islander|Male|Leukemia|2004|0.6|1.5|0.9
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Leukemia|2005|~|~|~
0-19|0.5|1.4|0.8|17|Mortality|1987530|Asian/Pacific Islander|Male|Leukemia|2006|0.5|1.4|0.9
0-19|0.5|1.4|0.9|18|Mortality|2032560|Asian/Pacific Islander|Male|Leukemia|2007|0.5|1.4|0.9
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|9735640|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Other|2003|~|~|~
0-19|0.4|0.8|0.6|58|Mortality|9735640|Asian/Pacific Islander|Male|Other|2003-2007|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1764865|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1796741|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1828604|Asian/Pacific Islander|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1865772|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|9735640|Asian/Pacific Islander|Male|Soft Tissue|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|1904159|Asian/Pacific Islander|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1945619|Asian/Pacific Islander|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1987530|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|2032560|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|0.2|0.4|0.3|57|Mortality|19051043|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003-2007|0.2|0.4|0.3
0-19|0.2|0.7|0.4|16|Mortality|3726444|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|0.2|0.7|0.4
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|~|~|~
0-19|0.2|0.4|0.3|51|Mortality|19051043|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003-2007|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|~|~|~
0-19|2.2|3.4|2.7|92|Mortality|3357235|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|2.2|3.4|2.7
0-19|2.0|3.1|2.5|86|Mortality|3458929|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|2.0|3.1|2.5
0-19|2.0|3.1|2.5|87|Mortality|3518700|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|2.0|3.0|2.5
0-19|2.0|3.1|2.5|91|Mortality|3580359|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|2.0|3.1|2.5
0-19|1.8|2.8|2.2|81|Mortality|3651957|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|1.8|2.8|2.2
0-19|2.1|2.5|2.3|428|Mortality|19051043|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003-2007|2.0|2.5|2.2
0-19|1.9|2.9|2.4|89|Mortality|3726444|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|1.9|2.9|2.4
0-19|1.7|2.7|2.2|82|Mortality|3806964|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|1.7|2.7|2.2
0-19|1.8|2.8|2.3|89|Mortality|3888824|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|1.8|2.8|2.3
0-19|1.8|2.7|2.2|87|Mortality|3976854|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|1.8|2.7|2.2
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|~|~|~
0-19|0.1|0.2|0.1|26|Mortality|19051043|Asian/Pacific Islander|Male and Female|Bones and Joints|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|~|~|~
0-19|0.3|0.9|0.6|19|Mortality|3357235|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|0.3|0.9|0.6
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|0.4|0.9|0.6|21|Mortality|3518700|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|0.4|0.9|0.6
0-19|0.3|0.9|0.6|20|Mortality|3580359|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|0.3|0.9|0.6
0-19|0.3|0.8|0.5|17|Mortality|3651957|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|0.3|0.7|0.5
0-19|0.4|0.7|0.5|102|Mortality|19051043|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003-2007|0.4|0.6|0.5
0-19|0.5|1.1|0.7|26|Mortality|3726444|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|0.5|1.0|0.7
0-19|0.3|0.8|0.5|20|Mortality|3806964|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|0.3|0.8|0.5
0-19|0.4|0.9|0.6|22|Mortality|3888824|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|0.4|0.9|0.6
0-19|0.2|0.7|0.4|17|Mortality|3976854|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|0.2|0.7|0.4
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|19051043|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|19051043|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.6|1.3|0.9|30|Mortality|3357235|Asian/Pacific Islander|Male and Female|Leukemia|1999|0.6|1.3|0.9
0-19|0.6|1.2|0.9|30|Mortality|3458929|Asian/Pacific Islander|Male and Female|Leukemia|2000|0.6|1.2|0.9
0-19|0.6|1.3|0.9|31|Mortality|3518700|Asian/Pacific Islander|Male and Female|Leukemia|2001|0.6|1.3|0.9
0-19|0.7|1.4|1.0|35|Mortality|3580359|Asian/Pacific Islander|Male and Female|Leukemia|2002|0.7|1.4|1.0
0-19|0.5|1.1|0.8|29|Mortality|3651957|Asian/Pacific Islander|Male and Female|Leukemia|2003|0.5|1.1|0.8
0-19|0.6|0.9|0.7|141|Mortality|19051043|Asian/Pacific Islander|Male and Female|Leukemia|2003-2007|0.6|0.9|0.7
0-19|0.5|1.1|0.8|30|Mortality|3726444|Asian/Pacific Islander|Male and Female|Leukemia|2004|0.5|1.1|0.8
0-19|0.4|1.0|0.7|25|Mortality|3806964|Asian/Pacific Islander|Male and Female|Leukemia|2005|0.4|1.0|0.7
0-19|0.4|0.9|0.6|25|Mortality|3888824|Asian/Pacific Islander|Male and Female|Leukemia|2006|0.4|0.9|0.6
0-19|0.6|1.1|0.8|32|Mortality|3976854|Asian/Pacific Islander|Male and Female|Leukemia|2007|0.6|1.1|0.8
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.1|0.2|0.1|20|Mortality|19051043|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.4|0.9|0.6|20|Mortality|3357235|Asian/Pacific Islander|Male and Female|Other|1999|0.4|0.9|0.6
0-19|0.4|1.0|0.7|23|Mortality|3458929|Asian/Pacific Islander|Male and Female|Other|2000|0.4|1.0|0.7
0-19|0.5|1.1|0.7|26|Mortality|3518700|Asian/Pacific Islander|Male and Female|Other|2001|0.5|1.1|0.7
0-19|0.3|0.8|0.5|20|Mortality|3580359|Asian/Pacific Islander|Male and Female|Other|2002|0.3|0.9|0.6
0-19|0.3|0.8|0.5|19|Mortality|3651957|Asian/Pacific Islander|Male and Female|Other|2003|0.3|0.8|0.5
0-19|0.4|0.7|0.5|104|Mortality|19051043|Asian/Pacific Islander|Male and Female|Other|2003-2007|0.4|0.7|0.5
0-19|0.3|0.8|0.5|19|Mortality|3726444|Asian/Pacific Islander|Male and Female|Other|2004|0.3|0.8|0.5
0-19|0.3|0.7|0.5|18|Mortality|3806964|Asian/Pacific Islander|Male and Female|Other|2005|0.3|0.7|0.5
0-19|0.5|1.0|0.7|27|Mortality|3888824|Asian/Pacific Islander|Male and Female|Other|2006|0.5|1.0|0.7
0-19|0.3|0.8|0.5|21|Mortality|3976854|Asian/Pacific Islander|Male and Female|Other|2007|0.3|0.8|0.5
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|3458929|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|3518700|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|3580359|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|3651957|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|~|~|~
0-19|0.1|0.2|0.1|25|Mortality|19051043|Asian/Pacific Islander|Male and Female|Soft Tissue|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3726444|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|3806964|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|3888824|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|3976854|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Acute Lymphocytic|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6439165|Black|Female|Acute Lymphocytic|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6451047|Black|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Acute Lymphocytic|2003|~|~|~
0-19|0.1|0.2|0.1|41|Mortality|32531725|Black|Female|Acute Lymphocytic|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|6480837|Black|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|6499735|Black|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Acute Lymphocytic|2007|~|~|~
0-19|0.1|0.4|0.3|16|Mortality|6375857|Black|Female|Acute Myeloid|1999|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6423690|Black|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Acute Myeloid|2001|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|6451047|Black|Female|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6462388|Black|Female|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.4|0.3|96|Mortality|32531725|Black|Female|Acute Myeloid|2003-2007|0.2|0.4|0.3
0-19|0.2|0.5|0.4|24|Mortality|6480837|Black|Female|Acute Myeloid|2004|0.2|0.6|0.4
0-19|~|~|~|~|Mortality|6499735|Black|Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.4|0.3|19|Mortality|6524555|Black|Female|Acute Myeloid|2006|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6564210|Black|Female|Acute Myeloid|2007|0.2|0.5|0.3
0-19|2.3|3.1|2.7|170|Mortality|6375857|Black|Female|All Cancer Sites Combined|1999|2.3|3.1|2.7
0-19|2.1|2.9|2.5|160|Mortality|6423690|Black|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|1.8|2.6|2.2|140|Mortality|6439165|Black|Female|All Cancer Sites Combined|2001|1.8|2.6|2.2
0-19|2.2|3.0|2.5|163|Mortality|6451047|Black|Female|All Cancer Sites Combined|2002|2.2|2.9|2.5
0-19|1.9|2.6|2.2|143|Mortality|6462388|Black|Female|All Cancer Sites Combined|2003|1.9|2.6|2.2
0-19|2.1|2.5|2.3|749|Mortality|32531725|Black|Female|All Cancer Sites Combined|2003-2007|2.1|2.5|2.3
0-19|2.3|3.1|2.7|176|Mortality|6480837|Black|Female|All Cancer Sites Combined|2004|2.3|3.1|2.7
0-19|1.9|2.6|2.2|145|Mortality|6499735|Black|Female|All Cancer Sites Combined|2005|1.9|2.6|2.2
0-19|1.8|2.5|2.1|139|Mortality|6524555|Black|Female|All Cancer Sites Combined|2006|1.8|2.5|2.1
0-19|1.9|2.6|2.2|146|Mortality|6564210|Black|Female|All Cancer Sites Combined|2007|1.9|2.6|2.2
0-19|~|~|~|~|Mortality|6375857|Black|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6451047|Black|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Bones and Joints|2003|~|~|~
0-19|0.1|0.2|0.2|55|Mortality|32531725|Black|Female|Bones and Joints|2003-2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6480837|Black|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|6499735|Black|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Bones and Joints|2007|~|~|~
0-19|0.5|1.0|0.7|46|Mortality|6375857|Black|Female|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.4|0.8|0.6|37|Mortality|6423690|Black|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.7|0.5|33|Mortality|6439165|Black|Female|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6451047|Black|Female|Brain and Other Nervous System|2002|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6462388|Black|Female|Brain and Other Nervous System|2003|0.4|0.8|0.6
0-19|0.5|0.7|0.6|203|Mortality|32531725|Black|Female|Brain and Other Nervous System|2003-2007|0.5|0.7|0.6
0-19|0.5|0.9|0.7|44|Mortality|6480837|Black|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Mortality|6499735|Black|Female|Brain and Other Nervous System|2005|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6524555|Black|Female|Brain and Other Nervous System|2006|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6564210|Black|Female|Brain and Other Nervous System|2007|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6375857|Black|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6451047|Black|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|32531725|Black|Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|6480837|Black|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6499735|Black|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6451047|Black|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.0|0.1|0.1|22|Mortality|32531725|Black|Female|Kidney and Renal Pelvis|2003-2007|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|6480837|Black|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6499735|Black|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.4|0.8|0.6|39|Mortality|6375857|Black|Female|Leukemia|1999|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6423690|Black|Female|Leukemia|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6439165|Black|Female|Leukemia|2001|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6451047|Black|Female|Leukemia|2002|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6462388|Black|Female|Leukemia|2003|0.4|0.8|0.6
0-19|0.5|0.7|0.6|196|Mortality|32531725|Black|Female|Leukemia|2003-2007|0.5|0.7|0.6
0-19|0.5|0.9|0.7|43|Mortality|6480837|Black|Female|Leukemia|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|40|Mortality|6499735|Black|Female|Leukemia|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|35|Mortality|6524555|Black|Female|Leukemia|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6564210|Black|Female|Leukemia|2007|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6375857|Black|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6451047|Black|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.1|0.1|0.1|27|Mortality|32531725|Black|Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6480837|Black|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6499735|Black|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.4|0.7|0.5|33|Mortality|6375857|Black|Female|Other|1999|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6423690|Black|Female|Other|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|32|Mortality|6439165|Black|Female|Other|2001|0.3|0.7|0.5
0-19|0.5|1.0|0.7|47|Mortality|6451047|Black|Female|Other|2002|0.5|1.0|0.7
0-19|0.3|0.7|0.5|32|Mortality|6462388|Black|Female|Other|2003|0.3|0.7|0.5
0-19|0.5|0.6|0.5|177|Mortality|32531725|Black|Female|Other|2003-2007|0.5|0.6|0.5
0-19|0.5|0.9|0.6|41|Mortality|6480837|Black|Female|Other|2004|0.5|0.9|0.6
0-19|0.4|0.8|0.6|40|Mortality|6499735|Black|Female|Other|2005|0.4|0.8|0.6
0-19|0.3|0.6|0.4|28|Mortality|6524555|Black|Female|Other|2006|0.3|0.6|0.4
0-19|0.4|0.8|0.5|36|Mortality|6564210|Black|Female|Other|2007|0.4|0.8|0.5
0-19|~|~|~|~|Mortality|6375857|Black|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6423690|Black|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6439165|Black|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|6451047|Black|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|6462388|Black|Female|Soft Tissue|2003|~|~|~
0-19|0.1|0.2|0.2|60|Mortality|32531725|Black|Female|Soft Tissue|2003-2007|0.1|0.2|0.2
0-19|0.2|0.5|0.3|20|Mortality|6480837|Black|Female|Soft Tissue|2004|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6499735|Black|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6524555|Black|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6564210|Black|Female|Soft Tissue|2007|~|~|~
0-19|0.3|0.6|0.4|26|Mortality|6562662|Black|Male|Acute Lymphocytic|1999|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6620845|Black|Male|Acute Lymphocytic|2000|0.2|0.5|0.3
0-19|0.3|0.6|0.4|29|Mortality|6649143|Black|Male|Acute Lymphocytic|2001|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6663484|Black|Male|Acute Lymphocytic|2002|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6670066|Black|Male|Acute Lymphocytic|2003|0.1|0.4|0.2
0-19|0.2|0.3|0.3|95|Mortality|33571872|Black|Male|Acute Lymphocytic|2003-2007|0.2|0.3|0.3
0-19|~|~|~|~|Mortality|6686638|Black|Male|Acute Lymphocytic|2004|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6705972|Black|Male|Acute Lymphocytic|2005|0.2|0.5|0.3
0-19|0.2|0.4|0.3|19|Mortality|6732249|Black|Male|Acute Lymphocytic|2006|0.2|0.4|0.3
0-19|0.2|0.5|0.4|24|Mortality|6776947|Black|Male|Acute Lymphocytic|2007|0.2|0.5|0.4
0-19|0.2|0.5|0.3|20|Mortality|6562662|Black|Male|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.3|0.6|0.4|25|Mortality|6620845|Black|Male|Acute Myeloid|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|20|Mortality|6649143|Black|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6663484|Black|Male|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6670066|Black|Male|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.3|0.4|0.3|106|Mortality|33571872|Black|Male|Acute Myeloid|2003-2007|0.3|0.4|0.3
0-19|0.2|0.5|0.4|24|Mortality|6686638|Black|Male|Acute Myeloid|2004|0.2|0.5|0.4
0-19|0.2|0.5|0.3|22|Mortality|6705972|Black|Male|Acute Myeloid|2005|0.2|0.5|0.3
0-19|0.1|0.4|0.3|17|Mortality|6732249|Black|Male|Acute Myeloid|2006|0.1|0.4|0.3
0-19|0.2|0.5|0.3|21|Mortality|6776947|Black|Male|Acute Myeloid|2007|0.2|0.5|0.3
0-19|2.8|3.7|3.3|212|Mortality|6562662|Black|Male|All Cancer Sites Combined|1999|2.8|3.7|3.2
0-19|2.7|3.6|3.2|207|Mortality|6620845|Black|Male|All Cancer Sites Combined|2000|2.7|3.6|3.1
0-19|2.7|3.5|3.1|203|Mortality|6649143|Black|Male|All Cancer Sites Combined|2001|2.6|3.5|3.1
0-19|2.8|3.6|3.2|210|Mortality|6663484|Black|Male|All Cancer Sites Combined|2002|2.7|3.6|3.2
0-19|2.4|3.2|2.8|188|Mortality|6670066|Black|Male|All Cancer Sites Combined|2003|2.4|3.3|2.8
0-19|2.6|3.0|2.8|938|Mortality|33571872|Black|Male|All Cancer Sites Combined|2003-2007|2.6|3.0|2.8
0-19|2.5|3.3|2.9|192|Mortality|6686638|Black|Male|All Cancer Sites Combined|2004|2.5|3.3|2.9
0-19|2.6|3.5|3.0|204|Mortality|6705972|Black|Male|All Cancer Sites Combined|2005|2.6|3.5|3.0
0-19|2.4|3.2|2.8|187|Mortality|6732249|Black|Male|All Cancer Sites Combined|2006|2.4|3.2|2.8
0-19|2.1|2.9|2.5|167|Mortality|6776947|Black|Male|All Cancer Sites Combined|2007|2.1|2.9|2.5
0-19|0.1|0.4|0.3|16|Mortality|6562662|Black|Male|Bones and Joints|1999|0.1|0.4|0.2
0-19|0.2|0.5|0.3|21|Mortality|6620845|Black|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6649143|Black|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6663484|Black|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6670066|Black|Male|Bones and Joints|2003|~|~|~
0-19|0.2|0.3|0.2|78|Mortality|33571872|Black|Male|Bones and Joints|2003-2007|0.2|0.3|0.2
0-19|0.2|0.5|0.3|22|Mortality|6686638|Black|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6705972|Black|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6732249|Black|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6776947|Black|Male|Bones and Joints|2007|~|~|~
0-19|0.5|0.9|0.7|47|Mortality|6562662|Black|Male|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.6|1.0|0.8|51|Mortality|6620845|Black|Male|Brain and Other Nervous System|2000|0.6|1.0|0.8
0-19|0.4|0.7|0.5|34|Mortality|6649143|Black|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.7|1.1|0.9|58|Mortality|6663484|Black|Male|Brain and Other Nervous System|2002|0.7|1.1|0.9
0-19|0.5|0.9|0.7|45|Mortality|6670066|Black|Male|Brain and Other Nervous System|2003|0.5|0.9|0.7
0-19|0.5|0.7|0.6|189|Mortality|33571872|Black|Male|Brain and Other Nervous System|2003-2007|0.5|0.6|0.6
0-19|0.4|0.8|0.6|41|Mortality|6686638|Black|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6705972|Black|Male|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.8|0.6|37|Mortality|6732249|Black|Male|Brain and Other Nervous System|2006|0.4|0.8|0.5
0-19|0.2|0.5|0.3|22|Mortality|6776947|Black|Male|Brain and Other Nervous System|2007|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6562662|Black|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6620845|Black|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6649143|Black|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6663484|Black|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6670066|Black|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|33571872|Black|Male|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|6686638|Black|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6705972|Black|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6732249|Black|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6776947|Black|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6562662|Black|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6620845|Black|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6649143|Black|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6663484|Black|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6670066|Black|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.1|0.2|0.1|39|Mortality|33571872|Black|Male|Kidney and Renal Pelvis|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|6686638|Black|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6705972|Black|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6732249|Black|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6776947|Black|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.8|1.3|1.0|65|Mortality|6562662|Black|Male|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|62|Mortality|6620845|Black|Male|Leukemia|2000|0.7|1.2|0.9
0-19|0.8|1.3|1.0|67|Mortality|6649143|Black|Male|Leukemia|2001|0.8|1.3|1.0
0-19|0.6|1.0|0.8|52|Mortality|6663484|Black|Male|Leukemia|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|6670066|Black|Male|Leukemia|2003|0.5|0.9|0.7
0-19|0.7|0.9|0.8|269|Mortality|33571872|Black|Male|Leukemia|2003-2007|0.7|0.9|0.8
0-19|0.6|1.1|0.8|54|Mortality|6686638|Black|Male|Leukemia|2004|0.6|1.1|0.8
0-19|0.7|1.1|0.9|60|Mortality|6705972|Black|Male|Leukemia|2005|0.7|1.2|0.9
0-19|0.6|1.1|0.8|55|Mortality|6732249|Black|Male|Leukemia|2006|0.6|1.1|0.8
0-19|0.6|1.0|0.8|53|Mortality|6776947|Black|Male|Leukemia|2007|0.6|1.0|0.8
0-19|~|~|~|~|Mortality|6562662|Black|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6620845|Black|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6649143|Black|Male|Non-Hodgkin Lymphoma|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6663484|Black|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6670066|Black|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.1|0.2|0.2|62|Mortality|33571872|Black|Male|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6686638|Black|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6705972|Black|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6732249|Black|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6776947|Black|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.5|0.9|0.7|46|Mortality|6562662|Black|Male|Other|1999|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6620845|Black|Male|Other|2000|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6649143|Black|Male|Other|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.7|47|Mortality|6663484|Black|Male|Other|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.8|52|Mortality|6670066|Black|Male|Other|2003|0.6|1.0|0.8
0-19|0.6|0.8|0.7|225|Mortality|33571872|Black|Male|Other|2003-2007|0.6|0.8|0.7
0-19|0.5|0.9|0.7|44|Mortality|6686638|Black|Male|Other|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.6|43|Mortality|6705972|Black|Male|Other|2005|0.5|0.9|0.6
0-19|0.4|0.8|0.6|41|Mortality|6732249|Black|Male|Other|2006|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6776947|Black|Male|Other|2007|0.5|0.9|0.7
0-19|0.2|0.4|0.3|17|Mortality|6562662|Black|Male|Soft Tissue|1999|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6620845|Black|Male|Soft Tissue|2000|~|~|~
0-19|0.2|0.4|0.3|18|Mortality|6649143|Black|Male|Soft Tissue|2001|0.2|0.4|0.3
0-19|0.2|0.5|0.3|19|Mortality|6663484|Black|Male|Soft Tissue|2002|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6670066|Black|Male|Soft Tissue|2003|~|~|~
0-19|0.2|0.3|0.2|71|Mortality|33571872|Black|Male|Soft Tissue|2003-2007|0.2|0.3|0.2
0-19|0.1|0.4|0.3|17|Mortality|6686638|Black|Male|Soft Tissue|2004|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6705972|Black|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6732249|Black|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6776947|Black|Male|Soft Tissue|2007|~|~|~
0-19|0.2|0.4|0.3|37|Mortality|12938519|Black|Male and Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13044535|Black|Male and Female|Acute Lymphocytic|2000|0.2|0.4|0.3
0-19|0.3|0.5|0.3|45|Mortality|13088308|Black|Male and Female|Acute Lymphocytic|2001|0.3|0.5|0.3
0-19|0.2|0.3|0.2|31|Mortality|13114531|Black|Male and Female|Acute Lymphocytic|2002|0.2|0.3|0.2
0-19|0.1|0.3|0.2|28|Mortality|13132454|Black|Male and Female|Acute Lymphocytic|2003|0.1|0.3|0.2
0-19|0.2|0.2|0.2|136|Mortality|66103597|Black|Male and Female|Acute Lymphocytic|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|20|Mortality|13167475|Black|Male and Female|Acute Lymphocytic|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13205707|Black|Male and Female|Acute Lymphocytic|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13256804|Black|Male and Female|Acute Lymphocytic|2006|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|13341157|Black|Male and Female|Acute Lymphocytic|2007|0.2|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|12938519|Black|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13044535|Black|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|33|Mortality|13088308|Black|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13114531|Black|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|13132454|Black|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.3|0.3|0.3|202|Mortality|66103597|Black|Male and Female|Acute Myeloid|2003-2007|0.3|0.4|0.3
0-19|0.3|0.5|0.4|48|Mortality|13167475|Black|Male and Female|Acute Myeloid|2004|0.3|0.5|0.4
0-19|0.2|0.4|0.3|37|Mortality|13205707|Black|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13256804|Black|Male and Female|Acute Myeloid|2006|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13341157|Black|Male and Female|Acute Myeloid|2007|0.2|0.4|0.3
0-19|2.7|3.3|3.0|382|Mortality|12938519|Black|Male and Female|All Cancer Sites Combined|1999|2.7|3.3|3.0
0-19|2.6|3.1|2.8|367|Mortality|13044535|Black|Male and Female|All Cancer Sites Combined|2000|2.5|3.1|2.8
0-19|2.4|2.9|2.6|343|Mortality|13088308|Black|Male and Female|All Cancer Sites Combined|2001|2.4|2.9|2.6
0-19|2.6|3.2|2.9|373|Mortality|13114531|Black|Male and Female|All Cancer Sites Combined|2002|2.6|3.1|2.8
0-19|2.3|2.8|2.5|331|Mortality|13132454|Black|Male and Female|All Cancer Sites Combined|2003|2.3|2.8|2.5
0-19|2.4|2.7|2.5|1687|Mortality|66103597|Black|Male and Female|All Cancer Sites Combined|2003-2007|2.4|2.7|2.6
0-19|2.5|3.1|2.8|368|Mortality|13167475|Black|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.4|2.9|2.6|349|Mortality|13205707|Black|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.6
0-19|2.2|2.7|2.5|326|Mortality|13256804|Black|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.5
0-19|2.1|2.6|2.3|313|Mortality|13341157|Black|Male and Female|All Cancer Sites Combined|2007|2.1|2.6|2.3
0-19|0.2|0.3|0.2|29|Mortality|12938519|Black|Male and Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|32|Mortality|13044535|Black|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13088308|Black|Male and Female|Bones and Joints|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13114531|Black|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13132454|Black|Male and Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.2|0.2|133|Mortality|66103597|Black|Male and Female|Bones and Joints|2003-2007|0.2|0.2|0.2
0-19|0.2|0.4|0.3|35|Mortality|13167475|Black|Male and Female|Bones and Joints|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|29|Mortality|13205707|Black|Male and Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|13256804|Black|Male and Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13341157|Black|Male and Female|Bones and Joints|2007|0.1|0.2|0.2
0-19|0.6|0.9|0.7|93|Mortality|12938519|Black|Male and Female|Brain and Other Nervous System|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.7|88|Mortality|13044535|Black|Male and Female|Brain and Other Nervous System|2000|0.5|0.8|0.7
0-19|0.4|0.6|0.5|67|Mortality|13088308|Black|Male and Female|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.6|0.9|0.8|100|Mortality|13114531|Black|Male and Female|Brain and Other Nervous System|2002|0.6|0.9|0.8
0-19|0.5|0.8|0.6|84|Mortality|13132454|Black|Male and Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.7|0.6|392|Mortality|66103597|Black|Male and Female|Brain and Other Nervous System|2003-2007|0.5|0.7|0.6
0-19|0.5|0.8|0.6|85|Mortality|13167475|Black|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|80|Mortality|13205707|Black|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.5|0.8|0.6|82|Mortality|13256804|Black|Male and Female|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|0.4|0.6|0.5|61|Mortality|13341157|Black|Male and Female|Brain and Other Nervous System|2007|0.3|0.6|0.5
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13044535|Black|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|13088308|Black|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|13114531|Black|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|13132454|Black|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|66103597|Black|Male and Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|13167475|Black|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|13205707|Black|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|13256804|Black|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|13341157|Black|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|0.1|0.2|0.1|16|Mortality|13044535|Black|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.2|21|Mortality|13088308|Black|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|13114531|Black|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|13132454|Black|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.1|0.1|0.1|61|Mortality|66103597|Black|Male and Female|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|13167475|Black|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|13205707|Black|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|13256804|Black|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|13341157|Black|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.7|1.0|0.8|104|Mortality|12938519|Black|Male and Female|Leukemia|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.8|100|Mortality|13044535|Black|Male and Female|Leukemia|2000|0.6|0.9|0.8
0-19|0.7|1.0|0.8|105|Mortality|13088308|Black|Male and Female|Leukemia|2001|0.7|1.0|0.8
0-19|0.6|0.9|0.7|91|Mortality|13114531|Black|Male and Female|Leukemia|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|85|Mortality|13132454|Black|Male and Female|Leukemia|2003|0.5|0.8|0.6
0-19|0.6|0.8|0.7|465|Mortality|66103597|Black|Male and Female|Leukemia|2003-2007|0.6|0.8|0.7
0-19|0.6|0.9|0.7|97|Mortality|13167475|Black|Male and Female|Leukemia|2004|0.6|0.9|0.7
0-19|0.6|0.9|0.8|100|Mortality|13205707|Black|Male and Female|Leukemia|2005|0.6|0.9|0.8
0-19|0.5|0.8|0.7|90|Mortality|13256804|Black|Male and Female|Leukemia|2006|0.5|0.8|0.7
0-19|0.6|0.9|0.7|93|Mortality|13341157|Black|Male and Female|Leukemia|2007|0.6|0.9|0.7
0-19|0.1|0.3|0.2|26|Mortality|12938519|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.3|0.2
0-19|0.1|0.2|0.1|16|Mortality|13044535|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.3|0.2|21|Mortality|13088308|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.3|0.2|23|Mortality|13114531|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13132454|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.1|89|Mortality|66103597|Black|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.1
0-19|0.1|0.2|0.1|17|Mortality|13167475|Black|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|17|Mortality|13205707|Black|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.2|0.1|19|Mortality|13256804|Black|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|13341157|Black|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.5|0.8|0.6|79|Mortality|12938519|Black|Male and Female|Other|1999|0.5|0.8|0.6
0-19|0.5|0.8|0.7|88|Mortality|13044535|Black|Male and Female|Other|2000|0.5|0.8|0.7
0-19|0.4|0.7|0.6|73|Mortality|13088308|Black|Male and Female|Other|2001|0.4|0.7|0.6
0-19|0.6|0.9|0.7|94|Mortality|13114531|Black|Male and Female|Other|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|84|Mortality|13132454|Black|Male and Female|Other|2003|0.5|0.8|0.6
0-19|0.6|0.7|0.6|402|Mortality|66103597|Black|Male and Female|Other|2003-2007|0.6|0.7|0.6
0-19|0.5|0.8|0.6|85|Mortality|13167475|Black|Male and Female|Other|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|83|Mortality|13205707|Black|Male and Female|Other|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.5|69|Mortality|13256804|Black|Male and Female|Other|2006|0.4|0.7|0.5
0-19|0.5|0.7|0.6|81|Mortality|13341157|Black|Male and Female|Other|2007|0.5|0.8|0.6
0-19|0.2|0.4|0.3|32|Mortality|12938519|Black|Male and Female|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.3|0.2|21|Mortality|13044535|Black|Male and Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13088308|Black|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13114531|Black|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.1|0.3|0.2|24|Mortality|13132454|Black|Male and Female|Soft Tissue|2003|0.1|0.3|0.2
0-19|0.2|0.2|0.2|131|Mortality|66103597|Black|Male and Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.2|0.4|0.3|37|Mortality|13167475|Black|Male and Female|Soft Tissue|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|23|Mortality|13205707|Black|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|25|Mortality|13256804|Black|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|22|Mortality|13341157|Black|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.4|0.7|0.5|32|Mortality|6382096|Hispanic|Female|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.4|0.7|0.5|34|Mortality|6663115|Hispanic|Female|Acute Lymphocytic|2000|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6866848|Hispanic|Female|Acute Lymphocytic|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.6|44|Mortality|7075381|Hispanic|Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.3|0.7|0.5|35|Mortality|7292616|Hispanic|Female|Acute Lymphocytic|2003|0.3|0.7|0.5
0-19|0.4|0.5|0.5|176|Mortality|38951862|Hispanic|Female|Acute Lymphocytic|2003-2007|0.4|0.5|0.5
0-19|0.4|0.8|0.6|41|Mortality|7525687|Hispanic|Female|Acute Lymphocytic|2004|0.4|0.7|0.5
0-19|0.3|0.6|0.4|28|Mortality|7773221|Hispanic|Female|Acute Lymphocytic|2005|0.2|0.5|0.4
0-19|0.2|0.5|0.4|28|Mortality|8040036|Hispanic|Female|Acute Lymphocytic|2006|0.2|0.5|0.3
0-19|0.4|0.7|0.6|44|Mortality|8320302|Hispanic|Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6663115|Hispanic|Female|Acute Myeloid|2000|0.1|0.4|0.2
0-19|0.2|0.4|0.3|20|Mortality|6866848|Hispanic|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|7075381|Hispanic|Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|21|Mortality|7292616|Hispanic|Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.3|0.2|95|Mortality|38951862|Hispanic|Female|Acute Myeloid|2003-2007|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|7773221|Hispanic|Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.1|0.4|0.2|19|Mortality|8040036|Hispanic|Female|Acute Myeloid|2006|0.1|0.4|0.2
0-19|0.1|0.3|0.2|17|Mortality|8320302|Hispanic|Female|Acute Myeloid|2007|0.1|0.3|0.2
0-19|2.2|3.1|2.6|166|Mortality|6382096|Hispanic|Female|All Cancer Sites Combined|1999|2.2|3.0|2.6
0-19|2.2|2.9|2.5|165|Mortality|6663115|Hispanic|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|2.3|3.2|2.7|185|Mortality|6866848|Hispanic|Female|All Cancer Sites Combined|2001|2.3|3.1|2.7
0-19|2.3|3.1|2.7|187|Mortality|7075381|Hispanic|Female|All Cancer Sites Combined|2002|2.3|3.1|2.6
0-19|2.0|2.8|2.4|174|Mortality|7292616|Hispanic|Female|All Cancer Sites Combined|2003|2.0|2.8|2.4
0-19|2.3|2.6|2.4|937|Mortality|38951862|Hispanic|Female|All Cancer Sites Combined|2003-2007|2.3|2.6|2.4
0-19|2.2|2.9|2.5|189|Mortality|7525687|Hispanic|Female|All Cancer Sites Combined|2004|2.2|2.9|2.5
0-19|2.1|2.8|2.5|186|Mortality|7773221|Hispanic|Female|All Cancer Sites Combined|2005|2.1|2.8|2.4
0-19|2.0|2.7|2.3|180|Mortality|8040036|Hispanic|Female|All Cancer Sites Combined|2006|1.9|2.6|2.2
0-19|2.2|3.0|2.6|208|Mortality|8320302|Hispanic|Female|All Cancer Sites Combined|2007|2.2|2.9|2.5
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|18|Mortality|6663115|Hispanic|Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|17|Mortality|6866848|Hispanic|Female|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7075381|Hispanic|Female|Bones and Joints|2002|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7292616|Hispanic|Female|Bones and Joints|2003|~|~|~
0-19|0.2|0.3|0.2|71|Mortality|38951862|Hispanic|Female|Bones and Joints|2003-2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Bones and Joints|2004|~|~|~
0-19|0.1|0.4|0.2|17|Mortality|7773221|Hispanic|Female|Bones and Joints|2005|0.1|0.4|0.2
0-19|0.1|0.3|0.2|16|Mortality|8040036|Hispanic|Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|8320302|Hispanic|Female|Bones and Joints|2007|~|~|~
0-19|0.5|0.9|0.6|42|Mortality|6382096|Hispanic|Female|Brain and Other Nervous System|1999|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6663115|Hispanic|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6866848|Hispanic|Female|Brain and Other Nervous System|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|38|Mortality|7075381|Hispanic|Female|Brain and Other Nervous System|2002|0.4|0.7|0.5
0-19|0.5|0.8|0.6|46|Mortality|7292616|Hispanic|Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.7|0.6|241|Mortality|38951862|Hispanic|Female|Brain and Other Nervous System|2003-2007|0.5|0.7|0.6
0-19|0.5|0.9|0.7|54|Mortality|7525687|Hispanic|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Mortality|7773221|Hispanic|Female|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|41|Mortality|8040036|Hispanic|Female|Brain and Other Nervous System|2006|0.4|0.7|0.5
0-19|0.4|0.7|0.5|44|Mortality|8320302|Hispanic|Female|Brain and Other Nervous System|2007|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6663115|Hispanic|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6866848|Hispanic|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7075381|Hispanic|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7292616|Hispanic|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|38951862|Hispanic|Female|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7773221|Hispanic|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8040036|Hispanic|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8320302|Hispanic|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6663115|Hispanic|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6866848|Hispanic|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7075381|Hispanic|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7292616|Hispanic|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.0|0.1|0.0|20|Mortality|38951862|Hispanic|Female|Kidney and Renal Pelvis|2003-2007|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|7773221|Hispanic|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|8040036|Hispanic|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8320302|Hispanic|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.8|1.4|1.1|67|Mortality|6382096|Hispanic|Female|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|63|Mortality|6663115|Hispanic|Female|Leukemia|2000|0.7|1.2|0.9
0-19|0.9|1.5|1.2|81|Mortality|6866848|Hispanic|Female|Leukemia|2001|0.9|1.5|1.2
0-19|0.8|1.3|1.0|73|Mortality|7075381|Hispanic|Female|Leukemia|2002|0.8|1.3|1.0
0-19|0.7|1.2|0.9|67|Mortality|7292616|Hispanic|Female|Leukemia|2003|0.7|1.2|0.9
0-19|0.8|1.0|0.9|343|Mortality|38951862|Hispanic|Female|Leukemia|2003-2007|0.8|1.0|0.9
0-19|0.7|1.2|1.0|71|Mortality|7525687|Hispanic|Female|Leukemia|2004|0.7|1.2|0.9
0-19|0.6|1.1|0.8|62|Mortality|7773221|Hispanic|Female|Leukemia|2005|0.6|1.0|0.8
0-19|0.6|1.0|0.8|63|Mortality|8040036|Hispanic|Female|Leukemia|2006|0.6|1.0|0.8
0-19|0.8|1.3|1.0|80|Mortality|8320302|Hispanic|Female|Leukemia|2007|0.8|1.2|1.0
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6663115|Hispanic|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6866848|Hispanic|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7075381|Hispanic|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7292616|Hispanic|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.1|0.1|0.1|31|Mortality|38951862|Hispanic|Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7773221|Hispanic|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8040036|Hispanic|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8320302|Hispanic|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|6382096|Hispanic|Female|Other|1999|0.2|0.5|0.4
0-19|0.2|0.6|0.4|25|Mortality|6663115|Hispanic|Female|Other|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6866848|Hispanic|Female|Other|2001|0.2|0.5|0.3
0-19|0.3|0.7|0.5|35|Mortality|7075381|Hispanic|Female|Other|2002|0.3|0.7|0.5
0-19|0.2|0.5|0.3|22|Mortality|7292616|Hispanic|Female|Other|2003|0.2|0.5|0.3
0-19|0.3|0.5|0.4|151|Mortality|38951862|Hispanic|Female|Other|2003-2007|0.3|0.5|0.4
0-19|0.3|0.6|0.4|30|Mortality|7525687|Hispanic|Female|Other|2004|0.3|0.6|0.4
0-19|0.2|0.5|0.3|26|Mortality|7773221|Hispanic|Female|Other|2005|0.2|0.5|0.3
0-19|0.3|0.6|0.4|31|Mortality|8040036|Hispanic|Female|Other|2006|0.3|0.5|0.4
0-19|0.4|0.7|0.5|42|Mortality|8320302|Hispanic|Female|Other|2007|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6663115|Hispanic|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6866848|Hispanic|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|7075381|Hispanic|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|7292616|Hispanic|Female|Soft Tissue|2003|~|~|~
0-19|0.2|0.2|0.2|73|Mortality|38951862|Hispanic|Female|Soft Tissue|2003-2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|7525687|Hispanic|Female|Soft Tissue|2004|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7773221|Hispanic|Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.4|0.2|18|Mortality|8040036|Hispanic|Female|Soft Tissue|2006|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|8320302|Hispanic|Female|Soft Tissue|2007|~|~|~
0-19|0.4|0.7|0.5|34|Mortality|6802550|Hispanic|Male|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.6|1.0|0.8|55|Mortality|7096427|Hispanic|Male|Acute Lymphocytic|2000|0.6|1.0|0.8
0-19|0.6|1.1|0.8|59|Mortality|7280096|Hispanic|Male|Acute Lymphocytic|2001|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|7467289|Hispanic|Male|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.7|1.1|0.9|65|Mortality|7668124|Hispanic|Male|Acute Lymphocytic|2003|0.7|1.1|0.8
0-19|0.6|0.8|0.7|272|Mortality|40869330|Hispanic|Male|Acute Lymphocytic|2003-2007|0.6|0.7|0.7
0-19|0.6|1.0|0.8|58|Mortality|7896624|Hispanic|Male|Acute Lymphocytic|2004|0.6|0.9|0.7
0-19|0.5|0.9|0.7|56|Mortality|8152179|Hispanic|Male|Acute Lymphocytic|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|44|Mortality|8428638|Hispanic|Male|Acute Lymphocytic|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|49|Mortality|8723765|Hispanic|Male|Acute Lymphocytic|2007|0.4|0.7|0.6
0-19|0.2|0.5|0.4|24|Mortality|6802550|Hispanic|Male|Acute Myeloid|1999|0.2|0.5|0.4
0-19|0.2|0.5|0.3|23|Mortality|7096427|Hispanic|Male|Acute Myeloid|2000|0.2|0.5|0.3
0-19|0.2|0.5|0.3|23|Mortality|7280096|Hispanic|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.5|0.4|26|Mortality|7467289|Hispanic|Male|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|7668124|Hispanic|Male|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.3|0.3|104|Mortality|40869330|Hispanic|Male|Acute Myeloid|2003-2007|0.2|0.3|0.3
0-19|0.2|0.5|0.3|26|Mortality|7896624|Hispanic|Male|Acute Myeloid|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|8152179|Hispanic|Male|Acute Myeloid|2005|0.1|0.4|0.2
0-19|0.1|0.3|0.2|18|Mortality|8428638|Hispanic|Male|Acute Myeloid|2006|0.1|0.3|0.2
0-19|0.1|0.4|0.2|20|Mortality|8723765|Hispanic|Male|Acute Myeloid|2007|0.1|0.4|0.2
0-19|2.5|3.3|2.8|192|Mortality|6802550|Hispanic|Male|All Cancer Sites Combined|1999|2.4|3.3|2.8
0-19|3.1|4.0|3.5|247|Mortality|7096427|Hispanic|Male|All Cancer Sites Combined|2000|3.1|3.9|3.5
0-19|2.9|3.7|3.3|233|Mortality|7280096|Hispanic|Male|All Cancer Sites Combined|2001|2.8|3.6|3.2
0-19|2.8|3.7|3.2|234|Mortality|7467289|Hispanic|Male|All Cancer Sites Combined|2002|2.7|3.6|3.1
0-19|3.3|4.2|3.7|278|Mortality|7668124|Hispanic|Male|All Cancer Sites Combined|2003|3.2|4.1|3.6
0-19|3.0|3.3|3.1|1243|Mortality|40869330|Hispanic|Male|All Cancer Sites Combined|2003-2007|2.9|3.2|3.0
0-19|2.9|3.7|3.3|248|Mortality|7896624|Hispanic|Male|All Cancer Sites Combined|2004|2.8|3.6|3.1
0-19|2.7|3.5|3.1|246|Mortality|8152179|Hispanic|Male|All Cancer Sites Combined|2005|2.7|3.4|3.0
0-19|2.4|3.1|2.7|226|Mortality|8428638|Hispanic|Male|All Cancer Sites Combined|2006|2.3|3.1|2.7
0-19|2.6|3.3|2.9|245|Mortality|8723765|Hispanic|Male|All Cancer Sites Combined|2007|2.5|3.2|2.8
0-19|0.2|0.5|0.3|21|Mortality|6802550|Hispanic|Male|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|22|Mortality|7096427|Hispanic|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|7280096|Hispanic|Male|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7467289|Hispanic|Male|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.4|0.3|19|Mortality|7668124|Hispanic|Male|Bones and Joints|2003|0.1|0.4|0.2
0-19|0.2|0.3|0.3|104|Mortality|40869330|Hispanic|Male|Bones and Joints|2003-2007|0.2|0.3|0.3
0-19|0.2|0.5|0.4|25|Mortality|7896624|Hispanic|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|21|Mortality|8152179|Hispanic|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|20|Mortality|8428638|Hispanic|Male|Bones and Joints|2006|0.1|0.4|0.2
0-19|0.1|0.4|0.2|19|Mortality|8723765|Hispanic|Male|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.4|0.8|0.6|39|Mortality|6802550|Hispanic|Male|Brain and Other Nervous System|1999|0.4|0.8|0.6
0-19|0.7|1.1|0.9|61|Mortality|7096427|Hispanic|Male|Brain and Other Nervous System|2000|0.7|1.1|0.9
0-19|0.4|0.8|0.6|40|Mortality|7280096|Hispanic|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|52|Mortality|7467289|Hispanic|Male|Brain and Other Nervous System|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.7|57|Mortality|7668124|Hispanic|Male|Brain and Other Nervous System|2003|0.6|1.0|0.7
0-19|0.5|0.7|0.6|251|Mortality|40869330|Hispanic|Male|Brain and Other Nervous System|2003-2007|0.5|0.7|0.6
0-19|0.5|0.8|0.6|48|Mortality|7896624|Hispanic|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.4|0.8|0.6|45|Mortality|8152179|Hispanic|Male|Brain and Other Nervous System|2005|0.4|0.7|0.6
0-19|0.4|0.8|0.6|51|Mortality|8428638|Hispanic|Male|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|0.4|0.7|0.6|50|Mortality|8723765|Hispanic|Male|Brain and Other Nervous System|2007|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7096427|Hispanic|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7280096|Hispanic|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7467289|Hispanic|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7668124|Hispanic|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|40869330|Hispanic|Male|Hodgkin Lymphoma|2003-2007|~|~|~
0-19|~|~|~|~|Mortality|7896624|Hispanic|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8152179|Hispanic|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8428638|Hispanic|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8723765|Hispanic|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|7096427|Hispanic|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|7280096|Hispanic|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7467289|Hispanic|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7668124|Hispanic|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.0|0.1|0.0|19|Mortality|40869330|Hispanic|Male|Kidney and Renal Pelvis|2003-2007|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|7896624|Hispanic|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|8152179|Hispanic|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|8428638|Hispanic|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8723765|Hispanic|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.9|1.4|1.1|74|Mortality|6802550|Hispanic|Male|Leukemia|1999|0.9|1.4|1.1
0-19|1.1|1.6|1.3|92|Mortality|7096427|Hispanic|Male|Leukemia|2000|1.0|1.6|1.3
0-19|1.2|1.8|1.5|106|Mortality|7280096|Hispanic|Male|Leukemia|2001|1.2|1.8|1.5
0-19|1.0|1.6|1.3|91|Mortality|7467289|Hispanic|Male|Leukemia|2002|1.0|1.5|1.2
0-19|1.1|1.7|1.4|105|Mortality|7668124|Hispanic|Male|Leukemia|2003|1.1|1.7|1.4
0-19|1.1|1.4|1.2|489|Mortality|40869330|Hispanic|Male|Leukemia|2003-2007|1.1|1.3|1.2
0-19|1.2|1.8|1.5|112|Mortality|7896624|Hispanic|Male|Leukemia|2004|1.2|1.7|1.4
0-19|1.1|1.6|1.3|103|Mortality|8152179|Hispanic|Male|Leukemia|2005|1.0|1.5|1.3
0-19|0.7|1.2|0.9|77|Mortality|8428638|Hispanic|Male|Leukemia|2006|0.7|1.1|0.9
0-19|0.9|1.4|1.1|92|Mortality|8723765|Hispanic|Male|Leukemia|2007|0.9|1.3|1.1
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7096427|Hispanic|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7280096|Hispanic|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7467289|Hispanic|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7668124|Hispanic|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|0.1|0.2|0.2|61|Mortality|40869330|Hispanic|Male|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|7896624|Hispanic|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8152179|Hispanic|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8428638|Hispanic|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8723765|Hispanic|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.3|0.6|0.4|29|Mortality|6802550|Hispanic|Male|Other|1999|0.3|0.6|0.4
0-19|0.5|0.9|0.7|49|Mortality|7096427|Hispanic|Male|Other|2000|0.5|0.9|0.7
0-19|0.3|0.6|0.4|31|Mortality|7280096|Hispanic|Male|Other|2001|0.3|0.6|0.4
0-19|0.4|0.8|0.6|46|Mortality|7467289|Hispanic|Male|Other|2002|0.5|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7668124|Hispanic|Male|Other|2003|0.5|0.9|0.7
0-19|0.5|0.6|0.6|230|Mortality|40869330|Hispanic|Male|Other|2003-2007|0.5|0.6|0.6
0-19|0.2|0.5|0.4|28|Mortality|7896624|Hispanic|Male|Other|2004|0.2|0.5|0.4
0-19|0.4|0.8|0.6|48|Mortality|8152179|Hispanic|Male|Other|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|46|Mortality|8428638|Hispanic|Male|Other|2006|0.4|0.7|0.5
0-19|0.5|0.8|0.6|54|Mortality|8723765|Hispanic|Male|Other|2007|0.5|0.8|0.6
0-19|0.1|0.4|0.2|16|Mortality|6802550|Hispanic|Male|Soft Tissue|1999|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7096427|Hispanic|Male|Soft Tissue|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7280096|Hispanic|Male|Soft Tissue|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7467289|Hispanic|Male|Soft Tissue|2002|~|~|~
0-19|0.2|0.4|0.3|21|Mortality|7668124|Hispanic|Male|Soft Tissue|2003|0.2|0.4|0.3
0-19|0.2|0.2|0.2|75|Mortality|40869330|Hispanic|Male|Soft Tissue|2003-2007|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|7896624|Hispanic|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|8152179|Hispanic|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|8428638|Hispanic|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|8723765|Hispanic|Male|Soft Tissue|2007|~|~|~
0-19|0.4|0.7|0.5|66|Mortality|13184646|Hispanic|Male and Female|Acute Lymphocytic|1999|0.4|0.6|0.5
0-19|0.5|0.8|0.7|89|Mortality|13759542|Hispanic|Male and Female|Acute Lymphocytic|2000|0.5|0.8|0.6
0-19|0.6|0.9|0.7|99|Mortality|14146944|Hispanic|Male and Female|Acute Lymphocytic|2001|0.6|0.9|0.7
0-19|0.5|0.8|0.7|91|Mortality|14542670|Hispanic|Male and Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.5|0.8|0.7|100|Mortality|14960740|Hispanic|Male and Female|Acute Lymphocytic|2003|0.5|0.8|0.7
0-19|0.5|0.6|0.6|448|Mortality|79821192|Hispanic|Male and Female|Acute Lymphocytic|2003-2007|0.5|0.6|0.6
0-19|0.5|0.8|0.7|99|Mortality|15422311|Hispanic|Male and Female|Acute Lymphocytic|2004|0.5|0.8|0.6
0-19|0.4|0.7|0.6|84|Mortality|15925400|Hispanic|Male and Female|Acute Lymphocytic|2005|0.4|0.7|0.5
0-19|0.4|0.6|0.5|72|Mortality|16468674|Hispanic|Male and Female|Acute Lymphocytic|2006|0.3|0.6|0.4
0-19|0.5|0.7|0.6|93|Mortality|17044067|Hispanic|Male and Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.2|0.4|0.3|43|Mortality|13184646|Hispanic|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|39|Mortality|13759542|Hispanic|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|14146944|Hispanic|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|45|Mortality|14542670|Hispanic|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|14960740|Hispanic|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.3|0.3|199|Mortality|79821192|Hispanic|Male and Female|Acute Myeloid|2003-2007|0.2|0.3|0.2
0-19|0.2|0.4|0.3|41|Mortality|15422311|Hispanic|Male and Female|Acute Myeloid|2004|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|15925400|Hispanic|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|37|Mortality|16468674|Hispanic|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|37|Mortality|17044067|Hispanic|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.5|3.0|2.7|358|Mortality|13184646|Hispanic|Male and Female|All Cancer Sites Combined|1999|2.4|3.0|2.7
0-19|2.8|3.4|3.0|412|Mortality|13759542|Hispanic|Male and Female|All Cancer Sites Combined|2000|2.7|3.3|3.0
0-19|2.7|3.3|3.0|418|Mortality|14146944|Hispanic|Male and Female|All Cancer Sites Combined|2001|2.7|3.3|3.0
0-19|2.7|3.3|3.0|421|Mortality|14542670|Hispanic|Male and Female|All Cancer Sites Combined|2002|2.6|3.2|2.9
0-19|2.8|3.4|3.1|452|Mortality|14960740|Hispanic|Male and Female|All Cancer Sites Combined|2003|2.7|3.3|3.0
0-19|2.7|2.9|2.8|2180|Mortality|79821192|Hispanic|Male and Female|All Cancer Sites Combined|2003-2007|2.6|2.8|2.7
0-19|2.7|3.2|2.9|437|Mortality|15422311|Hispanic|Male and Female|All Cancer Sites Combined|2004|2.6|3.1|2.8
0-19|2.5|3.1|2.8|432|Mortality|15925400|Hispanic|Male and Female|All Cancer Sites Combined|2005|2.5|3.0|2.7
0-19|2.3|2.8|2.5|406|Mortality|16468674|Hispanic|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.5
0-19|2.5|3.0|2.8|453|Mortality|17044067|Hispanic|Male and Female|All Cancer Sites Combined|2007|2.4|2.9|2.7
0-19|0.2|0.4|0.3|40|Mortality|13184646|Hispanic|Male and Female|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13759542|Hispanic|Male and Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|35|Mortality|14146944|Hispanic|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|32|Mortality|14542670|Hispanic|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.4|0.3|34|Mortality|14960740|Hispanic|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|175|Mortality|79821192|Hispanic|Male and Female|Bones and Joints|2003-2007|0.2|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|15422311|Hispanic|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.4|0.3|38|Mortality|15925400|Hispanic|Male and Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|36|Mortality|16468674|Hispanic|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.1|0.3|0.2|31|Mortality|17044067|Hispanic|Male and Female|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.5|0.7|0.6|81|Mortality|13184646|Hispanic|Male and Female|Brain and Other Nervous System|1999|0.5|0.8|0.6
0-19|0.6|0.9|0.7|100|Mortality|13759542|Hispanic|Male and Female|Brain and Other Nervous System|2000|0.6|0.9|0.7
0-19|0.4|0.7|0.6|79|Mortality|14146944|Hispanic|Male and Female|Brain and Other Nervous System|2001|0.4|0.7|0.6
0-19|0.5|0.8|0.6|90|Mortality|14542670|Hispanic|Male and Female|Brain and Other Nervous System|2002|0.5|0.8|0.6
0-19|0.6|0.8|0.7|103|Mortality|14960740|Hispanic|Male and Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|492|Mortality|79821192|Hispanic|Male and Female|Brain and Other Nervous System|2003-2007|0.6|0.7|0.6
0-19|0.5|0.8|0.7|102|Mortality|15422311|Hispanic|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.7
0-19|0.5|0.8|0.6|101|Mortality|15925400|Hispanic|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.5|92|Mortality|16468674|Hispanic|Male and Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.4|0.7|0.6|94|Mortality|17044067|Hispanic|Male and Female|Brain and Other Nervous System|2007|0.4|0.7|0.6
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13759542|Hispanic|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|14146944|Hispanic|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|14542670|Hispanic|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|14960740|Hispanic|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|0.0|0.0|0.0|21|Mortality|79821192|Hispanic|Male and Female|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|15422311|Hispanic|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|15925400|Hispanic|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|16468674|Hispanic|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|17044067|Hispanic|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|13759542|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|14146944|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|14542670|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|14960740|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|0.0|0.1|0.0|39|Mortality|79821192|Hispanic|Male and Female|Kidney and Renal Pelvis|2003-2007|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|15422311|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|15925400|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|16468674|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|17044067|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.9|1.3|1.1|141|Mortality|13184646|Hispanic|Male and Female|Leukemia|1999|0.9|1.3|1.1
0-19|1.0|1.3|1.2|155|Mortality|13759542|Hispanic|Male and Female|Leukemia|2000|1.0|1.3|1.1
0-19|1.2|1.6|1.3|187|Mortality|14146944|Hispanic|Male and Female|Leukemia|2001|1.1|1.5|1.3
0-19|1.0|1.4|1.2|164|Mortality|14542670|Hispanic|Male and Female|Leukemia|2002|1.0|1.3|1.1
0-19|1.0|1.3|1.2|172|Mortality|14960740|Hispanic|Male and Female|Leukemia|2003|1.0|1.3|1.1
0-19|1.0|1.2|1.1|832|Mortality|79821192|Hispanic|Male and Female|Leukemia|2003-2007|1.0|1.1|1.0
0-19|1.1|1.4|1.2|183|Mortality|15422311|Hispanic|Male and Female|Leukemia|2004|1.0|1.4|1.2
0-19|0.9|1.3|1.1|165|Mortality|15925400|Hispanic|Male and Female|Leukemia|2005|0.9|1.2|1.0
0-19|0.7|1.0|0.9|140|Mortality|16468674|Hispanic|Male and Female|Leukemia|2006|0.7|1.0|0.9
0-19|0.9|1.2|1.1|172|Mortality|17044067|Hispanic|Male and Female|Leukemia|2007|0.9|1.2|1.0
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13759542|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.2|0.1|17|Mortality|14146944|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|14542670|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.1|20|Mortality|14960740|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.1|92|Mortality|79821192|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|0.1|0.2|0.1|20|Mortality|15422311|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|15925400|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.2|0.1|19|Mortality|16468674|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|17044067|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.3|0.5|0.4|52|Mortality|13184646|Hispanic|Male and Female|Other|1999|0.3|0.5|0.4
0-19|0.4|0.7|0.5|74|Mortality|13759542|Hispanic|Male and Female|Other|2000|0.4|0.7|0.5
0-19|0.3|0.5|0.4|52|Mortality|14146944|Hispanic|Male and Female|Other|2001|0.3|0.5|0.4
0-19|0.4|0.7|0.6|81|Mortality|14542670|Hispanic|Male and Female|Other|2002|0.4|0.7|0.6
0-19|0.4|0.6|0.5|76|Mortality|14960740|Hispanic|Male and Female|Other|2003|0.4|0.6|0.5
0-19|0.4|0.5|0.5|381|Mortality|79821192|Hispanic|Male and Female|Other|2003-2007|0.4|0.5|0.5
0-19|0.3|0.5|0.4|58|Mortality|15422311|Hispanic|Male and Female|Other|2004|0.3|0.5|0.4
0-19|0.4|0.6|0.5|74|Mortality|15925400|Hispanic|Male and Female|Other|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|77|Mortality|16468674|Hispanic|Male and Female|Other|2006|0.4|0.6|0.5
0-19|0.5|0.7|0.6|96|Mortality|17044067|Hispanic|Male and Female|Other|2007|0.5|0.7|0.6
0-19|0.1|0.3|0.2|24|Mortality|13184646|Hispanic|Male and Female|Soft Tissue|1999|0.1|0.3|0.2
0-19|0.1|0.3|0.2|26|Mortality|13759542|Hispanic|Male and Female|Soft Tissue|2000|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|14146944|Hispanic|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|14542670|Hispanic|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.2|35|Mortality|14960740|Hispanic|Male and Female|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|148|Mortality|79821192|Hispanic|Male and Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|25|Mortality|15422311|Hispanic|Male and Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|15925400|Hispanic|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|30|Mortality|16468674|Hispanic|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|28|Mortality|17044067|Hispanic|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.4|0.3|92|Mortality|30457609|White|Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.3|0.4|0.4|108|Mortality|30580565|White|Female|Acute Lymphocytic|2000|0.3|0.4|0.4
0-19|0.3|0.4|0.3|99|Mortality|30639368|White|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.5|0.4|115|Mortality|30696071|White|Female|Acute Lymphocytic|2002|0.3|0.4|0.4
0-19|0.3|0.4|0.3|101|Mortality|30763390|White|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.3|0.3|0.3|490|Mortality|154594678|White|Female|Acute Lymphocytic|2003-2007|0.3|0.3|0.3
0-19|0.3|0.4|0.3|103|Mortality|30857914|White|Female|Acute Lymphocytic|2004|0.3|0.4|0.3
0-19|0.2|0.3|0.3|84|Mortality|30906558|White|Female|Acute Lymphocytic|2005|0.2|0.3|0.3
0-19|0.3|0.4|0.3|96|Mortality|30977009|White|Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.3|106|Mortality|31089807|White|Female|Acute Lymphocytic|2007|0.3|0.4|0.3
0-19|0.2|0.3|0.3|83|Mortality|30457609|White|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|76|Mortality|30580565|White|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.4|0.3|94|Mortality|30639368|White|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|76|Mortality|30696071|White|Female|Acute Myeloid|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|30763390|White|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|343|Mortality|154594678|White|Female|Acute Myeloid|2003-2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|69|Mortality|30857914|White|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|78|Mortality|30906558|White|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|67|Mortality|30977009|White|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|31089807|White|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.3|2.7|2.5|760|Mortality|30457609|White|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.7|2.5|767|Mortality|30580565|White|Female|All Cancer Sites Combined|2000|2.3|2.7|2.5
0-19|2.4|2.8|2.6|803|Mortality|30639368|White|Female|All Cancer Sites Combined|2001|2.4|2.8|2.6
0-19|2.4|2.7|2.5|776|Mortality|30696071|White|Female|All Cancer Sites Combined|2002|2.4|2.7|2.5
0-19|2.3|2.6|2.5|756|Mortality|30763390|White|Female|All Cancer Sites Combined|2003|2.3|2.6|2.5
0-19|2.3|2.5|2.4|3679|Mortality|154594678|White|Female|All Cancer Sites Combined|2003-2007|2.3|2.5|2.4
0-19|2.3|2.6|2.4|753|Mortality|30857914|White|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.6|2.4|741|Mortality|30906558|White|Female|All Cancer Sites Combined|2005|2.2|2.6|2.4
0-19|2.0|2.4|2.2|676|Mortality|30977009|White|Female|All Cancer Sites Combined|2006|2.0|2.4|2.2
0-19|2.3|2.6|2.4|753|Mortality|31089807|White|Female|All Cancer Sites Combined|2007|2.3|2.6|2.4
0-19|0.2|0.3|0.2|74|Mortality|30457609|White|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|30580565|White|Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|64|Mortality|30639368|White|Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|72|Mortality|30696071|White|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|53|Mortality|30763390|White|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.2|0.2|311|Mortality|154594678|White|Female|Bones and Joints|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|55|Mortality|30857914|White|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|77|Mortality|30906558|White|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|58|Mortality|30977009|White|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.3|0.2|68|Mortality|31089807|White|Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.6|0.8|0.7|201|Mortality|30457609|White|Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.5|0.7|0.6|189|Mortality|30580565|White|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.8|0.7|209|Mortality|30639368|White|Female|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.5|0.7|0.6|191|Mortality|30696071|White|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|220|Mortality|30763390|White|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1015|Mortality|154594678|White|Female|Brain and Other Nervous System|2003-2007|0.6|0.7|0.7
0-19|0.6|0.7|0.6|199|Mortality|30857914|White|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.6|0.8|0.7|204|Mortality|30906558|White|Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.5|0.7|0.6|177|Mortality|30977009|White|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.8|0.7|215|Mortality|31089807|White|Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|~|~|~|~|Mortality|30457609|White|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|0.0|0.1|0.1|16|Mortality|30580565|White|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|30639368|White|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|30696071|White|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|30763390|White|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|0.0|0.0|0.0|38|Mortality|154594678|White|Female|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|30857914|White|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|30906558|White|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|30977009|White|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|31089807|White|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|0.0|0.1|0.1|20|Mortality|30457609|White|Female|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|30580565|White|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30639368|White|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30696071|White|Female|Kidney and Renal Pelvis|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30763390|White|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|123|Mortality|154594678|White|Female|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30857914|White|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30906558|White|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|30977009|White|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31089807|White|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.7|0.9|0.8|238|Mortality|30457609|White|Female|Leukemia|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|253|Mortality|30580565|White|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.8|1.0|0.9|265|Mortality|30639368|White|Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|236|Mortality|30696071|White|Female|Leukemia|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|227|Mortality|30763390|White|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.7|0.7|0.7|1091|Mortality|154594678|White|Female|Leukemia|2003-2007|0.7|0.7|0.7
0-19|0.6|0.8|0.7|222|Mortality|30857914|White|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|206|Mortality|30906558|White|Female|Leukemia|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|216|Mortality|30977009|White|Female|Leukemia|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|220|Mortality|31089807|White|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.0|0.1|0.1|22|Mortality|30457609|White|Female|Non-Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30580565|White|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30639368|White|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30696071|White|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|26|Mortality|30763390|White|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|109|Mortality|154594678|White|Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30857914|White|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30906558|White|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|30977009|White|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.0|0.1|0.1|23|Mortality|31089807|White|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.4|0.6|0.5|149|Mortality|30457609|White|Female|Other|1999|0.4|0.6|0.5
0-19|0.4|0.6|0.5|151|Mortality|30580565|White|Female|Other|2000|0.4|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|30639368|White|Female|Other|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|30696071|White|Female|Other|2002|0.4|0.6|0.5
0-19|0.4|0.5|0.5|141|Mortality|30763390|White|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.5|0.5|711|Mortality|154594678|White|Female|Other|2003-2007|0.4|0.5|0.5
0-19|0.4|0.6|0.5|157|Mortality|30857914|White|Female|Other|2004|0.4|0.6|0.5
0-19|0.3|0.5|0.4|128|Mortality|30906558|White|Female|Other|2005|0.3|0.5|0.4
0-19|0.4|0.5|0.5|142|Mortality|30977009|White|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|143|Mortality|31089807|White|Female|Other|2007|0.4|0.5|0.5
0-19|0.1|0.2|0.1|43|Mortality|30457609|White|Female|Soft Tissue|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|30580565|White|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|50|Mortality|30639368|White|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|59|Mortality|30696071|White|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|51|Mortality|30763390|White|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.2|0.2|0.2|281|Mortality|154594678|White|Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|58|Mortality|30857914|White|Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|73|Mortality|30906558|White|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|44|Mortality|30977009|White|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|55|Mortality|31089807|White|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.4|0.5|0.4|144|Mortality|32187349|White|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.5|0.6|0.5|176|Mortality|32318595|White|Male|Acute Lymphocytic|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|32376289|White|Male|Acute Lymphocytic|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|32408077|White|Male|Acute Lymphocytic|2002|0.4|0.6|0.5
0-19|0.5|0.6|0.6|180|Mortality|32438710|White|Male|Acute Lymphocytic|2003|0.5|0.6|0.6
0-19|0.4|0.5|0.5|748|Mortality|162834466|White|Male|Acute Lymphocytic|2003-2007|0.4|0.5|0.5
0-19|0.4|0.5|0.5|151|Mortality|32512352|White|Male|Acute Lymphocytic|2004|0.4|0.5|0.5
0-19|0.4|0.5|0.4|146|Mortality|32548989|White|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.5|0.4|129|Mortality|32612779|White|Male|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.4|0.5|0.4|142|Mortality|32721636|White|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.2|0.3|0.2|75|Mortality|32187349|White|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|95|Mortality|32318595|White|Male|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.3|0.3|89|Mortality|32376289|White|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32408077|White|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|84|Mortality|32438710|White|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|414|Mortality|162834466|White|Male|Acute Myeloid|2003-2007|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32512352|White|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32548989|White|Male|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|84|Mortality|32612779|White|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32721636|White|Male|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.9|3.3|3.1|994|Mortality|32187349|White|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1032|Mortality|32318595|White|Male|All Cancer Sites Combined|2000|3.0|3.4|3.2
0-19|2.8|3.2|3.0|971|Mortality|32376289|White|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1006|Mortality|32408077|White|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1041|Mortality|32438710|White|Male|All Cancer Sites Combined|2003|3.0|3.4|3.2
0-19|2.9|3.1|3.0|4850|Mortality|162834466|White|Male|All Cancer Sites Combined|2003-2007|2.9|3.1|3.0
0-19|2.9|3.3|3.1|995|Mortality|32512352|White|Male|All Cancer Sites Combined|2004|2.9|3.3|3.1
0-19|2.9|3.2|3.0|993|Mortality|32548989|White|Male|All Cancer Sites Combined|2005|2.9|3.2|3.1
0-19|2.6|3.0|2.8|925|Mortality|32612779|White|Male|All Cancer Sites Combined|2006|2.7|3.0|2.8
0-19|2.6|2.9|2.7|896|Mortality|32721636|White|Male|All Cancer Sites Combined|2007|2.6|2.9|2.7
0-19|0.2|0.4|0.3|94|Mortality|32187349|White|Male|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.3|0.3|82|Mortality|32318595|White|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.4|0.3|95|Mortality|32376289|White|Male|Bones and Joints|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|79|Mortality|32408077|White|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.3|0.4|0.3|103|Mortality|32438710|White|Male|Bones and Joints|2003|0.3|0.4|0.3
0-19|0.2|0.3|0.3|450|Mortality|162834466|White|Male|Bones and Joints|2003-2007|0.3|0.3|0.3
0-19|0.2|0.3|0.3|92|Mortality|32512352|White|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.4|0.3|98|Mortality|32548989|White|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|80|Mortality|32612779|White|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|32721636|White|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.6|0.8|0.7|230|Mortality|32187349|White|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|248|Mortality|32318595|White|Male|Brain and Other Nervous System|2000|0.7|0.9|0.8
0-19|0.6|0.8|0.7|219|Mortality|32376289|White|Male|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.7|0.9|0.8|249|Mortality|32408077|White|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.9|0.8|250|Mortality|32438710|White|Male|Brain and Other Nervous System|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1187|Mortality|162834466|White|Male|Brain and Other Nervous System|2003-2007|0.7|0.8|0.7
0-19|0.7|0.8|0.7|241|Mortality|32512352|White|Male|Brain and Other Nervous System|2004|0.7|0.8|0.7
0-19|0.6|0.8|0.7|234|Mortality|32548989|White|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|238|Mortality|32612779|White|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|224|Mortality|32721636|White|Male|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.0|0.1|0.1|21|Mortality|32187349|White|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32318595|White|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|32376289|White|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.1|17|Mortality|32408077|White|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32438710|White|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|0.0|0.0|0.0|52|Mortality|162834466|White|Male|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|32512352|White|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|32548989|White|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|32612779|White|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|32721636|White|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|0.0|0.1|0.1|24|Mortality|32187349|White|Male|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|32318595|White|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32376289|White|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|0.0|0.1|0.1|17|Mortality|32408077|White|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|32438710|White|Male|Kidney and Renal Pelvis|2003|0.0|0.1|0.1
0-19|0.0|0.1|0.1|95|Mortality|162834466|White|Male|Kidney and Renal Pelvis|2003-2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|32512352|White|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32548989|White|Male|Kidney and Renal Pelvis|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32612779|White|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32721636|White|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.8|1.0|0.9|296|Mortality|32187349|White|Male|Leukemia|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|343|Mortality|32318595|White|Male|Leukemia|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|321|Mortality|32376289|White|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|310|Mortality|32408077|White|Male|Leukemia|2002|0.9|1.1|1.0
0-19|0.9|1.2|1.0|335|Mortality|32438710|White|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.9|1.0|0.9|1520|Mortality|162834466|White|Male|Leukemia|2003-2007|0.9|1.0|0.9
0-19|0.9|1.1|1.0|310|Mortality|32512352|White|Male|Leukemia|2004|0.9|1.1|1.0
0-19|0.8|1.0|0.9|302|Mortality|32548989|White|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|1.0|0.9|284|Mortality|32612779|White|Male|Leukemia|2006|0.8|1.0|0.9
0-19|0.8|1.0|0.9|289|Mortality|32721636|White|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.1|0.2|0.2|53|Mortality|32187349|White|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.3|0.2|66|Mortality|32318595|White|Male|Non-Hodgkin Lymphoma|2000|0.2|0.3|0.2
0-19|0.1|0.2|0.2|56|Mortality|32376289|White|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32408077|White|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.1|48|Mortality|32438710|White|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.2|262|Mortality|162834466|White|Male|Non-Hodgkin Lymphoma|2003-2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|54|Mortality|32512352|White|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32548989|White|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|54|Mortality|32612779|White|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|45|Mortality|32721636|White|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.5|0.7|0.6|203|Mortality|32187349|White|Male|Other|1999|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32318595|White|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|187|Mortality|32376289|White|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|214|Mortality|32408077|White|Male|Other|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|200|Mortality|32438710|White|Male|Other|2003|0.5|0.7|0.6
0-19|0.6|0.6|0.6|971|Mortality|162834466|White|Male|Other|2003-2007|0.6|0.6|0.6
0-19|0.5|0.7|0.6|205|Mortality|32512352|White|Male|Other|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32548989|White|Male|Other|2005|0.6|0.7|0.6
0-19|0.4|0.6|0.5|168|Mortality|32612779|White|Male|Other|2006|0.4|0.6|0.5
0-19|0.5|0.7|0.6|190|Mortality|32721636|White|Male|Other|2007|0.5|0.7|0.6
0-19|0.2|0.3|0.2|73|Mortality|32187349|White|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32318595|White|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|65|Mortality|32376289|White|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.1|0.2|0.2|59|Mortality|32408077|White|Male|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.3|0.2|70|Mortality|32438710|White|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|313|Mortality|162834466|White|Male|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.1|0.2|0.2|62|Mortality|32512352|White|Male|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|57|Mortality|32548989|White|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.3|0.2|67|Mortality|32612779|White|Male|Soft Tissue|2006|0.2|0.3|0.2
0-19|0.1|0.2|0.2|57|Mortality|32721636|White|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.3|0.4|0.4|236|Mortality|62644958|White|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.5|284|Mortality|62899160|White|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.5
0-19|0.4|0.5|0.4|253|Mortality|63015657|White|Male and Female|Acute Lymphocytic|2001|0.4|0.5|0.4
0-19|0.4|0.5|0.4|273|Mortality|63104148|White|Male and Female|Acute Lymphocytic|2002|0.4|0.5|0.4
0-19|0.4|0.5|0.4|281|Mortality|63202100|White|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.4|0.4|0.4|1238|Mortality|317429144|White|Male and Female|Acute Lymphocytic|2003-2007|0.4|0.4|0.4
0-19|0.4|0.5|0.4|254|Mortality|63370266|White|Male and Female|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.3|0.4|0.4|230|Mortality|63455547|White|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.4
0-19|0.3|0.4|0.4|225|Mortality|63589788|White|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.3|0.4|0.4|248|Mortality|63811443|White|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.2|0.3|0.3|158|Mortality|62644958|White|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|171|Mortality|62899160|White|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.3|0.3|0.3|183|Mortality|63015657|White|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|162|Mortality|63104148|White|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63202100|White|Male and Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|757|Mortality|317429144|White|Male and Female|Acute Myeloid|2003-2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|155|Mortality|63370266|White|Male and Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|158|Mortality|63455547|White|Male and Female|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|151|Mortality|63589788|White|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|142|Mortality|63811443|White|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|2.7|2.9|2.8|1754|Mortality|62644958|White|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|3.0|2.9|1799|Mortality|62899160|White|Male and Female|All Cancer Sites Combined|2000|2.7|3.0|2.9
0-19|2.7|2.9|2.8|1774|Mortality|63015657|White|Male and Female|All Cancer Sites Combined|2001|2.7|2.9|2.8
0-19|2.7|3.0|2.8|1782|Mortality|63104148|White|Male and Female|All Cancer Sites Combined|2002|2.7|3.0|2.8
0-19|2.7|3.0|2.8|1797|Mortality|63202100|White|Male and Female|All Cancer Sites Combined|2003|2.7|3.0|2.8
0-19|2.6|2.7|2.7|8529|Mortality|317429144|White|Male and Female|All Cancer Sites Combined|2003-2007|2.6|2.7|2.7
0-19|2.6|2.9|2.8|1748|Mortality|63370266|White|Male and Female|All Cancer Sites Combined|2004|2.6|2.9|2.8
0-19|2.6|2.9|2.7|1734|Mortality|63455547|White|Male and Female|All Cancer Sites Combined|2005|2.6|2.9|2.7
0-19|2.4|2.6|2.5|1601|Mortality|63589788|White|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.5|2.7|2.6|1649|Mortality|63811443|White|Male and Female|All Cancer Sites Combined|2007|2.5|2.7|2.6
0-19|0.2|0.3|0.3|168|Mortality|62644958|White|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|144|Mortality|62899160|White|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|159|Mortality|63015657|White|Male and Female|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63104148|White|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|156|Mortality|63202100|White|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|761|Mortality|317429144|White|Male and Female|Bones and Joints|2003-2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|147|Mortality|63370266|White|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|175|Mortality|63455547|White|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|138|Mortality|63589788|White|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|145|Mortality|63811443|White|Male and Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.6|0.8|0.7|431|Mortality|62644958|White|Male and Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|437|Mortality|62899160|White|Male and Female|Brain and Other Nervous System|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.7|428|Mortality|63015657|White|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|440|Mortality|63104148|White|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|470|Mortality|63202100|White|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.7|0.7|0.7|2202|Mortality|317429144|White|Male and Female|Brain and Other Nervous System|2003-2007|0.7|0.7|0.7
0-19|0.6|0.8|0.7|440|Mortality|63370266|White|Male and Female|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|438|Mortality|63455547|White|Male and Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|415|Mortality|63589788|White|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.7
0-19|0.6|0.8|0.7|439|Mortality|63811443|White|Male and Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.0|0.1|0.1|34|Mortality|62644958|White|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|22|Mortality|62899160|White|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63015657|White|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63104148|White|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|20|Mortality|63202100|White|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|90|Mortality|317429144|White|Male and Female|Hodgkin Lymphoma|2003-2007|0.0|0.0|0.0
0-19|0.0|0.0|0.0|20|Mortality|63370266|White|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63455547|White|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63589788|White|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|63811443|White|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|0.1|0.1|0.1|44|Mortality|62644958|White|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|35|Mortality|62899160|White|Male and Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63015657|White|Male and Female|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63104148|White|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|53|Mortality|63202100|White|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|218|Mortality|317429144|White|Male and Female|Kidney and Renal Pelvis|2003-2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|48|Mortality|63370266|White|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|45|Mortality|63455547|White|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63589788|White|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|31|Mortality|63811443|White|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.8|0.9|0.9|534|Mortality|62644958|White|Male and Female|Leukemia|1999|0.8|0.9|0.9
0-19|0.9|1.0|0.9|596|Mortality|62899160|White|Male and Female|Leukemia|2000|0.9|1.0|0.9
0-19|0.9|1.0|0.9|586|Mortality|63015657|White|Male and Female|Leukemia|2001|0.9|1.0|0.9
0-19|0.8|0.9|0.9|546|Mortality|63104148|White|Male and Female|Leukemia|2002|0.8|0.9|0.9
0-19|0.8|1.0|0.9|562|Mortality|63202100|White|Male and Female|Leukemia|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|2611|Mortality|317429144|White|Male and Female|Leukemia|2003-2007|0.8|0.9|0.8
0-19|0.8|0.9|0.8|532|Mortality|63370266|White|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.9|0.8|508|Mortality|63455547|White|Male and Female|Leukemia|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|500|Mortality|63589788|White|Male and Female|Leukemia|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|509|Mortality|63811443|White|Male and Female|Leukemia|2007|0.7|0.9|0.8
0-19|0.1|0.2|0.1|75|Mortality|62644958|White|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|90|Mortality|62899160|White|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|78|Mortality|63015657|White|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|88|Mortality|63104148|White|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.1|0.1|74|Mortality|63202100|White|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|371|Mortality|317429144|White|Male and Female|Non-Hodgkin Lymphoma|2003-2007|0.1|0.1|0.1
0-19|0.1|0.2|0.1|79|Mortality|63370266|White|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|83|Mortality|63455547|White|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|67|Mortality|63589788|White|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|68|Mortality|63811443|White|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.5|0.6|0.6|352|Mortality|62644958|White|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|359|Mortality|62899160|White|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|341|Mortality|63015657|White|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.5|0.7|0.6|372|Mortality|63104148|White|Male and Female|Other|2002|0.5|0.7|0.6
0-19|0.5|0.6|0.5|341|Mortality|63202100|White|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.5|1682|Mortality|317429144|White|Male and Female|Other|2003-2007|0.5|0.6|0.5
0-19|0.5|0.6|0.6|362|Mortality|63370266|White|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|336|Mortality|63455547|White|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.4|0.5|0.5|310|Mortality|63589788|White|Male and Female|Other|2006|0.4|0.5|0.5
0-19|0.5|0.6|0.5|333|Mortality|63811443|White|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.2|0.2|0.2|116|Mortality|62644958|White|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|116|Mortality|62899160|White|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|115|Mortality|63015657|White|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|118|Mortality|63104148|White|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|121|Mortality|63202100|White|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|594|Mortality|317429144|White|Male and Female|Soft Tissue|2003-2007|0.2|0.2|0.2
0-19|0.2|0.2|0.2|120|Mortality|63370266|White|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|130|Mortality|63455547|White|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|111|Mortality|63589788|White|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|112|Mortality|63811443|White|Male and Female|Soft Tissue|2007|0.1|0.2|0.2